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ABSTRACT 
 
The ubiquitous presence of anthropogenic chemicals and their transformation products in 
surface water represents a toxicological concern from both an ecological standpoint and a human 
perspective as many of these chemicals are capable of altering hormonal function. Endocrine 
disrupting compounds can be traced back to numerous sources and may fall under the class of 
pesticide, industrial chemical, pharmaceutical, personal care product, and/or heavy metals. The 
adrenal gland is the most common target for endocrine disruptors, although in comparison to the 
sex steroids, this system has received much less attention in published research. Corticosteroids 
play a pivotal role in many physiological processes, including immunity, cognitive function, 
growth, metabolism, reproduction, mineral balance, and blood pressure. A primary cell culture of 
rainbow trout adrenocortical cells was used to investigate the endocrine disrupting activity of two 
commonly detected water-borne toxicants, a personal care product, triclosan (TCS), a pesticide, 
dichlorophenoxyacetic acid (2,4-D), and their transformation products, methyl-triclosan (M-TCS) 
and dichlorophenol (DCP). Previously, it has been shown that TCS, 2,4-D, and DCP exhibit a 
potential for endocrine disruption, although it is currently unknown if these chemicals are capable 
of affecting corticosteroid balance. In this study, all four chemicals showed significant inhibitory 
effects on corticosteroid synthesis, even though there were considerable differences in their 
activity. The chemical that exhibited the highest toxicity was 2,4-D, followed by TCS, DCP, and 
M-TCS. Both parent-compounds proved to be more toxic than their degradation products. More 
research with suitable test systems is needed to determine the mechanism(s) of action of these 
corticosteroid disruptors and the health risk that they may present. 
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CHAPTER 1. TRICLOSAN, 2,4-D, AND THEIR BY-PRODUCTS: 
KNOWLEDGE GAPS AND RESEARCH OBJECTIVES 
 
1.1 Introduction 
 
There exists a number of different pathways for anthropogenic chemicals to enter the 
aquatic environment. The primary source(s) of water-borne toxicants include municipal and 
industrial wastewater, non-point source runoff and atmospheric deposition (Campbell et al., 
2006). Once in the aquatic environment, chemicals may undergo a number of different 
degradation processes to produce by-products (Lin et al., 2006). Water-borne chemicals are 
widely distributed in surface water around the world and are typically detected in the ng l-1 to µg 
l-1 range. Many classes of chemicals, such as pharmaceuticals, pesticides, industrial chemicals, 
and phytochemicals have a ubiquitous presence in most rivers and streams (Kolpin et al., 2002). 
Accordingly, fish and other aquatic biota are chronically exposed to varying levels of potentially 
biologically active water-borne toxicants. Many of these chemicals are capable of interfering with 
the endocrine systems of non-target species. Endocrine disrupting compounds (EDCs) represent a 
class of environmental toxicants that interfere with synthesis, secretion, transport, binding, action, 
or elimination of endogenous hormones (Crisp et al., 1998). Chlorinated insecticides, herbicides, 
PCB’s, plasticizers, and xenoestrogens have all been shown to alter steroidogenesis, the 
biosynthesis of steroid hormones (Andersen and Barton, 1999; Matozzo et al., 2008). More 
research is needed to determine the effects of complex mixtures of water-borne toxicants on non-
target species, particularly fish. 
The most common target organ for endocrine disruption is the adrenal gland (Harvey et 
al., 2007). Until recently, the bulk of research on how chemicals in the environment alter 
hormone function has been narrowly focused upon the sex steroids. The number of toxicants that 
interfere with the function of the adrenal gland is extensive, ranging from heavy metals (Lacroix  
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Figure 1.1. Schematic representation of the different processes and compartments that need to be 
monitored to characterize the fate and transport of EDCs in the environment (adapted from 
Campbell et al., 2006). 
 
and Hontela, 2004) to organochlorides (Brogan et al., 1984), to aromatic hydrocarbons 
(Engelhardt et al., 1991). To investigate adrenal toxicity in vitro, the H295 adrenocortical 
carcinoma cell line is commonly studied and is particularly helpful for the isolation of molecular 
targets for steroidogenic disruption. Corticosteroid production occurs in the cortex of the adrenal 
gland, or the interrenal cells of fish and amphibians. The biosynthesis of cortisol is regulated by 
adrenocorticotropin hormone (ACTH), which is released from the anterior pituitary under the 
control of the hypothalamus, via corticotrophin releasing hormone (CRH) (Mommsen et al., 
1999). In fish, corticosteroids play an important role in mediating the stress response, but are also 
essential for the regulation of growth, reproduction, immune function, osmoregulation, cell 
proliferation and differentiation (Mommsen et al., 1999). The importance of corticosteroids in 
biological processes must not be underestimated. Abnormal levels of corticosteroids are 
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implicated in a number of diseases, including osteoporosis, cataract formation, obesity, type 2 
diabetes, cardiovascular, inflammatory, and autoimmune disease (Carnahan and Goldstein, 2000; 
Cooper 2004; Freel and Connell, 2004; Rosmond 2005). 
While the adrenal gland of mammals is identical in function to the cortisol producing 
interrenal cells of teleost fish, important structural differences do exist. Adrenal tissue in 
mammals is situated in a compact, highly vascularized gland, whereas in fish and amphibians, 
corticosteroid producing cells are diffusely located in the interrenal tissue (Hinson and Raven, 
2006). Based on these structural differences, it would seem that in order to most accurately assess 
the impact of water-borne toxicants on the biosynthetic pathways of cortisol production in fish, a 
fish cell culture should be favoured over more frequently used mammalian cell lines, including 
the H295 cells. According to Mommsen et al. (1999), researchers should refrain from using 
mammalian models to explain the stress response in fish, because the differences between 
mammals and fish are too great to allow for such generalizations. A primary cell culture of 
rainbow trout interrenal cells was developed by Leblond and Hontela (1999), for a species 
specific model for use in endocrine toxicology testing. This model has been used successfully to 
screen for a number of different chemicals that target the HPI (hypothalamus-pituitary-interrenal) 
axis (Goulet and Hontela, 2003; LeBlond and Hontela, 1999; Hontela and Vijayan, 2009). Fish 
cultures of interrenal cells constitute an excellent tool for the screening of EDCs, in addition to 
being well-suited for studies seeking to elucidate the molecular mechanisms of HPI toxicity.  In 
the present study, the potential of a personal care product (Triclosan,TCS), an herbicide (2,4-D) 
and their by-products, to disrupt the synthesis of cortisol, the corticosteroid hormone of teleost 
fish, will be assessed in vitro using the primary culture of rainbow trout interrenal cells.    
 
1.2 Triclosan 
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1.2.1 Properties and Sources 
Triclosan [TCS; (5-chloro-2-(2,4-dichlorophenoxy)phenol], a halogenated phenol, is a 
commonly used antimicrobial that is incorporated into dish soap, detergent, toothpaste, 
mouthwash, hand soap, fabric, deodorant, and shampoo, in addition to innumerable other 
personal care and household products (see Chapter 2, review by Dann and Hontela, 2011). TCS is 
the generic name for the chemical and brand names include Irgasan DP300, Aquasept, 
Gamophen, Sapoderm, and Ster-Zac (Merck Index, 2006). TCS is lipophilic, as evidenced by its 
octanol/water partition coefficient of 4.8 (Adolfsson-Erici et al., 2002), giving it the potential to 
bioaccumulate in aquatic species. Most of the products containing TCS are washed down 
residential drains, eventually entering waste water treatment plants (WWTP). As such, there is 
concern about the fate of TCS during the sewage treatment process. This concern is well 
warranted, as TCS is one of the most frequently detected organic wastewater contaminants in 
North America, having been detected in 57.6% of US streams and rivers (Kolpin et al., 2002). 
TCS’s presence in surface water is ubiquitous around the world (Kolpin et al., 2002; Bester, 
2005; Nakada et al., 2008). 
1.2.2 Occurrence in the Aquatic Environment 
In samples collected from a water treatment facility in Ontario, influent concentrations of 
TCS ranged from 0.01-4.01 µg/L, with corresponding effluent concentrations being reduced to 
0.01-0.324 µg l-1. According to this particular study, the reduction of TCS ranged from 74% to 
98% (Lishman et al., 2006). These results are consistent with tests conducted at several WWTPs 
in Switzerland and Germany, where 4% to 10% of TCS remained dissolved in out-flowing water 
(Singer et al., 2002; Bester, 2003). Field measurements from a Swiss WWTP have detailed the 
elimination process of TCS; 79% was biologically degraded, 15% was sorped to sludge, and 6% 
left the plant in the final effluent at a concentration of 42 ng l-1 (Singer et al., 2002). Levels of 
TCS in Canadian surface waters (Servos et al., 2007) are similar to those reported elsewhere in 
the world.  
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1.2.3 Environmental Behavior of Triclosan 
The environmental fate of TCS is not completely understood, although during the sewage 
treatment process, a small percentage of TCS is methylated to form Methyl-Triclosan (M-TCS). 
Approximately 20-30% of TCS that is released from WWTPs is converted into M-TCS (Bester 
2005). However, in addition to M-TCS, the photodegradation of TCS produces several toxic 
transformation products. These include 2,7/2,8-dibenzodichloro-p-dioxin, toxic chlorophenols; 
2,4-dichlorophenol and 2,4,6-trichlorophenol , chlorophenoxyphenols; 5,6-dichloro-2-(2,4-
dichlorophenoxy)phenol, 4,5-dichloro-2-(2,4-dichlorophenoxy)phenol, and 4,5,6-trichloro-(2,4-
dichlorophenoxy)phenol, an unknown radical compound with the formula C12H4O3Cl4 , and 
chloroform (Canosa et al., 2005; Rule et al., 2005; Greyshock and Vikesland, 2006; Fiss et al., 
2007; Vanderford et al., 2008). The most stable by-products of TCS are 2,4- dichlorophenol and 
2,4,6 trichlorophenol, which have been measured along with TCS in several raw waste water 
samples (Canosa et al., 2005). Direct photolysis of TCS is responsible for the production of 
2,7/2,8-dibenzodichloro-p-dioxin, while reactions with chlorine lead to the formation of 
chlorinated phenols.  
1.2.4 Effects in Animals 
Triclosan’s ability to act both estrogenically and androgenically, along with its potential 
to mimic thyroid hormones, is enough to warrant further research on its endocrine disrupting 
effects in both aquatic species and humans. Unfortunately at the present time, data on TCS and 
endocrine disruption in fish is scarce (see Chapter 2, review by Dann and Hontela, 2011), with 
the exception of a small number of studies that investigated the estrogenic/androgenic effects of 
the compound in Japanese Medaka (Oryzia latipes).  
It is apparent that further studies are needed to confirm TCS’s endocrine disrupting 
effects, especially in aquatic animals, which are chronically exposed to low levels of the chemical 
and its metabolites. Specifically, more research is needed to fully comprehend the endocrine 
disrupting effects of TCS in fish species whereby endocrine disruption parameters are not solely 
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focused on reproductive function. In general, more information on the adverse effects, 
mechanisms of actions, and risk potential of TCS is needed, in order to ensure that aquatic 
ecosystems are sufficiently protected from any adverse effects the chemical may produce. A 
comprehensive review of the aquatic toxicity of TCS is presented in Chapter 2 of this thesis 
(Dann and Hontela, 2011). 
1.3 2,4-D 
  
1.3.1 Properties and Sources 
In 2007, the Canadian pesticide market was valued at an impressive 1.424 billion dollars, 
representing a slight increase over sales in 2006 (Crop Protection, 2008). Herbicides account for 
the majority of pesticides sold in Canada, constituting 75% of all pesticide sales in 2007 (Brook, 
2008). In 2003, 9 264 487.7 kg of pesticide active ingredients were sold or shipped into Alberta 
(Byrtus, 2007). Of these active ingredients, phenoxy acids (primarily 2,4-D) accounted for 21.1% 
of all pesticide sales in Alberta which translates into 763 357.6 kg of 2,4-dichlorophenoxyacetic 
acid (2,4-D) across all sectors (agricultural, domestic, and industrial). Between 1998 and 2003, 
2,4-D sales increased by 1.5 % which serves to reinforce the pesticide’s longstanding relevance in 
agricultural sectors. 2,4-D, a broad leaf phenoxy herbicide, is one of the most commonly used 
pesticides in North America, if not globally, and is frequently detected in surface water and air. 
This is unremarkable considering that in 1990, more than 3.8 million kg of 2,4-D were applied in 
Alberta, Saskatchewan, and Manitoba alone (Waite et al., 2002). 2,4-D was introduced into the 
commercial pesticide market in the 1940’s (Bus and Hammond, 2007) and has enjoyed 
widespread market success ever since. It is a versatile pesticide that can be used in wide variety of 
settings including agriculture crops, forestry, turf, non-crop, and aquatic weeds (Bus and 
Hammond, 2007). 
2,4-D exists in one of three forms: acid, 2-ethylhexl ester, or dimethylamine salts (Bus 
and Hammond, 2007). Henceforth, any reference to “2,4-D” with no specifications will include 
all three of the chemical forms. The phenoxy acid family of pesticides disrupts plant cell growth 
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in newly formed areas of the plant; affecting protein synthesis and mitosis thereby leading to 
dysfunctional growth and tumors (Brook, 2008). Regardless of whether the pesticide was applied 
as an ester or amine salt, it is hydrolyzed to the acid form in the environment (Waite et al., 2002). 
2,4-D amine salts are nonvolatile and are considerably more water soluble than the acid whereas 
the low-volatile esters are more volatile but less water soluble than the acid (Waite et al., 2002). 
The log octanol/water partition coefficient of 2,4-D is 2.81 indicating that the chemical is slightly 
lipophilic (Howard, 1991).  
1.3.2 Occurrence in the Aquatic Environment 
When pesticides are applied to a given area, some degree of movement away from the 
target site is likely to occur and should be expected, although the applicator must attempt to 
minimize migration. There are several ways in which pesticides can migrate away from their 
target site, including dissolution in runoff water and subsequent transportation to surface and/or 
groundwater, or volatilization into the atmosphere (Kumar, 2001). Once pesticides enter the 
environment, they can travel significant distances before they are deposited in land or water. 
Agriculture and Agri-Food Canada determined that 2,4-D is the principal pesticide detected in 
rainfall in southern Alberta (Anderson, 2005). The extent to which a given pesticide will be 
detected in land, water, or air depends on the log octanol water partition coefficient (propensity 
to bioaccumulate), organic carbon partitioning coefficient (adsorption to soil), hydrophilicity 
(solubility in water), and Henry’s Law Constant (volatilization) (Byrtus et al., 2002). In water, a 
certain percentage of the herbicide will be degraded by photolysis, hydrolysis, or other 
degradation pathways (Borges et al., 2004).  
In Alberta, 2,4-D is the most commonly detected pesticide in surface water, with a 
detection rate of 53% (Anderson, 2005), a rate which is particularly high in the south, where 
agriculture is most practiced. One might assume that pesticides would be detected in river 
systems primarily during their period of application (May-July period). This, however, is not the 
case. Pesticides, including 2,4-D, are detected year round and surprisingly enough, 
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concentrations do not peak during the application period (Anderson, 2005). Intense agriculture 
surrounding the Oldman river basin resulted in the river system receiving the highest frequency 
of pesticide detection in Alberta, with a rate of 46.9%.  
When comparing pesticide concentrations in untreated and treated water, data from 
water treatment processes in Lethbridge and Carmangay indicate that water treatment processes 
are unable to effectively remove pesticides (Anderson, 2005). From this data, it can then be 
concluded that water treatment processes in Alberta are not always effective in ensuring the 
removal of pesticide residue(s). It is most certainly no coincidence that 2,4-D is the most 
commonly detected pesticide in surface water and precipitation in southern Alberta, a fact which 
is mirrored by detection rates closely paralleling the sales and use of the pesticide in this region. 
Concerns have been raised about the large volumes of 2,4-D that are currently used in 
agriculture, especially since numerous researchers have voiced concerns that 2,4-D may carry 
reproductive risks and/or pose mutagenic and carcinogenic risks. Epidemiological studies have 
provided equivocal evidence that 2,4-D is a possible carcinogen, while any such links have not 
been proven in laboratory studies (Garabrant and Philbert, 2002). Widespread concern over the 
use of 2,4-D is probably linked to 2,4-D’s connection with Agent Orange, which was a 50:50 
mixture of 2,4-D and 2,4,5-T that was tainted with dioxin. Epidemiological studies may have 
provided inconclusive results because 2,4-D mixtures may exhibit varying degrees of TCDD 
contamination (Masunaga et al., 2001).  In addition, pesticide applicators are often exposed to 
numerous different chemicals, making it difficult to link a specific chemical with an increased 
risk for cancer.  
1.3.3 Environmental Behaviour 
2,4-D enters the environment primarily through agricultural applications, although 
commercial and domestic applications represent minor pathways for environmental 
contamination. 2,4-D has been detected in air, surface water, and ground water in Canada (Waite 
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et al., 2002). The migration (drift and runoff) of pesticides from their area of application to 
groundwater and surface water is a common problem. In soil, the biodegradation of 2,4-D is the 
single most important elimination pathway for the chemical (Howard, 1991). The degradation of 
2,4-D in soil is a rapid process, with the chemical having a half-life of 6.2 days on average 
(USEPA, 2005). However, the elimination of 2,4-D from aquatic ecosystems is a considerably 
slower process. 
The functional groups of 2,4-D make the chemical somewhat resistant to hydrolysis, but 
as the pH of the water increases, the chemical becomes more hydrophilic, especially at pH’s 
greater than 8 (Howard 1991). 2,4-D esters are rapidly hydrolyzed in alkaline conditions where 
2,4-D amine salts have the propensity to dissociate in water. Under a wide array of 
environmental conditions, 2,4-D amine and esters will degrade swiftly to form 2,4-D acid 
(USEPA, 2005). Degradation products of 2,4-D acid include 1,2,4-benzenetriol, 2,4-
dichlorophenol (2,4-DCP), 2,4-dichloroanisol (2,4-DCA), chlorohydroquinone (CHQ), 4-
chlorophenol, volatile organics, bound residues, and carbon dioxide (Borges et al., 2004). 
According to the US Environmental Protection Agency (EPA) Office of Pesticide Programs 
(OPP), the degradation products of 2,4-D are not considered to be an environmental or health 
concern and as such, are not included in ecological risk assessments (Borges et al., 2004). 
The rate of 2,4-D breakdown in aquatic environments depends heavily on dissolved 
oxygen concentrations in the water. The chemical degrades rapidly in well oxygenated waters, 
with a half-life of 15 days, whereas anaerobic aquatic environments result in 2,4-D persistence, 
with half-life of 41 to 333 days (USEPA, 2005). 2,4-D esters are volatile, especially under 
conditions of low humidity and high temperatures. Generally speaking, 2,4-D does not adhere to 
sediment and is frequently detected in surface and ground water. Biological, chemical, and 
photodegradation all play a role in the environmental fate of 2,4-D in aquatic ecosystems (Waite 
et al., 2002). 
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1.3.4 Effects of 2,4-D in Animals 
2,4-D is soluble in water, distributing widely through aquatic environments and having a 
tendency to persist over time. The pesticide can act as a direct toxicant to fish, but may also act 
indirectly when fish consume invertebrates or aquatic plants contaminated with 2,4-D (Borges et 
al., 2004). In the body, 2,4-D exists primarily in the ionized form and active transport is required 
in order for it to pass through the lipid bilayer of cells (Garabrant and Philbert, 2002). Excretion 
occurs primarily through renal elimination, whereas the dose of the chemical increases, 
metabolite excretion in feces becomes a more important elimination pathway (Garabrant and 
Philbert, 2002). 2,4-D acids and salts are practically non-toxic to slightly toxic to fish, whereas 
the ester form has proven to be slightly toxic to highly toxic to freshwater fish species (Borges et 
al., 2004). Specifically, 2,4-D ester formulations in 96-hour acute toxicity tests with freshwater 
fish resulted in an LC50 that was three magnitudes greater than the other forms. However, it is 
important to note that the “inert ingredients” in commercial pesticide formulations of 2,4-D 
could affect its toxicity, either additively, synergistically and/or antagonistically.  
The estrogenic potential of 2,4-D and a binary mixture of the herbicide with one of two 
surfactants (R-11 and Target Prospreader Activator) was examined in juvenile rainbow trout 
(Xie et al., 2005). Juvenile rainbow trout that were exposed to 2,4-D for a period of 7 days had a 
93- fold increase in plasma vitellogenin levels, compared to untreated fish. When the fish were 
exposed to the binary mixtures, the estrogenic effects of 2,4-D were enhanced. The binary 
mixture of alkylphenol ethoxylate-containing surfactants with 2,4-D resulted in greater than 
additive estrogenic effects in fish, as evidenced by marked increases in vitellogenin production. 
As previously mentioned, one of the degradation products of 2,4-D in water is 2,4-
dichlorophenol, which can bind to estrogen receptors in fish, stimulating vitellogenin production 
in male and/or juvenile fish (Jobling et al., 1995).  Currently, this is one of the only studies in 
the literature that has examined the endocrine disrupting effects of pesticides with surfactants.  
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An in vitro study by Orton et al. (2009) using a recombinant yeast screen assay failed to 
detect any receptor mediated (anti-)estrogenic and (anti-) androgenic activity for 2,4-D. Previous 
studies on 2,4-D and gonadal steroids have failed to provide evidence of any direct estrogenic 
activity (Nishihara et al., 2000; Seifert et al., 1998; Crain et al., 1997). However, when 
combined with testosterone, 2,4-D has androgenic synergistic effects (Kim et al., 2005). Despite 
the lack of clear evidence linking 2,4-D to alteration in steroid hormone activity, the phenoxy 
herbicide elevates LH levels in humans (Garry et al., 2001). 
Gonadal steroids are not the only target for 2,4-D induced endocrine disruption. 
Pathology data in a subchronic study on the toxicity of the three forms of 2,4-D in rats showed 
alterations in the testicular tissue, the adrenal cortex, and the thyroid gland (Charles et al., 1996).  
The exposure of teleosts and mammals to 2,4-D decreases thyroxine (T4) content in the thyroid 
gland and lower serum levels of both triidothyronine (T3) and T4 (Kobal et al., 2000; Raldua and 
Babin, 2009). Rats exposed to all three forms of 2,4-D exhibited a decrease in thyroid weight 
and a concomitant decrease in circulating thyroid hormone levels (Charles et al., 1996). Lastly, 
in a reporter gene assay for pregnane X receptor agonist activity, 2,4-D possessed PXR-
mediated transcriptional activity (Kojima et al., 2011). The ability of 2,4-D to mediate PXR 
transcriptional activity could potentially explain why the herbicide can alter steroid hormone 
production, as the induced proteins play a role in steroid hormone catabolism. 
1.3.5 Commercial Pesticide Formulations 
Surfactants, solvents, and other ingredients consist of what is referred to as “inert” 
ingredients in pesticide formulations. The term “inert ingredients” is incredibly misleading to 
consumers, because it implies that the ingredients are safe and/or inactive, when the reality is 
they may be more toxic than the active ingredient itself. In addition, these “inert” ingredients 
may be present in large amounts, constituting up to 99% of certain pesticide formulations. To 
further complicate things, many pesticide formulations contain several active ingredients in 
addition to mixtures of “inert” ingredients. When the complex composition of some pesticide 
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formulations is taken into consideration, it soon becomes apparent that toxicity testing using 
commercial formulations of 2,4-D mixtures is the most environmentally relevant way to assess 
the pesticide’s effects on aquatic organisms. 
Comparing the toxicity of commercial pesticide mixtures to the active ingredient alone 
is of considerable importance in toxicology because it allows for the detection of any additive, 
synergistic, or antagonistic effects that the formulated product may have. This approach is 
practical and more efficient than testing individual chemicals for two reasons: 1) getting 
information on the inert ingredients in a pesticide formulation is a difficult process as chemical 
companies claim they are “trade secrets”, a situation which is compounded by a lack of 
transparency in government agencies that regulate pesticide use; and 2) testing individual inert 
ingredients is time consuming and would not include the sum of the effects of all ingredients 
(Borges et al., 2004). Unfortunately, data on the aquatic toxicity of various pesticide 
formulations of 2,4-D is scant. In order for pesticide research to be considered environmentally 
relevant, toxicological studies on commercial formulations of 2,4-D must be conducted. If future 
studies do not include commercial formulations, interactions between the active ingredient(s) 
and the “inerts” may go undetected.  
1.4 Dichlorophenol (DCP) 
 
1.4.1 Properties and sources 
In the aquatic environment, both TCS and 2,4-D undergo degradation processes that 
yield the phenolic by-product, DCP (CAS: 120-83-2). The molecular formula for DCP is C6-H4-
Cl2-O, with the chemical existing in the form of a white solid and carrying a strong medicinal 
odour (HSDB, 2009). Its molecular weight is 163.00, and with a log octanol water coefficient of 
3.06, the chemical can be expected to display a slight to moderate potential for bioaccumulation. 
Dichlorophenol is used to manufacture a number of different commercial products such as the 
phenoxy herbicides, 2,4-D and 2,4,5-T, dyes, mothproofing, antiseptics, seed disinfectants, 
wood preservatives, antihelminthic agents, and is a major waste product produced by pulp and 
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paper mills (HSDB, 2009). The use of DCP in the synthesis of numerous chemicals provides a 
pathway of entry for the chemical into the aquatic environment, although it is the degradation of 
2,4-D that is the primary source of the DCP (HSDB, 2009) . 
1.4.2 Occurrence in the Aquatic Environment 
The detection frequency of DCP in surface water is similar to those of its parent 
compound(s). In fact, DCP is one of the most commonly detected chlorophenols in the aquatic 
environment (House et al., 1997). Surface water levels of DCP have been reported up to a 
maximum concentration of 19.96 µg l-1 (Gao et al., 2008).  Both the U.S. EPA and the European 
Union have flagged DCP as a priority pollutant in effluent and the aquatic environment. 
DCP in surface water has been measured in China (n.d.-19.96 µg l-1) (Gao et al., 2008), 
France (n.d.- 4.72 µg l-1) (Chiron et al., 2007), Greece (n.d.-6.11 µg l-1) (Dimou et al., 2006), 
Spain (1-10 µg l-1) (Brossa et al., 2005), England (n.d.- <1.0 ug l-1) (House et al., 1997), and 
Canada (n.d.- 1.58 µg l-1) (Anderson, 2005).  
1.4.3 Environmental Behaviour 
In the aquatic environment, DCP will absorb to particulate matter and sediment, due to 
its octanol-water partition cofefficient (Kow) value of 3.06 (Hansch et al., 1995; HSDB, 2009). 
The estimated river and lake half-lives of DCP are 14 and 103 days, respectively (HSDB, 2009). 
Water analysis is not the only way to monitor the prevalence of chlorophenols in the aquatic 
environment. It is known that chlorophenols are metabolized and excreted in the bile of fish (Al-
Arabi et al., 2005) and fish bile and/or whole fish samples are frequently used as biomonitoring 
tools for the determination of fish exposure to water-borne chemicals. DCP has been measured 
in the bile of Nile tilapia (Oreochromis niloticus) and sharp tooth catfish (Clarias gariepinus) 
from a Bangladeshi river (Al-Arabi et al., 2005), the bile of perch (Perca fluviatilis) collected 
from the Baltic Sea (Soderstrom et al., 1994), and in whole fish samples collected from Lake 
Michigan tributaries (Camanzo et al., 1987).   
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The first researchers to investigate the bioconcentration of DCP were Kishino and 
Kobayashi (1996). At a concentration of 0.5 mg l-1, over pH ranges of 6, 8, and 10, the 
bioconcentration factor (BCF) of DCP in goldfish (Carassius auratus) was 40, 33, and 2.5, 
respectively. A later study by Kondo et al. (2005) determined the bioconcentration factor for 
environmentally relevant levels of DCP in Japanese medaka. Following an exposure period of 
60 days, at concentrations between 0.3-30 µg l-1, BCF values were reported as the following: 
3.4x102 at 0.235 µg l-1 up to 92 at 27.3 µg l-1. These values indicate a low to moderate 
bioconcentration potential for DCP. 
1.4.4 Effects in Animals 
For fish, the LC50 value of DCP ranges from 7.0 to 11.6 mg l-1 (Phipps et al., 1981), with 
a no observed effect concentration (NOEC) of 3.3 mg l-1 in medaka (Kondo et al., 2005). Zhang 
et al. (2008), exposed rare minnows (Gobiocypris rarus) to various concentrations of DCP for 3 
and 21 day. At concentrations at or above 0.3 mg l-1 of DCP, toxicity and endocrine disruption 
were observed in both exposure periods. In female fish, Vtg expression (mRNA) and protein 
was significantly increased following a 21-d exposure period, while the expression of hepatic 
ER β mRNA was downregulated. In male fish, the opposite phenomenon was observed; protein 
and mRNA Vtg levels were not affected, while the expression of hepatic ER β was upregulated. 
The reason for these sex differences is not known. During both exposure periods, the GSI of 
male and female fish was reduced. Due to abnormal gonadal histopathology, it is possible that 
the decrease in GSI could be the result of sex tissue degeneration.  
Based on the chemical structure of DCP, there is reason to suspect that the phenol may 
be an endocrine disruptor. Although DCP is suspected of having estrogenic activity, results from 
in vitro receptor binding tests are equivocal. Studies by Jobling et al. (1995), Korner et al. 
(1998), and Kramer and Giesy (1999), failed to uncover an estrogenic potential for the phenol. 
On the other hand, studies by Jones et al. (1998), Nishihara et al. (2000), and Han et al. (2002) 
reported estrogenic activity for DCP, and although these findings were statistically significant, 
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the magnitude of the activity was weak, and their biological relevance questionable. Building on 
the findings from previous in vitro studies, an in vivo study was conducted by Aoyama et al. 
(2005) to profile the two-generation reproductive effects of DCP in Wistar-Hannover rats. In the 
rats who received DCP in their diets, implantation sites and live births were decreased, whereas 
uterine weights for F1 and F2 weanlings increased significantly. This in vivo study provides 
evidence of DCP reproductive toxicity, and although the mechanism of the toxicity is not 
known, it is possible that these effects can be attributed to an estrogenic potential of the 
chemical. 
In mammalian studies, when combined with dihydroxytestosterone (DHT), DCP 
stimulates AR transcriptional activity in human prostate cancer cell lines (Kim et al., 2005). A 
previous study by the same authors demonstrated that an oral dose of DCP alone (100 mg kg-1 
day-1) increased the weights of androgen dependent tissue, and in the presence of testosterone (1 
mg kg-1), these increases became synergistic in nature (Kim et al., 2002). The results of the 
previous two studies were confirmed by Li et al. (2010), whose in vitro reporter assay test 
system established that DCP is an AR antagonist, inhibiting β-galactosidase activity in a dose-
dependent fashion. 
There is a growing body of evidence to suggest that DCP acts as an AR antagonist. The 
ubiquitous presence of DCP in the aquatic environment is of concern, as AR antagonists 
negatively impact normal male development. Kiparissis et al. (2003) demonstrated that the 
exposure of fish to anti-androgens is associated with gonadal abnormalities, specifically the 
induction of intersex, decreased spermatogenesis, and lower sperm counts. The long-term effects 
of fish exposure to AR antagonists are unknown, although when coupled with xenoestrogen 
exposure, the effect on fish reproduction could be profound. 
1.5 Methyl-Triclosan (M-TCS) 
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1.5.1 Properties and Sources 
In WWTPs, TCS undergoes biological methylation to produce its primary by-product, 
M-TCS. The levels of M-TCS that discharged from WWTPs into receiving waters are equal to 
approximately 2% of outflowing TCS (Poiger et al., 2003), with M-TCS levels increasing after 
water treatment processes. Once TCS has undergone methylation, its lipophilicity increases. The 
octanol-water partition coefficient of M-TCS is 5.4, compared to 4.76 for the parent compound, 
indicating that M-TCS is more lipophilic and potentially more environmentally persistent.  
1.5.2 Occurrence in the Aquatic Environment 
M-TCS levels have been measured in surface in water in Canada (Andressen et al., 
2007), Germany (Bester, 2005), and Switzerland (Poiger et al., 2003; Lindstrom et al., 2002; 
Balmer et al., 2005), with levels ranging from n.d.-10 ng l-1. M-TCS levels in effluent range 
between n.d.-20 ng l-1(Coogan et al., 2007; Bester, 2005). While concentrations of TCS in 
influent are far greater than in effluent, M-TCS exhibits the reverse pattern, supporting the fact 
that during wastewater treatment processes, TCS undergoes biological methylation to yield M-
TCS.  
Concentrations of M-TCS measured in semi-permeable membrane devices are 
magnitudes higher than concentrations typically measured in surface water, indicating that M-
TCS is likely to accumulate in aquatic organisms.  The tendency for M-TCS to accumulate in 
semi-permeable membrane devices suggests that M-TCS will bioaccumulate in aquatic 
organisms. M-TCS levels in fish tissue range from n.d.-2800 µg kg-1 per wet weight basis 
(Leiker et al., 2009; Buser et al., 2006; Balmer et al., 2004), in caged snails downstream from a 
WWTP, with levels reaching 49.8 ng g-1 (Coogan and La Point, 2008), and in algae at 
concentrations upwards of 89 ng g-1 (Coogan et al., 2007; Coogan and La Point 2008). Based on 
the levels of M-TCS measured in algae and snails, the bioaccumulation factor of the chemical is 
1,200, a factor of approximately three orders of magnitude. 
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1.5.3 Environmental Behaviour of M-TCS 
Evidence to support a higher bioaccumulation potential for M-TCS comes from a study 
by Lindstrom et al. (2002) who measured M-TCS in passive semi-permeable sampling devices, 
but failed to detect any presence of the parent compound. Both Lindstrom et al. (2002) and 
Balmer et al. (2004) demonstrated that TCS is photolabile, while M-TCS is relatively unaffected 
by photolysis. Sorption and sedimentation are expected to play a role in the removal pathway of 
M-TCS from aquatic environments (Lindstrom et al., 2002). The estimated half-life of M-TCS 
in river systems is at least 11 days (Bester, 2005), with removal rates varying considerably, 
depending on the individual characteristics of an aquatic system.  
According to Boehmer et al. (2004), M-TCS is a persistent organic pollutant commonly 
detected in surface water, and little is known about its aquatic toxicity. Future studies are needed 
to determine what, if any, ecological impact M-TCS is having, or will have on aquatic 
ecosystems. 
1.6 Mixtures 
 
The endocrine disrupting potential of environmental contaminants is a relevant area of 
research, with many studies reporting that these chemical mixtures are affecting the estrogen 
receptor (ER) in cells and subsequently interfering with normal hormone function (Ahn et al., 
2008). To a lesser degree, researchers have begun to address the presence of androgenic 
chemicals in the environment, which can cause decreases in spermatogenesis and genital 
abnormalities (Ahn et al., 2008). Considering that the adrenal gland is extremely vulnerable to 
endocrine disruption, it is surprising that the bulk of research on endocrine disruption has 
focused disproportionately on the estrogenic and anti-androgenic effects of water-borne 
toxicants. To further complicate things, it is highly implausible that fish in river systems would 
ever be exposed to only one chemical. Aquatic environments almost always contain complex 
mixtures of chemicals including pharmaceuticals, pesticides, metals, surfactants, and personal 
care products, many of which may exhibit an endocrine disrupting potential. 
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Investigation of endocrine disruption in aquatic ecosystems necessitates a ‘real world’ 
approach, where fish are exposed to mixtures of environmental contaminants rather than 
individual chemicals. Studies conducted by Sumpter and Jobling (1995) suggested that fish living 
in an estrogenic milieu might exhibit more pronounced endocrine disruption when exposed to a 
mixture of estrogenic chemicals, than if they were exposed to just a single estrogenic chemical at 
the same concentration. The synergistic potential of mixtures of environmental contaminants 
should not be underestimated, as the interplay between chemicals can elicit responses from 
biological systems that might be greater or less than what would be anticipated.   
For urban centers, input from WWTP into river systems downstream can be significant, 
especially in periods of low rainfall, so much so that entire river systems may become estrogenic 
(Sumpter, 1998). With climate change, water scarcity in semi-arid regions such as Southern 
Alberta will almost certainly result in higher concentrations of contaminants in aquatic 
environments, potentially increasing their endocrine disrupting effects. Many studies focused on 
Vtg induction in male fish as a biomarker of estrogen exposure, and Kidd et al. (2007) provided 
key evidence, linked to Vtg induction, about population collapse in fathead minnow. Other 
endocrine disruption parameters such as disruption to the adrenal and/or thyroid axis have not 
been sufficiently researched. Specifically, more research is needed to profile the magnitude of the 
endocrine disrupting potential of chemicals that are commonly detected in river systems, to what 
extent these chemicals may bioaccumulate in fish species, and what the consequences of chronic 
exposure may be. Fish are an excellent choice of sentinel species for the assessment of water 
quality, especially now that the general public is becoming cognizant that human and 
environmental health are inextricably linked.  
1.7 Physiological Stress Response 
 
1.7.1 Hypothalamic-Pituitary-Interrenal Axis 
As is the case in most vertebrate species, the hypothalamus and the pituitary regulate the 
secretion of corticosteroids, with corticotrophin-releasing hormone (CRH) and 
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adrenocorticotropic hormone (ACTH) released from their respective regulatory centers (Bonga 
1997). In contrast to mammals where corticosteroid production occurs in the adrenal cortex, 
corticosteroids in fish are synthesized in the interrenal cells located in the head kidney. Unlike the 
adrenal cortex, interrenal cells do not collectively form a gland, but rather are organized into 
layers around the posterior cardinal veins whose branches run through the head kidney (Norris 
and Carr, 2006). Henceforth, the stress axis in fish shall be referred to as the hypothalamic-
pituitary-interrenal axis (HPI), which is homologous to the hypothalamic-pituitary-adrenal axis in 
higher vertebrates. The cortisol secreting cells will be referred to as adrenocortical cells (Hontela 
and Vijayan, 2009). 
When a fish is subjected to a stressor, the hypothalamus releases CRH which stimulates 
the anterior pituitary to secrete ACTH. Fish have a number of sensory systems that are able to 
detect stressors including strong light, changes in temperature, pressure, and water-borne 
pollutant(s), stress-inducing stimuli which will induce an increase in plasma cortisol levels. 
ACTH is an important regulator of corticosteroid release in fish, although elevated levels of 
cortisol are not exclusively the result of ACTH stimulation (Bonga, 1997). ACTH acts on the 
adrenocortical cells, inducing them to begin synthesizing and releasing corticosteroids. The 
production of corticosteroids is dependent on the steroidogenic acute regulatory (StAR) protein, 
whose function is to bring cholesterol into the inner mitochondrial membrane (Stocco, 2000). 
Once inside the inner membrane, cytochrome P450 side-chain cleavage enzyme (P450scc) 
converts cholesterol into pregnenolone, which is a precursor to all steroid hormones. During this 
process, StAR protein functions as the rate limiting step in the steroidogenic cascade. Cortisol 
production and secretion is controlled by a negative feedback loop, where excess levels of 
corticosteroids decrease ACTH and CRH secretion from the pituitary and the hypothalamus 
(Hontela, 1998).  
In fish, cortisol elicits changes in numerous physiological systems. Cortisol targets the 
intestines, gills, and liver, regulating ion balances and metabolism (Bonga, 1997). Cortisol 
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secretion also affects immune function, reproductive status, secretion of growth hormone and 
food intake (Mommsen et al., 1999). One of the primary features of the stress response is the 
redirection of energy away from growth and reproduction, channeling energy stores towards 
returning the body to homeostasis, most notably acting on respiration, locomotion, ion balances, 
and tissue repair (Bonga, 1997). Cortisol triggers gluconeogenesis and lipolysis, which partially 
explains why chronic stress causes weight loss. Another contributing factor to stress related  
 
Figure 1.2. Schematic representation of steps involved in glucocorticoid homeostasis (adapted 
from Odermatt et al., 2006). 
 
weight loss, is the fact that both intense acute and chronic stressors will act as appetite 
suppressors through the release of CRF, which is known to have anorexigenic effects in the 
hypothalamic feeding centre of the brain (Bernier and Peter 2001; Bernier 2006).  
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In salmonid species, cortisol secretion plays an important role in smoltification and 
spawning migration, and it is only when plasma cortisol levels are perpetually elevated that the 
response is no longer adaptive (Pickering, 1993). This phenomenon occurs in many different fish 
species, where acute spikes in cortisol are adaptive and prolonged increases in cortisol have 
deleterious effects on physiological systems, compromising immune functioning and 
reproduction. Cortisol is such an important hormone in fish, that if the stress response is blunted 
by the presence of aquatic pollutants which may disrupt cortisol steroidogenesis, the survivability 
of fish populations may be jeopardized.  
1.7.2 Pollutants and the Stress Response 
Environmental contaminants such as metals, pesticides, and organic chemicals may 
trigger and/or act to suppress the stress response in fish. Currently, the effect of 2,4-D, TCS, and 
their by-products, on the HPI axis are unknown. Several researchers have demonstrated that 
short-term exposures to complex mixtures of chemicals will initially elicit an increase in plasma 
cortisol and glucose, whereas chronic exposures will eventually exhaust the hypothalamic-
pituitary-interrenal axis, as indicated by marked decreases in corticosteroid production (Hontela 
et al., 1992; Brodeur et al., 1997; Nolan et al., 2003). For example, sub-lethal exposures to 
mixtures of agricultural chemicals impair the ability of fish to upregulate the production of 
cortisol in response to an acute stressor (Cericato et al., 2009). Pollutants may also exert their 
toxic effects on the stress response by damaging adrenocortical cells, thus directly interfering 
with their ability to produce and secrete corticosteroids (Hontela and Vijayan, 2009). It is also 
worth noting that during certain periods of the year, fish may be more vulnerable to the effects of 
toxicants. Winter Stress Syndrome is brought about by a significant decline in the fat reserves of 
fish, precipitated by both natural and external stressors (Lemly, 1996). During this time, fish are 
especially susceptible to adverse environmental conditions. The risk posed to fish from chemicals 
released from wastewater treatment plants, industry, and agriculture may increase significantly. It 
is likely that global warming and the squaring of the population pyramid will affect the 
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concentration of pollutants in aquatic environments, as both of these phenomena could very likely 
increase fish exposure to toxicants. 
 In vivo, high concentrations of serum cortisol are frequently used to indicate exposure to 
a stressor (Bonga, 1997). This method of assessment is quite reliable as basal levels of cortisol are 
very low, and it is possible to detect increases in blood cortisol following the exposure to a 
stressor(s). Endocrine disruption in the stress axis is frequently overlooked by researchers who 
have the propensity to focus their attention disproportionately on reproductive systems. More 
research is needed in this area, considering the broad range of regulatory effects that 
corticosteroids elicit, affecting the ability of fish populations to survive and thrive. 
Sentinel species, such as fish, may provide evidence of endocrine disruption in their 
natural environments (Hontela and Vijayan, 2009). To further investigate the role of 
environmental contaminants in the disruption of the HPI axis, interrenal cells can be harvested, 
exposed to the toxicant(s), and then challenged with ACTH in vitro. If the ability of these cells to 
respond to ACTH is blunted or blocked, the stress response in the fish may be impaired. The 
ACTH challenge test is routinely performed in endocrine toxicology to determine the effect of a 
toxicant(s) on the HPI axis. An advantage of primary cell cultures is that they tend to retain the 
characteristics of the tissue from which they were excised, meaning that the in vitro results are 
usually a fairly accurate representation of what would be expected to occur in vivo. 
Primary cell cultures of fish interrenal cells are an important tool for the ecotoxicological 
testing of commonly detected water-borne contaminants. This cell bioassay screens for the 
endocrine disrupting effects of water-borne chemicals, but is also well suited as a diagnostic tool 
for the determination of the cellular and molecular mechanisms causing the disruption. In the 
past, scientists have focused the bulk of their attention on the estrogenic potential of endocrine 
disruptors, through mechanisms involving direct binding to estrogen receptors. The rainbow trout 
adrenocortical cell bioassay is not a measure of endocrine disruption via specific receptor 
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binding, but instead provides researchers with a tool for identifying chemicals that impair cortisol 
biosynthesis, including chemicals acting through indirect mechanisms.  
A potentially important non-receptor mediated mechanism of action is the suppression of 
steroidogenic enzyme activity and/or alterations in key proteins, most notably P450scc and StAR 
protein (Arukwe, 2008).  In addition to the adrenal gland, steroids are synthesized in the testis, 
ovary, brain, placenta, and fat deposits. The rate-limiting step in the synthesis of all steroid 
hormones is the transfer of cholesterol from the outer to the inner mitochondrial membrane. The 
commencement of steroidogenesis is marked by the conversion of cholesterol to pregnolone by 
cytochrome P450scc. Due to similarities in steroid hormone synthesis pathways, xenobiotic- 
induced alterations to the expression of StAR and P450scc in adrenocortical cells will likely carry 
over to other steroid producing tissues.  
A number of chemicals induce adrenocortical and steroidogenic toxicity, including 
pesticides, pharmaceuticals, and heavy metals (Walsh et al., 2000; Hilscherova et al., 2004; Zhao 
et al., 2005). Considering that the adrenal gland is the most common target for endocrine 
disruption (Harvey et al, 2007), more research is needed to identify adrenal toxicants and 
determine the mechanism(s) of action. In vitro bioassays based on the ACTH challenge test are 
excellent screening tools for assessing adrenocortical inhibition, identifying molecular targets, 
and measuring steroids, enzymes, or gene expression (Harvey et al., 2007). 
1.8 Hypotheses 
 
A number of different water-borne chemicals alter steroidogenesis by acting on several 
endocrine targets, including steroid hormone receptors, cholesterol production, StAR protein, and 
other steroidogenic enzymes. Based on the structural similarities of TCS, M-TCS, 2,4-D and DCP 
to known endocrine disruptors, it was hypothesized that the exposure of rainbow trout interrenal 
cells to these chemicals would alter their ability to produce cortisol in response to ACTH 
stimulation.  
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1.9 Objectives 
 
The objective of this project was to determine the effect(s) of single toxicants and binary 
mixtures on the corticosteroid producing cells of the interrenal tissue of rainbow trout. Binary 
mixtures of chemicals may have additive or synergistic toxicity. The EC50 (Effective 
concentration of the test toxicant which inhibits 50% of the normal secretory response to ACTH) 
of the parent compounds was used to determine how the addition of a by-product affected the 
toxicity of the parent-compound. There is very little information on how the toxicity of the by-
products, M-TCS and DCP, compares to that of their parent-compounds, TCS and 2,4-D. This 
study sought to determine if the by-products were more toxic, less toxic, or equally toxic in 
relation to their parent compounds. 
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CHAPTER 2. TRICLOSAN:  ENVIRONMENTAL EXPOSURE, TOXICITY AND 
MECHANISMS OF ACTION 
(Invited literature review, Dann and Hontela, 2011 J Applied Toxicol, 31, 285-311) 
2.1 Background 
  
Triclosan  [(5-chloro-2-(2,4-dichlorophenoxy)phenol: TCS], a halogenated phenol, is a 
non-ionic, broad spectrum antimicrobial used throughout North America, Europe, and Asia, as an 
ingredient in disinfectants, soap, detergent, toothpaste, mouthwash, fabric, deodorant, shampoo, 
and plastic additives, in addition to innumerable other personal care, veterinary, industrial and 
household products.  TCS is effective against many types of bacteria and certain types of fungi, 
preventing bacterial propagation and/or eventually resulting in cell death. It permeates the 
bacterial cell wall and targets multiple cytoplasmic and membrane sites, including RNA synthesis 
and the production of marcomolecules (Russell, 2004).  TCS also blocks synthesis of fatty acids 
through inhibition of enoyl reductase, but has no effect on bacterial spores (McMurray et al., 
1998; Levy et al., 1999; Russell, 2004). TCS may be classified as a halogenated aromatic 
hydrocarbon, containing phenol, diphenyl ether, and polychlorinated biphenyl functional groups 
(Ahn et al., 2008).  The chemical structure of TCS (Fig. 1), a halogenated biphenyl ether, is 
similar to polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), bispenol 
A, dioxins, and thyroid hormones (Veldhoen et al., 2006; Cabana et al., 2007; Crofton et al., 
2007; Allmyr et al., 2008), molecules with two aromatic rings.  
TCS was invented over 40 years ago and has been used increasingly over the past 25 
years (Jones et al., 2000; Russell, 2004). In the period from 1992 to 1999, a majority of the 700 
antibacterial products on the market contained TCS as an active ingredient (Schweizer, 2001). 
TCS is the generic name for the chemical, with brand names including Irgasan DP300, Aquasept, 
Sapoderm, and Ster-Zac. Fibres and other materials that have TCS incorporated into them may be 
referred to as Ultra-Fresh, Amicor, Microban, Monolith, Bactonix, and Sanitized (Adolfsson-
Erici et al., 2002). The antimicrobial has the capability to migrate from treated surfaces into 
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foodstuffs. Notwithstanding, the addition of TCS to food coverings and surfaces that are in 
contact with food during processing is currently being considered (Canosa et al., 2008). However, 
as of March 2010, TCS was removed from the EU list of provisional additives for use in plastic 
food-contact materials.  
Unlike some other organochlorine compounds, TCS use is not highly regulated, as the 
antimicrobial has a low acute toxicity and is generally accepted as well tolerated and safe (Jones 
et al., 2000; Rodericks et al., 2010). Concentrations of TCS in personal care products are typically 
in the range of 0.1-0.3% of product weight (Sabaliunas et al., 2003), with significant amounts of 
the antimicrobial entering wastewater treatment facilities (Table 2.1). The prevalence of TCS in 
waterways is likely to increase as consumer demand for antimicrobial products is anticipated to 
grow. TCS is being increasingly scrutinized after concerns emerged that the product might be 
harmful to human health and the environment. TCS has been detected in surface water, sediment, 
biosolids, soils, aquatic species, and humans (Chu and Metcalfe, 2007; Chalew and Halden, 2009; 
Reiss et al., 2009). Potential health issues surrounding the use of TCS include antibiotic 
resistance, skin irritations, endocrine disruption, increasing rates of allergies, and the formation of 
carcinogenic by-products (Schweizer, 2001; Adolfsson-Erici et al., 2002; Latch et al., 2003), yet a 
recent review by Rodericks et al. (2010) concluded that exposure to TCS in consumer products is 
not expected to cause adverse health effects in children or adults who use the products as 
intended. 
Despite the widespread use of TCS, few independently published studies have 
investigated the emerging health concerns surrounding the use of this antimicrobial and the 
environmental impact it may have. Previous reviews of TCS focused primarily on its toxicity in 
laboratory animals and humans, its fate in the environment, or its link to antibiotic cross-
resistance. The objective of this review is to provide a comprehensive review of the literature on 
TCS, its occurrence in aquatic and terrestrial environments, exposure levels in humans and 
wildlife, including aquatic species, its toxicity and endocrine disrupting potential.   
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2. 2 Identity, physical and chemical properties, manufacture, and use 
 
2.2.1 Identity, physical, and chemical properties 
Triclosan (CAS registration number of 3380-34-5), is a diphenyl ether and may be 
referred to as 5-chloro-2-(2,4-dichlorophenoxy)phenol or 2,4,4'-trichloro-2'-hydroxydiphenyl 
ether. The molecular formula for TCS is C12-H7-Cl3-O2 and the chemical has a molecular weight 
of 289.55. Most commercially obtained grades of TCS are over 99% pure and are available in the 
solid form as a white to off-white crystalline powder with a barely detectable aromatic odour. 
TCS is a stable compound with a boiling point between 280-290˚C, and a melting point between 
54-57˚C. The thermal stability of TCS is why certain manufacturers have chosen the 
antimicrobial for the incorporation into plastics and fibers. The octanol/water partition coefficient 
(log Kow) of TCS is 4.76; it is not readily soluble in water (10 mg l-1 at 20˚C), although solubility 
increases as the pH becomes more alkaline. TCS is however, easily dissolved in a wide array of 
organic solvents (Bhargava and Leonard, 1996).  
In aquatic ecosystems, the majority of TCS exists in the ionized form (Orvos et al., 2002) 
and it is primarily the un-ionized form that is responsible for the majority of TCS’s toxic effects. 
The half-life of TCS in surface water is approximately 41 min, with most of the parent compound 
converting to 2,4-dichlorophenol, although degradation rates vary considerably across aquatic 
ecosystems (Reiss et al., 2002; Lyndall et al., 2010).  
2.2.2 Manufacture and use 
During the synthesis of TCS, a chlorinated phenoxyphenol, the potential for 
contamination with toxic impurities exists.  Beck et al. (1989) reported trace amounts of lower 
chlorinated dibenzodioxins and furans in Irgasan DP300, but not in excess of the µg kg-1 range, 
leading to the conclusion that presence of these compounds in TCS is of little concern. Low 
levels of dioxins and dibenzofurans may be present as unwanted by-products, depending on the 
quality of the initial materials used to synthesize TCS, as well as manufacturing conditions such 
as temperature and pressure (Ni et al., 2005). The U.S. EPA (1994) considers that TCS may be 
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potentially contaminated with dioxins, with the EU, Canada and the United States having taken 
initiatives to set standards for maximum permissible levels of impurities in this compound.  
Between 1992 and 1999, over 700 antibacterial products, the majority of which contained 
TCS, entered the consumer market. Personal care products are the most common form of 
exposure to the antimicrobial, typically at concentrations of 0.1% up to 0.3%, levels which are 
regulated by the European Community Cosmetic Directive or the US Food and Drug Agency 
(USFDA) in Europe and the Unites States, respectively (Sabaliunas et al., 2003; Rodricks et al., 
2010). In Sweden, 25% of toothpaste brands contain TCS which translates into two tons of TCS 
consumption per year. Soaps, deodorants, and other personal care products account for another 
300 kg of the chemical in Sweden alone (Adolfsson-Erici et al., 2002). On the global front, the 
production of TCS has now exceeded 1500 tons per year, with Europe being responsible for 350 
tons of total production (Singer et al., 2002). As public concern over the transmission of disease 
is heightened, the use of antimicrobials is anticipated to increase.  TCS will continue to be an 
environmental pollutant that warrants monitoring, especially since its transformation products are 
not yet fully understood. 
2.3 Environmental exposure 
 
2.3.1 Occurrence in the aquatic environment 
2.3.1.1 Triclosan  
The antimicrobial TCS is commonly detected in aquatic ecosystems (Table 2.1; 
Capdevielle et al., 2008; Chalew and Halden, 2009; Lyndall et al., 2010).  The majority (96%) of 
consumer products containing TCS are eventually rinsed down the drain (Reiss et al., 2002) and 
discharged with wastewater effluent. Although wastewater treatment plants (WWTP) are 
generally highly effective in removing TCS, a small percentage of the antimicrobial is usually 
discharged with effluent into receiving waters, usually a river system (Morrall et al., 2004; 
Nakada et al., 2008). The efficiency of TCS removal can be highly variable, with elimination 
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rates ranging from complete removal to 100% ineffective (Kanda et al., 2003; Heilder and 
Halden, 2007).  
The variability in removal rates for TCS is due in part to different treatment processes, as 
the antimicrobial is readily degraded in aerobic conditions but not under anaerobic conditions 
(McAvoy et al., 2002). Field measurements from a Swiss WWTP have detailed the elimination 
process of TCS: 79% was biologically degraded, 15% was sorbed to sludge, and 6% left the plant 
in the final effluent at a concentration of 42 ng l-1 (Singer et al., 2002; Table 2.1). These results 
are consistent with tests conducted at several WWTPs in Germany, where 4 - 10% of TCS 
remained dissolved in out-flowing water (Bester, 2003). Generally, WWTP influent 
concentrations of the antimicrobial range from 1.86-26.8 µg l-1, with effluent concentrations 
ranging from 0.027 to 2.7 µg l-1 (Morrall et al., 2004; Chalew and Halden, 2009; Nakada et al., 
2010).  In the period from 1999 to 2000, the U.S. Geological Survey detected TCS in 57.6% of 
streams and rivers sampled, at concentrations ranging from below the detection limit up to 2.3 µg 
l-1 (Kolpin et al., 2002).  In addition to the incomplete removal from WWTP effluent, the 
antimicrobial exhibits a tendency to accumulate and persist in biosolids; it is estimated that up to 
50% of TCS in WWTP influent will remain in biosolids, in WWTPs which utilize activated 
sludge treatments in combination with anaerobic biosolid digestion (Heidler and Halden, 2006; 
Chalew and Halden, 2009; Lozano et al., 2010).  The TCS removal capacities of various sorbents, 
including activated charcoal and kaolinite, and the effects of pH, ionic strength and humic acid on 
the sorptive interactions have been investigated (Behera et al., 2010).  Organic matter content was 
a major factor controlling the sorption of TCS.  The occurence of TCS and other organic 
contaminants has been reported in Canadian municipal sewage sludge and biosolids samples (Lee 
and Peart, 2002; Chu and Metcalfe, 2007; Mackay and Barnthouse, 2010; Table 2.1). Thus the 
two main sources of TCS release into the environment are: 1. discharge of WWTP effluent into 
receiving waters, and 2. land application of biosolids containing residues of the antimicrobial. 
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A multitude of factors influence TCS concentrations in aquatic systems, including the 
TCS load in effluent, physical and chemical properties of TCS, characteristics of the aquatic 
ecosystem (pH, sediment density and organic matter content, water flow and velocity, depth), and 
even season and intensity of sunlight (Reiss et al., 2002; Trixier et al., 2002; Lyndall et al., 2010). 
TCS has been measured not only in surface waters, but also in freshwater and estuarine sediment, 
at concentrations of 800 to 53,000 µg kg-1 (Miller et al., 2008; Chalew and Halden, 2009; Table 
2.1). Monitoring TCS concentrations in surface water is important, as the antimicrobial has 
demonstrated a propensity for bioaccumulation in aquatic species (Balmer et al., 2004) and can 
persist in aquatic ecosystems for extended periods of time.  The antimicrobial has been measured 
in 30 year old sediment from lake Greifensee in Switzerland (Singer et al., 2002). This study 
provided evidence of the persistence of TCS in sediment and detailed the pattern of use of TCS. 
TCS concentrations in sediment increased between the early 1960’s until the mid-1970’s, 
reflecting steadily increasing patterns of use, then  a reverse in this trend was observed from the 
mid-1970’s until the early 1980s, when a new process of wastewater treatment was introduced 
into most WWTPs. Increases in TCS concentrations occurred again from the early 1980’s until 
the present time. Similar depth-time profiles for TCS spanning last 40 years were reported by 
Miller et al. (2008) for estuarine sediments in the US. The environmental persistence of TCS in 
sediment is indicative of the antimicrobial’s potential to partition into sediment and resist 
degradation processes under anaerobic conditions.  Buth et al. (2009) chronicled the historical 
pattern of dioxin photoproducts of TCS and its chlorinated derivatives in sediment cores from the 
Mississippi river. Between 1963-2008, TCS levels markedly increased, corresponding to 
increases in the concentration of several chlorinated derivatives of TCS (CTDs), including 
dichlorodibenzo-p-dioxin (2,8-DCDD), a direct transformation product of the photolysis of TCS. 
A further source of TCS derived dioxins comes from the solar irradiation of CTDs, leading to the 
formation of higher level chlorinated dioxins.  
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Table 2.1. Concentrations of Triclosan (TCS) in the aquatic environment 
  
Medium Sample Description Location 
Concentration 
       of TCS Reference 
Surface Water Natural 
streams/rivers 
United States ND a - 2.3 μg l-1 Kolpin et al. 2002; Morrall et al. 2004 
Switzerland ND-0.074 μg l-1 Lindstrom et al. 2002 
 
Germany ND-0.01 μg l-1 Bester, 2005 
 
Sweden 
 
Australia 
 
Japan 
ND 
 
0.075  μg l-1 
 
<0.0006-0.059  μg l-1 
Bendz et al. 2005 
 
Ying and Kookana, 2007 
 
Nakada et al. 2008 
 
Streams with inputs 
of raw wastewater 
 
Switzerland 
 
0.011-0.098 μg l-1 
 
Singer et al. 2002 
 
United States 
 
1.6 μg l-1 
 
Halden and Paull, 2005 
 
Estuarine waters 
 
 
United States 
 
0.0075 μg l-1 
 
 
Fair et al. 2009 
 
Sediment Freshwater  
 
 
Switzerland 
 
Spain 
 
53 µg kg-1 
 
ND-35.7µg kg-1 
Singer et al. 2002 
 
Morales et al. 2005 
 
Estuarine  United States ND-800 µg kg-1 Miller et al. 2008 
 
Marine  
 
Spain 
 
 
0.27-130.7 µg kg-1 
 
Aguëra et al. 2003 
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  Sewage Sludge Activated Sludge United States 0.5-15.6 µg g-1  McAvoy et al. 2002 
 
Spain 0.4-5.4  µg g-1 Morales et al. 2005 
 
Germany 1.2  µg g-1 Bester, 2003 
 
Canada 0.62-1.45 µg g-1 Chu and Metcalfe, 2007 
 
Biosolids 
 
Australia 
 
90-16 790 µg kg-1 
 
Ying and Kookana, 2007 
 
United States 10 500-30 000 µg kg-1 Kinney et al. 2008;  Heidler et al. 2007 
Spain 1508 µg kg-1 
 
Morales et al. 2005 
Canada 680-12 500  µg kg-1 
 
Lee and Peart, 2002;  Chu and Metcalfe, 
2007 
 
WWTP Influent In-Flowing Waste 
Water 
United States 2.70-26.80 μg l-1  McAvoy et al. 2002;  Halden and Paull, 
2005;  Heidler and Halden. 2007;  
Waltman et al. 2006;  Fair et al. 2009 
 
Canada 
 
0.01-4.01 μg l-1 
 
Lishman et al. 2006 
 
Germany 
 
1.2 μg l-1 
 
Bester, 2003 
 
Sweden 
 
Japan 
 
0.38  μg l-1 
 
2.7-11.9  μg l-1 
 
Bendz et al. 2005 
 
Nakada et al. 2010  
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WWTP Effluent Treated Water Switzerland 0.042-0.213 μg l-1 Singer et al. 2002 
Germany 0.01-0.6 μg l-1 Bester, 2003; 2005 
Canada 0.01-0.324 μg l-1 Lishman et al. 2006 
 
United States 
 
0.03-2.7 μg l-1 
 
McAvoy et al. 2002;  Waltman et al. 
2006;  Heidler and Halden, 2007;  
Halden and Paull, 2005;  Fair et al. 2009 
 
United 
Kingdom 
 
0.34-3.1  μg l-1 
 
Kanda et al. 2003;  Sabaliunas et al. 
2003 
 
Australia 
 
0.023-0.434 μg l-1 
 
Ying and Kookana, 2007 
Sweden 
 
Japan 
0.16 μg l-1 
 
0.26-0.27 μg l-1 
 
Bendz et al. 2005 
 
Nakada et al. 2010 
 
 
a   ND= Not detectable 
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2.3.1.1 Degradation products of TCS 
Methyltriclosan (MTCS)- During the wastewater treatment process, TCS is transformed by 
biological methylation into methyltriclosan (MTCS; 5-chloro-2-(2,4 dichloropheoxy)anisole; 
CAS No. 4640-01-1) (Boehmer et al., 2004; Bester, 2005), a more lipophilic compound (Kow 5.2), 
which is then released into receiving waters.   The presence of MTCS in fish has in fact been 
proposed for use as marker of exposure to WWTP effluent, specifically to lipophilic WWTP 
contaminants (Balmer et al., 2004).  The lipophilicity of MTCS and its resistance to 
biodegradation processes and photolysis (Lindström et al., 2002) means this metabolite will 
exhibit a higher degree of environmental persistence than its parent compound.   
Dioxins- Over the last decade there has been increasing concern regarding the degradation 
products of TCS, most notably dioxins, and consequently, the transformation of TCS during 
manufacturing, incineration, and in the aquatic environment. The photolysis of TCS constitutes 
the principal removal pathway of the antimicrobial in the aquatic environment, with some studies 
having documented the formation of 2,8-dichlorodibenzodioxin (DCDD) and other dioxin 
derivatives during the photodegradation of TCS in aqueous solutions (Latch et al., 2003; Mezcua 
et al., 2004; Lores et al., 2005; Sanchez-Prado et al., 2006; Aranami and Readman, 2007).    
There is evidence that the pH of aqueous solutions spiked with TCS influences the formation 
of dioxin by-products. Latch et al. (2003) reported that 1-12% of TCS is converted to DCDD in 
aqueous solutions buffered at a pH 8 or higher. Considering the pKa of TCS is 7.9, it is probable 
that the dissociated form of TCS is the photoreactive species, potentially explaining why DCDD 
was not observed in experiments using methanol solutions spiked with TCS (Latch et al., 2003). 
From this study, it is apparent that in sunlight irradiated waters, the conversion of TCS into dioxin 
by-products is dependent on both the pH and the irradiation wavelength. The findings of Latch et 
al. (2003) were confirmed by Mezcua et al. (2004) who were the first to investigate the 
photodegradation of TCS to dioxins in wastewater samples. The study indicated that 2,7/2,8-
dibenzodichloro-p-dioxin is indeed a by-product of the photolysis of TCS, in both water and 
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wastewater samples spiked with 8 μg ml-1 of the antimicrobial. The degree of photolytic 
conversion was dependent upon pH and the organic matter content in the sample.  Sanchez-Prado 
et al. (2006) were the first to use a solar simulator photoreactor, in conjunction with actual 
contaminated wastewater samples, identifying the formation of 2,8-DCDD and a possible DCDD 
isomer or dichlorohydroxydibenzofuran independently of sample pH.  Aranami and Readman 
(2007) irradiated freshwater and seawater samples with a low intensity artificial white light 
source for a 12 day period. Similar to previous studies, the photodegradation of TCS produced 
DCDD, in both freshwater and seawater samples after 3 days of irradiation.   
The photochemical conversion of TCS in natural water samples, specifically Mississippi 
river and Lake Josephine waters, was investigated by Buth et al. (2009).  The photolysis of the 
antimicrobial was dependent on speciation, with the phenolate form of TCS being degraded 44-
586 times faster than the phenol form. The conversion of chlorinated TCS derivatives into dioxins 
was substantiated in natural and buffered pure water, with yields of 0.5 to 2.5%, respectively. The 
majority of TCS’s photolytic transformation products and their kinetics, along with the 
environmental factors influencing their degradation, have yet to be identified. (Aranami and 
Readman, 2007). Of great importance in quantifying the level of risk to both aquatic 
environments and humans, is determining to what extent and under which environmental 
conditions the conversion of TCS into toxic by-products occurs.  
Chlorophenols - Dioxins are not the only toxic transformation product of TCS that warrants 
further study. The photochemical transformation of TCS has also been shown to produce 2,4 
dichlorophenol and 2,4,6-trichlorophenol, chemicals which the US EPA has flagged as priority 
pollutants. The generation of chlorophenols from TCS was originally demonstrated by Kanetoshi 
et al. (1987) however, the study used high concentrations of chlorine and TCS, calling into 
question the environmental relevance of the findings. Later studies validated the finding that 
chlorophenols are transformation products of TCS, even in the presence of low levels of chlorine 
or chloramines (Rule et al., 2005; Canosa et al., 2005; Greyshock and Vikesland, 2006). TCS 
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reacted with free chlorine under drinking water conditions and 2,4-dichlorophenol was formed 
via the ether cleavage of TCS, which then underwent electrophilic substitution to form 2,4,6-
trichlorophenol. Consistent with other studies, based on the effect of pH on the formation of TCS 
by-products, Rule et al. (2005) concluded that it was primarily the ionized phenolate form of TCS 
that reacts with hypochlorous acid.  Canosa et al. (2005) tested low concentrations of both TCS 
(ng ml-1) and chlorine (mg l-1 and less), and consistently detected 2,4-dichlorophenol and 2,4,6-
trichlorophenol in all of the samples analyzed. Even though the molar yields of TCS conversion 
were <10%, these findings are significant, as it has been demonstrated that these two phenolic by-
products are relatively stable over time and potentially toxic (Canosa et al., 2005). The formation 
of chlorophenols from the degradation of TCS has been confirmed by others (Sanchez-Prado et 
al., 2006; Latch et al., 2005; Fiss et al., 2007). 
Chloroform -There is evidence that, like other phenols, TCS in water or in various  consumer 
products will react with free chlorine or chloramine to produce chloroform and other chlorinated 
products over a range of pHs (Rule et al., 2005; Greyshock and Vikesland, 2006; Fiss et al., 
2007). Rule et al. (2005) also assessed the propensity of a dish soap containing TCS to form 
chloroform when added to chlorinated water. After 5 min, 15 μg l-1 of chloroform was produced, 
with chloroform levels attaining 49 μg l-1 after 120 min. Based on the results of this study, while 
it is unlikely that significant amounts of chloroform are generated from TCS in surface waters, 
chloroform may be formed during the daily use of household products containing the 
antimicrobial. The conversion of TCS to chlorinated derivatives is also dependent on temperature, 
with higher temperatures resulting in increased chloroform yields (Fiss et al., 2007). An exposure 
model completed by the authors indicated that, under certain conditions, the amount of 
chloroform produced could be significant, and where chloroform formation is inconsequential, 
other chlorinated by-products are produced, which may place consumers at an increased risk for 
adverse health effects.  
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2.4 Exposure to Triclosan and its degradation products in aquatic organisms 
 
2.4.1 Algae and Invertebrates  
The incomplete removal of TCS during the wastewater treatment process leads to the 
continual exposure of aquatic biota in receiving waters, and the accumulation of the antimicrobial 
and its degradation products in tissues of aquatic organisms (Table 2.2).  Algae, a primary food 
source for many aquatic species, constitute an important pathway for the accumulation of 
lipophilic water-borne contaminants, such as TCS (Capdeveille et al., 2008). Coogan et al. (2007) 
sampled the filamentous algae (Cladophora spp) in a receiving stream for the city of Denton 
(Texas) for TCS and MTCS, measuring 100 - 150 µg kg-1  and 50-89 µg kg-1 , respectively. From 
these measurements, bioaccumulation factors of 1600 and 1100 were estimated for the parent 
compound and its methylated by-product. The bioaccumulation potential of TCS and MTCS was 
also determined in freshwater snails (Helisoma trivolvis) and again in algae (Cladophora spp.), 
using isotope dilution GC-MS (Coogan and La Point, 2008).  Bioaccumulation factors for snail 
tissue were 500 and 1200 for TCS and MTCS, respectively. The algal bioaccumulation factor was 
also high, 1,400 and 1,200, respectively.  The occurrence and formation of TCS metabolites was 
also investigated in estuarine systems.  In a study by DeLorenzo et al. (2008), adult grass shrimp 
(Palaemonetes pugio) were exposed to 100 μg l-1 of TCS and even though TCS was not 
measured, they were found to accumulate MTCS after a 14-day exposure period.  This finding 
provides evidence for both the conversion of TCS to MTCS in seawater, and of the 
bioaccumulation potential of the metabolite in aquatic organisms. Yet, even though MTCS is 
resistant to biodegradation processes and has demonstrated the ability to persist in the 
environment for longer periods of time than the parent compound, it has received considerably 
less attention in the literature.  As snails and other aquatic invertebrates depend on algae as a 
source of nutrients, and considering the ubiquity of TCS in the aquatic environment, it is probable 
that grazed algal compartments will contain TCS and MTCS, potentially making these 
compounds available to higher aquatic organisms.  
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2.4.2 Fish  
In addition to invertebrates, TCS and its transformation products have been detected in 
higher level aquatic organisms, most notably fish (Table 2.2).  Miyazaki et al. (1984) was the first 
to report the presence of MTCS in aquatic biota. Fish and shellfish were collected from the Tama 
River and Tokyo Bay, and MCTS was identified by GC/MS in all of the freshwater fish samples 
(1-38 µg kg-1 whole body) and 3 of the 4 shellfish samples (3 - 20 µg kg-1, Table 2.2).  A well 
cited study by Adolfsson-Erici et al. (2002), measured TCS levels in rainbow trout 
(Oncorhynchus mykiss)  caged in the receiving waters of a WWTP in Sweden, in wild fish living 
downstream from the plant, and in rainbow trout exposed to treated water in tanks. Bile fluid 
from the fish contained TCS at concentrations ranging from <0.01 – 0.08 mg kg-1 fresh weight in 
controls and fish sampled at reference sites, and 0.44 - 120 mg kg-1 in fish exposed to sewage 
water. Houtman et al. (2004) also used GC/MS to identify a multitude of xenobiotic compounds, 
including TCS, in the bile of male breams (Abramis brama) living in Dutch surface waters. TCS 
was detected in two of the three locations sampled, at relatively high concentrations of 14 μg ml-1 
and 80 μg ml-1 of bile. The results of these two studies provide evidence for the accumulation of 
TCS in the bile of fish. Other European studies have reported TCS and its derivatives in fish 
tissues. Buser et al. (2006) analyzed levels of MTCS in juvenile (1-2 year old) brown trout 
(Salmo trutta fario) from rivers in Northern Switzerland receiving effluent from WWTPs.  
Concentrations of MTCS in fish were reported between 130-2100 ng g-1 of lipid weight.  Balmer 
et al. (2004) detected MTCS in lake fish in the range of 4-370 ng g-1, lower levels compared to 
those previously measured in fish samples from rivers.  This difference is to be expected as 
concentrations of MTCS should typically be higher in river systems that receive inputs from 
WWTPs. A large monitoring study on TCS and MTCS was conducted by Boehmer et al. (2004) 
using fish tissues from the German Environmental Specimen Bank. Samples of muscle tissue 
from breams (Abramis brama) from the period of 1994-2003 were analyzed for TCS and MTCS.  
While TCS was only detected in a small number of samples, MTCS was present in all of the 
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muscle samples analyzed. A pattern of increasing MTCS concentrations was observed in bream 
muscle tissue from the mid 1990’s until after 2000, with levels of MTCS increasing from 10 ng g-
1 to14-26 ng g-1 of wet weight.  TCS concentrations ranged from below the limit of quantification 
up to 3.4 ng g-1. From their retrospective monitoring data, the authors of the study concluded that 
MTCS is a persistent pollutant with the potential to accumulate in the muscle tissue of fish.  
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Table 2.2. Concentrations of Triclosan (TCS) in aquatic organisms 
Organisms Type of Sample Site Description 
      TCS  
   (µg kg-1) Reference 
Algae and Invertebrates 
     
Filamentous algae                     
(Cladophora spp)  
Whole 
organism 
Receiving stream for the city of Denton 
(TX,USA) WWTP 
100-150 Coogan et al. 2007  
 Whole 
organism 
 50-400 Coogan and La Point, 
2008 
 
Freshwater snails                       
(Helisoma trivolvis) 
 
Muscle
 
 
 
 
50-300 
 
Coogan and La Point, 
2008 
 
Vertebrates 
 
Rainbow trout 
(Oncorhynchus mykiss) 
 
 
Bile 
 
 
Upstream from WWTP, Sweden 
(caged); Downstream 2km from WWTP 
(caged) 
 
 
710 
17000 
 
 
Adolfsson-Erici et al. 
2002 
 
Breams, male                           
(Abramis brama) 
 
Bile
 
River sites (Netherlands) 
 
14000-80000 
 
Houtman et al. 2004  
 Muscle River sites (Germany) 0.25-3.4 
 
Boehmer et al. 2004 
Pelagic fish Plasma Detroit river (USA) 0.75-10 Valters et al. 2005 
Atlantic Bottlenose 
Dolphins  
(Tursiops truncates) 
Plasma Estuary, South Carolina 
Estuary, Florida 
0.12-0.27 
0.025-0.11 
Fair et al. 2009 
 
Killer Whale                        
(Orcinus orca)  
 
Plasma 
 
Vancouver Aquarium  
Marine Science Centre 
 
9.0 
 
Bennett et al. 2009  
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To date, only a few North American studies have monitored TCS and MTCS levels in 
freshwater fish (Table 2.2). Valters et al. (2005) detected TCS in the plasma samples of 13 
species of fish sampled from the Detroit River, in the range of 750 to >10 000 pg g-1 of wet 
weight. MTCS was also detected in the plasma samples, albeit in much lower concentrations, 
ranging from 0.4-13.4 pg g-1 of wet weight. Based on these plasma samples, the authors estimated 
the body burden of TCS to be 2 to 67 ng. Leiker et al. (2009) identified MTCS in male common 
carp (Cyprinus carpio) from the Las Vegas Bay and in the Las Vegas Wash, Nevada;  MTCS was 
detected in all carp sampled (n=29), with a mean concentration of 520 of 596 μg kg-1 per wet 
weight basis. The concentrations of MTCS detected in this study were much higher than those 
documented in previous studies, with the authors indicating that this might be due to the sediment 
foraging behaviour of carp, which exposes them to higher levels of lipophilic water-borne 
chemicals than other fish species. TCS and its metabolites have been detected in sediments, both 
freshwater and marine (Agüera et al., 2003; Miller et al., 2008; Chalew and Halden, 2009). A 
national pilot study in the United States surveyed the presence of pharmaceuticals and personal 
care products, including TCS, in fish sampled from five effluent-dominated rivers receiving 
discharge from WWTPs in large urban centers and a reference river (Ramirez et al., 2009). 
Although several products, including carbamazepine and norfluoxetine were detected at ng g-1 
concentrations in fish tissues, GC/MS analysis revealed only trace amounts of TCS in fillets.  
2.4.3 Marine mammals 
Fair et al. (2009) characterized the occurrence of TCS in the plasma of wild Atlantic 
bottlenose dolphins (Tursiops truncates), a top level predator, and then correlated biological 
levels with environmental concentrations. This study was the first to document the 
bioaccumulation of TCS in a marine mammal. Plasma samples were collected from the dolphins 
in Charleston, South Carolina and Indian River Lagoon, Florida, two southeast US estuarine sites. 
TCS measured in estuarine water samples ranged from 4.9 -13.7 ng l-1, averaging 7.5 ng l-1. 
Plasma concentrations ranged from 0.12 - 0.27 ng g-1 and 0.025-0.11 ng g-1 wet weight, at the two 
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estuaries respectively. Subsequently, TCS has also been detected at a concentration of 9.0 ng g-1 
of wet weight in the plasma of a captive killer whale (Orcinus orca) fed a diet of herring 
harvested from the coast of British Columbia (Bennett et al., 2009). These studies further 
highlight the need to monitor TCS and assess its effects in wild species. 
2.5 Occurrence of TCS and its derivatives in the terrestrial environment 
 
Although TCS is considered to be primarily a water-borne contaminant, the antimicrobial 
can, and does, enter the terrestrial environment during the application of sewage sludge to 
agricultural and/or industrial land (Lozano et al., 2010; Fuchsman et al., 2010).  Activated sludge 
concentrations of TCS are typically measured between 580-14,700 µg kg-1 of dry weight, whereas 
concentrations in biosolids have been documented in the range of 90-32,900 µg kg-1 (Chalew and 
Halden, 2009; Lozano et al., 2010). Studies across three continents examined TCS levels in 
sewage WWTP sludge and reported similar concentrations of the antimicrobial, with a median 
concentration of 5000 µg kg-1 of dry weight (Reiss et al., 2009). In WWTPs that use activated 
sludge treatment in combination with anaerobic biosolid digestion, 50±19 of the influent mass of 
TCS will accumulate and persist in sewage sludge (Chalew and Halden, 2009).  Although it is 
clear that the amendment of agricultural lands with biosolids produced from WWTPs represents a 
significant pathway for the release of TCS into the terrestrial environment, the environmental 
impact of land amendment practices that use biosolids from WWTPs has not been assessed. 
To predict the effects of TCS in biosolids on the terrestrial environment, it is necessary to 
understand its fate in soil. Ying et al. (2007) investigated the biological degradation of TCS in 
soil under aerobic and anaerobic conditions. Quantitative structure-activity relationship analyses 
confirmed findings from previous studies, demonstrating TCS’s propensity to sequester in soil 
and sediment. Laboratory experiments under aerobic conditions showed that TCS had a half-life 
of 18 days.  However, the antimicrobial persisted in anaerobic soil for the entire duration of the 
70 day experiment. These findings agree with McAvoy et al. (2002) who reported that the bulk of 
TCS in WWTPs was removed during aerobic sludge digestion, with anaerobic sludge digestion 
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accounting for a very small portion of TCS removal. Thus in both terrestrial and aquatic 
environments, the biodegradation of TCS occurs primarily under aerobic conditions as the 
antimicrobial is resistant to anaerobic degradation. Due to TCS’s lipophilic nature, the 
antimicrobial partitions into sediment and soil, but its transport potential from biosolids into 
surface runoff has been characterized as low (Sabourin et al., 2009).  
Although TCS may not be physically mobile between soil compartments, other processes 
may transfer TCS from soil to biota.  Kinney et al. (2008) assessed the potential for organic 
biosolid- or manure-derived soil contaminants in amended agriculture land to accumulate in 
biota.  Tissue concentrations of TCS in earthworms inhabiting the amended soil reached 2610 μg 
kg-1, translating into a bioaccumulation factor of 27. Based on the findings of this study, the 
predation of earthworms by birds and other animals could result in the transfer of TCS up the 
food chain, although this has not yet been documented.   
2.6 Human exposure and levels 
 
The presence of TCS in human tissues has been documented by a number of studies from 
populations in Europe, USA, and Australia, which would be expected considering the number of 
personal care products containing the antimicrobial and the ability of TCS to be absorbed 
dermally (Queckenberg et al., 2010).  
2.6.1 Urine 
Measuring the levels of environmental chemicals, such as TCS, in urine represents an 
important biomonitoring tool for exposure assessment, especially considering TCS and its 
metabolites are excreted primarily in urine (Queckenberg et al., 2010). One of the earlier 
characterizations of the baseline excretion of TCS in urine, along with plasma levels, was 
published by Sandborgh-Englund et al. (2006).  Five male and five female subjects with a median 
age of 28 years were exposed to a single oral dose of TCS, and urine and blood samples were 
collected before and up to 8 days after exposure. The baseline excretion of TCS was in the range 
of 0.1 to 743 µg d-1, and although maximal plasma levels were reached within 1 - 3 h in all 
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subjects, plasma levels varied considerably, ranging between 0.1 to 8.1 µg l-1. Neither baseline 
urinary excretion of TCS nor plasma levels were correlated with the use of TCS containing 
personal care products. The authors provided three possible explanations for these unexpected 
results: 1. the monitoring of personal hygiene products was not exhaustive, 2. labelling of product 
contents was not complete, 3. other sources of exposure explain the variable baseline levels. 
Indeed, other sources of TCS exposure may include sportswear items, shoes, socks, and 
impregnated household items (Adolfsson-Erici et al., 2002). The full range of consumer, 
industrial, and pharmaceutical products that contain TCS needs to be included in future exposure 
assessment studies in humans.   
To further assess the exposure to TCS in a representative sample of the U.S. population, 
the National Health and Nutrition Examination Survey (NHANES) collected 2,517 urine samples 
and detected TCS in 74.6% of the samples at concentrations of 2.4-3,790 µg l-1 (Calafat et al., 
2008). TCS concentrations varied with age and socio-economic status, but not race/ethnicity or 
sex. Concentrations were the highest amongst people in their 30’s and those with higher 
household incomes. The high frequency of detection resulting from this study is not surprising, 
since a significant proportion of personal care products on the market today contain TCS, with 
personal care products considered the primary route of exposure. 
As with other toxicants, including potential endocrine disruptors, childhood exposures are 
a concern, as it is uncertain how these chemicals may alter growth and development processes. In 
light of the high potential for exposure to TCS, a better understanding of TCS exposure and levels 
in children is urgently needed.  A pilot study by Wolff et al. (2007) collected urine samples from 
90 girls between the ages of 6 and 8. Sampling was conducted in a manner that ensured that 
participants represented four racial groups (Asian, African American, White, and Hispanic) and 
three regional locations (New York City, Cincinnati, and the San Francisco Bay area of 
California). Urinary concentrations of TCS for all sites were between 1.6-956.0 µg l-1, with a 
median concentration of 7.2 µg l-1.  
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2.6.2 Plasma 
TCS was detected in human plasma in a study investigating the body burden of phenolic 
halogenated compounds (PHC) (Hovander et al., 2002).  Ten samples of blood plasma were 
randomly selected from male donors between the ages of 30 and 40, donated from a blood donor 
central at a hospital in Stockholm, Sweden. The authors identified TCS as one of more than 100 
PHC’s present in the plasma of Swedish males. Building on the work of Hovander et al. (2002), 
later studies, including the study of baseline plasma levels and urine excretion of TCS 
(Sandborgh-Eglund et al., 2006, see section 4.1), have detected the antimicrobial in humans.  
The ubiquitous presence of TCS in the plasma of nursing mothers in Sweden has been 
documented by Allmyr et al. (2006).  Plasma concentrations of TCS ranged from 0.010–38 ng g-1, 
and in contrast to the study by Sandborgh-Eglund et al. (2006), median TCS concentrations in 
subjects classified as users of products containing TCS were significantly higher than those in the 
control group, although the antimicrobial was detected in plasma samples from both the exposed 
and the control group. Of interest is the presence of TCS in the entire study population, indicating 
that other routes of exposure than personal care products influence plasma concentrations of TCS. 
Determining the various potential sources of TCS in human tissues warrants further research. As 
it currently stands, not all countries require TCS to be listed on a product’s label, making it 
difficult to ascertain all the potential sources of exposure to the antimicrobial.  
The influence of age, gender, and place of residence on plasma concentrations of TCS in 
the Australian population have been examined by Allmyr et al. (2007). In this particular study, 
place of residence had no effect on serum concentrations of TCS, while age and gender exerted 
minimal yet significant influence. TCS concentrations were more elevated in males than females, 
and reached peak concentrations in the group of 31-45 year old males and females. Due to the 
lack of marked differences in plasma concentrations observed in the study, the authors concluded 
that the exposure of the Australian population to TCS is relatively homogenous. In comparison to 
data from the Swedish population, serum levels of TCS were 2 times higher in the Australian 
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population, a phenomenon which is most likely due to the fact that the Swedish government 
strongly discourages consumers from using antibacterial products (Swedish Chemical Agency, 
2001). 
Dirtu et al. (2008) tested the sensitivity of solid-phase extraction and gas chromatography 
coupled to electron-capture negative-ionization mass spectrometry to detect phenolic compounds, 
including TCS, in human serum. The method used in the study yielded results that were 
comparable to previous data collected on the levels of TCS in human fluids. In this study, the 
median concentration of TCS in Belgian human serum samples (n=21) was 0.52 ng ml-1. As in 
earlier studies, TCS exhibited a high detection frequency as was evidenced by its presence in all 
the samples. 
2.6.3 Breast milk 
The lipophilicity of TCS (Kow=4.76) coupled with its relative stability in human tissues 
makes it probable that the antimicrobial will be present in breast milk, with concentrations 
relating to maternal serum levels and the fat content of the milk (Ito and Lee, 2003). The presence 
of TCS in the breast milk of Swedish women was first reported by Adolfsson-Erici et al. (2002).  
A second study measuring TCS in breast milk was carried out by Allmyr et al. (2006), confirming 
the findings that were initially reported Adolfsson-Erici et al. (2002). Concentrations of TCS in 
milk samples were higher in women who used personal care products containing TCS, compared 
to women who did not, although TCS and/or its metabolites were detected in all the milk samples. 
Concentrations of TCS ranged from < 0.018 to 0.95 ng g-1, which is comparable to the 
concentrations measured by Adolfsson-Erici et al. (2002). The universal presence of TCS in both 
groups indicates that personal care products are not the only source of human exposure to the 
antimicrobial. The levels of TCS in the subject’s milk were significantly lower than levels 
measured in their plasma, indicating that infants receive a smaller dose of TCS than what is 
present in maternal systemic circulation.  
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Building on the landmark study conducted by Adolsson-Erici et al. (2002), a risk 
assessment for TCS in human breast milk was conducted by Dayan (2007). The study obtained 62 
samples of breast milk from The Mothers Milk Banks in California and Texas.  A GC/MS 
method was used to measure TCS levels in the milk samples, expressing the results as TCS per 
lipid basis. The results of the study were as follows: no TCS detected in 2 of the samples, trace 
amounts present in 9 of the samples, with the remaining 51 samples ranging in TCS 
concentrations from 100-2100 µg kg-1 lipid. Based on the finding that a 6500-fold margin of 
safety exists between the levels of human exposure and the highest concentration of TCS that 
would elicit any adverse effects in human systems, the author concluded that the levels of TCS 
measured in breast milk do not pose a risk to breastfeeding infants. Interestingly, a recent review 
on TCS and development of margins of safety for consumer products by Rodrick et al. (2010) did 
not assess the exposure of infants to TCS through breast milk and the associated risks. The 
prevalence of TCS in human systems warrants further investigation into the bioaccumulation 
potential and toxicological effects of the antimicrobial, especially during sensitive periods of fetal 
and neonatal development.  
2.7 Kinetics and Metabolism 
 
2.7.1 Dermal 
The percutaneous absorption of TCS from personal care product preparations was first 
investigated by Black et al. (1975). Rat skin was treated with shampoo or aerosol deodorant 
containing 0.05% (w/v) and 0.1% (w/v) [3H] TCS, respectively. The degree of TCS penetration 
was calculated from the amount of radioactivity excreted from the animals. Of the total amount of 
shampoo and aerosol deodorant applied, the bulk of TCS was removed by rinsing, with only 
small amounts penetrating the skin. Kanetoshi et al. (1992) confirmed that in mice, TCS is 
absorbed through the skin and is widely distributed throughout the various compartments in the 
body. Tissue concentrations of TCS peaked at 12 or 18 h and were present in decreasing order in 
the following tissues: gall bladder, liver, lung, adipose tissue, and blood. Moss et al. (2000) used a 
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similar approach to characterize the metabolism and kinetics of TCS.  Following a dermal 
application of 3H-labelled TCS to the backs of female rats, the antimicrobial penetrated the 
dermis within the first hour of the experiment and was subsequently removed from the 
bloodstream. The primary elimination route of radioactivity was through fecal matter, with 
urinary excretion constituting a secondary removal pathway. In both urine and feces, TCS 
glucuronide and sulphate were detected, indicating that phase II biotransformation reactions play 
an essential role in the metabolism of the antimicrobial. Moreover, TCS glucuronide and sulphate 
were extracted from rat skin in vivo, suggesting that the antimicrobial is locally metabolised in 
skin cells. The amount of TCS that entered systemic circulation over the 24 hour period was 21%; 
12% of radioactivity was in the feces, 8% in the carcass, 1% in the urine, 30% in the stratum 
corneum, with 26% remaining on the surface of the skin.  
Queckenberg et al. (2010) characterized the absorption and pharmacokinetics of TCS 
after a dermal administration in human subjects. A hydrophobic cream containing 2% TCS was 
applied to the skin of six Caucasian volunteers. The 12 h exposure period culminated by the 
subjects taking a shower to eliminate any cream that remained on their skin. Urinary excretion of 
free and conjugated TCS was measured in intervals up to 168 h post-application. Of the TCS 
absorbed, the majority of the antimicrobial was excreted within 24 h.  The half-life of TCS was 
calculated to be 10.8 h. This value is consistent with the previous study by Sandborgh-Englund et 
al. (2006), which determined the median half-life of TCS based on urinary excretion to be 11 h, 
following an oral administration. The total amount of TCS excreted is reflective of the amount 
absorbed, indicating a limited potential for accumulation in the body, and further reinforcing 
previous findings that in humans, urinary excretion is a major elimination route for the 
antimicrobial. 
2.7.2 Subcutaneous 
To investigate the kinetics of subcutaneous exposure, female rats were injected with 0.5 
ml of [3H] TCS solution in aqueous polyethylene glycol (Black et al., 1975). The animals were 
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housed in individual metabolic cages, and urine and feces were collected for the analysis of 
radioactivity. Within 4 days of the injection, 89.2% of the dose was recovered, with 33% of TCS 
recovered in urine. In agreement with other animal studies on the pharmacokinetics of TCS, a 
greater proportion of radioactivity was eliminated in feces than urine. TCS levels in the blood 
peaked at 6 hours after the administration of the dose, decreasing steadily after this time, and the 
biological half-life was calculated as 14 hours. 
2.7.3 Oral 
The earliest published kinetic study of orally administered TCS is the study by Tulp et al. 
(1979).  A single oral dose of 500 mg kg-1 TCS was given to male albino Wistar rats housed in 
metabolic cages for 7 days. Fecal matter and urine was collected daily and upon termination of 
the experiment, liver and abdominal fat were collected for analysis.  TCS was metabolised 
primarily through hydroxylation, with scission of the ether bond representing a minor 
biotransformation pathway. Five hydroxylated metabolites were detected in urine, whereas only 
three of these metabolites were present in feces. The metabolite 2,4-dichlorophenol was detected 
in both urine and feces, with 4-chlorocatechol occurring in urine only, both of these metabolites 
being the product of the scission of the ether bond. In feces, TCS and its metabolites were 
excreted primarily unconjugated, with significant amounts of the parent compound present in 
both urine and feces. On completion of the experiment (7 days), TCS was present in both liver 
and abdominal fat samples, but because the dose of the TCS was so high (500mg kg-1), no 
conclusions could be made about its bioaccumulation potential. The authors concluded that the 
metabolism of TCS is unlikely to yield chlorodibenzo-p-dioxins or chlorodibenzofurans.  
A later study by Kanetoshi et al. (1988) examined the disposition and excretion of TCS 
and its three chlorinated derivatives in mice. [3H]-TCS and 2',3,4,4'-tetrachloro-2-
hydroxydiphenyl ether, 2',4,4',5-tetrachloro-2 hydroxydiphenyl ether and 2',3,4,4',5-pentachloro-
2-hydroxydiphenyl ether were orally administered to male mice. Radioactivity was primarily 
distributed in the gall bladder, liver, lung, heart, and kidneys. Of the five tissues, TCS was most 
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concentrated in the gall bladder, which the authors attributed to biliary excretion via enterohepatic 
circulation. These results are consistent with other studies that have determined that in animals, 
radiolabelled TCS is excreted primarily in feces and secondarily in urine (Siddiqui and Buttar, 
1979; Moss et al., 2000). The 3H-labelled TCS was rapidly absorbed and excreted, with 
calculated half-life of 8 hours. At the 24 hour mark, the radioactivities of TCS and its three 
chlorinated derivatives were nearly completely eliminated from all tissues, indicating that TCS 
and/or its metabolites do not accumulate in the body.  Gilbert and Williams (1987) investigated 
the oral retention and pharmacokinetics of [3H]-TCS in an antimicrobial toothpaste. Twelve 
healthy male volunteers between the ages of 19-37 were recruited for the study and brushed their 
teeth with 1g of toothpaste containing 0.02% of [3H]-TCS. The oral retention of TCS was found 
to be 36.3 ± 1.4%. TCS remained in bacterial plaque for at least 8 hours after dosage and in oral 
mucosa for three hours. A review on the safety of TCS was conducted by DeSalva et al. (1989), 
evaluating data from multiple sources including pre-clinical and clinical studies, data submitted to 
the Antimicrobial I OTC Review Panel and unpublished work from the Pharmacology and 
Toxicology Department of the Colgate-Palmolive company. Humans, dogs, rabbits, and rats were 
used to study the pharmacokinetics of TCS. Routes of administration included oral, dermal, and 
intravenous; pharmacokinetic data on the antimicrobial indicated that in humans, the kidneys are 
the main excretory organ responsible for the elimination of TCS, as is evidenced by the 
proportion of TCS and its conjugates that are concentrated in urine. 
The buccal absorption of TCS from 0.03% mouthwash was calculated by Lin (2000). 
Subjects were given 15 ml of TCS oral mouthrinse or a placebo oral rinse to be used twice daily. 
Blood and dental plaque samples were collected 4 hours and 1 hour after rinsing, respectively. 
The average daily retention dose of TCS was 0.660 mg which translates into 7.33% of the 
original dose. On average, TCS concentrations in plaque were in the range of 20.5-46.4 µg per g 
of plaque collected. The average concentration of TCS in plasma ranged from 74.5-94.2 µg ml-1, 
with peak concentrations attained two days following exposure. Plasma levels of TCS returned to 
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baseline concentrations eight days after the last treatment. More recently, Sanborgh-Englund et 
al. (2006) examined the pharmacokinetic pattern of TCS in humans after a single dose oral 
administration. Subjects were required to fast overnight and the following morning they were 
given 13 ml of a 0.03% mouthwash solution, equivalent to a 4 mg oral dose of TCS.  Blood and 
urine levels were monitored prior to exposure and up to 8 days after exposure, and baseline levels 
of TCS in plasma and urine were determined for each subject. Plasma concentrations of TCS 
increased rapidly after dosing, attaining peak levels within 1 to 3 hours, resulting in a terminal 
plasma half-life of 21 hours. In plasma, 30-35% of TCS was present in the unconjugated form. 
These results are different from those of DeSalva et al. (1989), who reported that the entirety of 
TCS measured in plasma was in the conjugated form (either glucuronide or sulfonate). 
Unfortunately, the basis for these differences is unknown. Lastly, the cumulative urinary 
excretion of TCS was 54%, occurring 4 days after exposure and the calculated urinary excretion 
half-life was 11 hours. The results of this study confirmed again that TCS is rapidly absorbed 
from the gastrointestinal tract and swiftly eliminated from the body, usually within a 24 hour 
period. 
2.7.4 Intravenous 
Siddiqui and Buttar (1979) investigated the pharmacokinetics of intravenous and 
intravaginal injections of TCS in sexually mature virgin Wistar rats. 14C-Triclosan was injected 
into the femoral vein (5 mg kg-1 in polyethylene glycol-400) or the vaginal orifice (5 mg kg-1 in 
corn oil) and liquid scintillation spectrophotometry was used to determine radioactivity. In both 
treatments, the rate of transfer from plasma to tissues was rapid, likely attributable to the 
lipophilicity of TCS. The half-life of TCS in the β phase was 8.8 ±0.6 hr and the blood clearance 
rate was 77.5±11.3 ml kg-1 hr-1 after intravenous injection or intravaginal administration. In the 
intravenous administration, after 24 hours, 18% of TCS was excreted in feces and 9% was 
eliminated in urine. In contrast, the intravaginal injections resulted in excretions of 26% in feces 
and 14% in urine.  
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 2.7.5 Phase I and II enzymes 
There is evidence for the ability of TCS to interact with cytochrome P450 enzymes in 
liver microsomes, although the effects may be dose- and species-dependent. The antimicrobial 
inhibited in vitro methylcholanthrene (MC)- and phenobarbital (PB)-inducible P450-dependent 
monoxygenases, specifically pentoxyresorufin O-depentylase (PROD) and ethoxyresorufin O-
deethylase (EROD) activity, competitively or noncompetitively  (Hanioka et al., 1996).  These 
results are important since induction of P450 isoforms of the CYP1A or CYP2B subfamily 
closely relates to toxicity of the antimicrobial.  A later study (Hanioka et al., 1997) reported that 
TCS (Irgasan DP300) induces the P450 isoforms of the CYP2B subfamily.  Similar results 
suggesting that TCS is a phenobarbital-type inducer were reported by Jinno et al. (1997), in 
cultured rat hepatocytes and by Katenoshi et al. (1992), in mice liver microsomes.  In contrast, 
Ishibashi et al. (2004) found no evidence that TCS induces EROD and PROD activity in the 
hepatic microsomes of female medaka, Oryzias latipes. This discrepancy may be due to 
physiological differences between mammals and fish, and/or differences in exposure.  Jacobs et 
al. (2005) presented in vitro evidence for TCS acting as a ligand, with a moderate affinity for the 
human pregnane X receptor (hPXR). The hPXR regulates the expression of phase I enzymes such 
as cytochrome P450 3A4 (CYP3A4), which play an integral role in the biotransformation of 
approximately 50% of pharmaceuticals (Luo et al., 2002; Jacobs et al., 2005). Compounds that 
are capable of upregulating the transcription of CYP3A4 enzymes can alter the rate at which 
pharmaceuticals are metabolised, creating the potential for adverse effects. 
TCS, structurally similar to hydroxylated polychlorinated biphenyls, also interacts with 
Phase II enzymes. TCS is both a substrate and inhibitor of sulfonation and glucoronidation in 
human liver cytosol and microsomes (Wang et al., 2004). The inhibition of sulfonation was non-
competitive, while the inhibition of glucuronidation was competitive. These results confirm 
earlier evidence of the inhibition of sulfation, specifically that of thyroid hormones, by TCS and 
other hydroxylated halogenated chemicals (Schuur et al., 1998). TCS sulfonation in polar bear 
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liver, similar to human liver in respect to enzyme affinity, was characterized by Sacco and James 
(2005).  In addition to effects on Phase I and Phase II enzymes, TCS may have direct effects on 
mitochondria, impairing function through an uncoupler effect and disrupting mitochondrial 
membrane fluidity (Newton et al., 2005).   
  The available evidence indicates that the two most probable routes of exposure to TCS in 
humans are ingestion and/or percutaneous absorption.  Low but detectable levels of TCS have 
been reported in drinking water (Loraine and Pettigrove, 2006; Servos et al., 2007).  Blanset et al. 
(2007) estimated the ADI (acceptable daily intake) for TCS at 0.05 mg kg-1.day-1, and concluded 
that based on TCS levels typically measured in drinking water, the risk to human health is 
minimal.  Concentrations of TCS in the blood are directly related to consumer use patterns of the 
antimicrobial. In humans, after an oral dose of TCS, the antimicrobial is eliminated primarily as 
conjugated metabolites in urine.  In the study by Sandborogh et al. (2006), approximately 70% of 
the total amount of TCS measured in plasma existed as either sulphate or glucuronide conjugates. 
TCS interacts with phase I and II enzymes, contributing to its toxicity and endocrine disrupting 
properties.   
2.8 Toxicity 
 
Numerous studies have evaluated the toxicity of TCS in various organisms, including 
algae, invertebrates, amphibians, fish, birds and mammals.  Data from mammalian studies, 
including humans, has recently been reviewed by Rodricks et al. (2010).  The following section 
briefly summarizes those studies and provides a more detailed review of toxicity data from non- 
mammalian species.  
2.8.1 Acute Toxicity 
2.8.1.1 Terrestrial organisms 
Several recent studies investigated the terrestrial ecotoxicological effects of TCS.  TCS 
inhibited plant growth (EC50 57-108 mg kg-1) and soil respiration, with some evidence for 
recovery after 2 days, possibly linked to degradation of TCS (Liu et al., 2009). Waller and 
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Kookana (2009) reported that TCS, at concentrations below 10 mg kg-1, disturbs the nitrogen 
cycle in some soils. An ecological risk assessment for TCS in the terrestrial environment has been 
published by Reiss et al. (2009).  The assessment reviewed available data and found satisfactory 
margins of safety for terrestrial organisms, including earthworms, plants, and soil microorganisms 
exposed to TCS in soils amended with sewage sludge, and to birds and mammals exposed 
indirectly through the consumption of earthworms and fish. However, the number of studies 
available for the risk assessment was relatively small (n=31), indicating that further investigations 
of the potential impact of TCS on the terrestrial ecosystems are needed.    
2.8.1.2 Aquatic organisms 
Microorganisms and algae- TCS is primarily a water-borne pollutant, with numerous 
studies having investigated its toxicity in aquatic organisms (Table 2.3). The toxicity of TCS to 
WWTP sludge organisms, algae, daphnids, and fish was assessed by Orvos et al. (2002). While 
sludge microorganisms were unaffected by TCS, the aquatic species that appeared most 
vulnerable to the toxic effects of TCS were algal species such as Scenedesmus subspicatus, with a 
96-h biomass EC50 (median effective concentration) of 1.4 µg l-1 and a 96-h No-Observed-Effect-
Concentration (NOEC) of 0.69 µg l-1 (Orvos et al., 2002). Similar evidence regarding algal 
sensitivity was provided by Tatarazako et al. (2004) for Selenastrum capricornutum, and by 
DeLorenzo and Fleming (2008) for a marine phytoplankton, Dunaliella tertiolecta, (Table 2.3).  
The toxic effects of TCS were primarily due to the neutral form of TCS, where sorption and 
ionization could potentially temper these effects in the aquatic ecosystems.  The lowest NOEC for 
algae, integral components of aquatic food webs, is less than 1 µg l-1, with TCS being measured 
in the range of 0.2-2.7 µg l-1 in U.S. wastewater effluent (Reiss et al., 2002). It is then possible 
that current levels of TCS in rivers and streams (PEC, Predicted Environmental Concentration) 
may surpass the NOEC for algae, as indicated by  HQ value (Hazard Quotient, PEC divided by 
NOEC) greater than 1. Coogan et al. (2007) measured TCS levels in the algal species, 
Cladophora spp., located downstream from a WWTP. Although TCS concentrations in the water 
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column decreased downstream from the effluent output (0.12 – 0.06 µg l-1), concentrations of the 
antimicrobial in algae demonstrated the reverse pattern (100 - 150 µg l-1), indicating 
bioaccumulation. It is unclear how the propensity of algae to accumulate TCS affects the species 
vulnerability to the toxicity of the antimicrobial.  
Invertebrates- Aquatic invertebrates also exhibit vulnerability to TCS (Table 2.3).  Short 
term (30 min) exposure of hemocytes, the immune cells of bivalve Mytilus galloprovincialis, to 
TCS reduced lysosomal stability and induced the release of lysosomal hydrolytic enzymes 
(Canesi et al., 2007).  Moreover, in vivo exposures of the bivalve affected glycolytic enzymes and 
redox balance in different systems/organs. For Daphnia magna, a key invertebrate aquatic 
species, the 48-h median effective concentration was 390 µg l-1 (Orvos et al., 2002).  The toxicity 
of TCS to the midge, Chironomus tentans, and the freshwater amphipod, Hyalella azteca, was 
evaluated in a 10-day exposure test (LC50 0.4 mg l-1 and 0.2 mg l-1, respectively).  TCS was more 
toxic than carbamazepine, an anticonvulsant, and atorvastatin, a lipid regulator (Dussault et al., 
2008).  
Fish- Kim et al. (2009) assessed the acute toxicity of TCS in two test species, a 
freshwater crustacean (Thamnocephalus platyurus) and a fish (Oryzias latipes). The organisms 
were exposed to a range of TCS concentrations and the 24-h LC50 values were determined by 
probit analysis. The LC50 values of TCS for T. Platyurus and O. Latipes were 0.47 mg l-1 and 0.60 
mg l-1, respectively. The LC50 (96-h) value for O. Latipes calculated in this study confirms the 
previous findings of Tarazako et al. (2004), in which an LC50 value of 0.40 mg l-1 was ascertained 
for the antimicrobial.  
Nassef et al. (2010) applied in ovo nanoinjection of TCS to medaka embryos and 
determined 4.2 ng egg-1 as the EC50 value based on survival and embryonic development.  Foran 
et al. (2000) examined the acute toxicity of TCS in medaka fry (Table 2.3). Concentrations of 1 
mg l-1 and 500 µg l-1 resulted in fry death within 24 hours and 3 days, respectively.  The LC50 (48-
h) for medaka fry was calculated to be 352 µg l-1.  A 96-h median lethal concentration of 602 µg 
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l-1 for medaka fry was reported by Ishibashi et al. (2004).   Although this value is higher than the 
LC50 (48-h) of 352 µg l-1 previously determined by Foran et al. (2000), it appears that during early 
development, fish are especially vulnerable to the toxic effects of TCS.  Nassef et al. (2009) used 
adult Japanese medaka as the test organism in an acute toxicity study and observed concentration- 
and time-dependent mortality.  Test solutions of TCS were 1, 2, 2.4, and 3 mg l-1 and the adult 
fish were exposed to TCS for a period of 96 h. Reported 96-h survival rates were 100% (1mg l-1), 
16.7% (2 mg l-1), 3.3% (2.4 mg l-1), and 0% (3 mg l-1).  At higher exposure levels (2.4 and 3 mg l-
1), fish displayed abnormal behaviours and experienced a loss of equilibrium. The LC50 (96-h) of 
TCS for adult medaka was 1.7 mg l-1, while the NOEC was estimated at 1.7 µg l-1, which is 12 
times higher than the PEC for the antimicrobial.  The authors of this study are in agreement with 
Ishibashi et al. (2004), in their conclusion that TCS is highly toxic to fish. 
Oliveira et al. (2009), in an experiment similar to the one by Nassef et al. (2009), studied 
the acute toxicity of TCS in different life stages of zebrafish (Danio rerio). The effect of TCS on 
mortality, and developmental, genetic and enzymatic biomarkers were determined in adult fish 
and embryo/larvae using the OECD guidelines on Fish Embryo Toxicity. At concentrations above 
0.7 mg l-1, TCS exhibited teratogenic effects, delaying embryo development and resulting in 
mortality within 48 hours. The LC50 (96-h) of TCS for embryo/larvae was 0.42 mg l-1. The results 
of the biomarker analysis indicated that TCS increased the activity of ChE (0.25 mg l-1), LDH 
(0.25 mg l-1), and GST (0.25 and 0.35 mg l-1). Based on the results, concentrations of TCS equal 
to, or above 0.3 mg l-1, were estimated to constitute a hazard for aquatic ecosystems. Using the 
OECD Guideline TG 203 in semi-static conditions, the LC50 (96-h) value for adult zebrafish was 
determined as 0.34 mg l-1, a value similar to the LC50 (96-h) of 0.42 mg l-1 for zebrafish larvae. 
The acute toxicity of TCS was primarily limited to behavioural effects, none of which were 
studied in detail. Abnormal behavioural patterns observed during the study included irregular 
swimming, loss of equilibrium, and anomalous gill movement.  In contrast to the embryo/larvae 
stage, there was no evidence of genotoxicity or changes in enzyme levels of ChE, GST, and LDH 
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in adult zebrafish. Although there are differences in species sensitivity to TCS, the range of LC50 
(96-h) is relatively small (Table 2.3);  the 96-h median lethal concentration values for Pimephales 
promelas and Lepomis macrochirus were 260 and 370 µg l-1, respectively (Orvos et al., 2002), 
while the value for adult zebrafish was 340 µg l-1. During early development, juvenile fish are 
more sensitive to TCS than adults. In an early life-stage toxicity test with Oncorhynchus mykiss, 
the NOEC and the lowest-observed-effect concentration (LOEC) were 34.1 µg l-1 and 71.3 µg l-1, 
respectively (Orvos et al., 2002).  
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Table 2.3: Effects of Triclosan (TCS) in freshwater (FW) and marine (SW) organisms 
Test species Life stage System  
type 
Route of 
exposure 
Test 
duration 
TCS  
exposure 
Endpoint Reference 
 
Phytoplankton  
(Dunaliella tertiolecta) 
 
  
SW 
 
Water 
(static) 
 
Acute  
(96-h) 
 
3.5 µg l-1 
 
EC50 
(population 
density) 
 
deLorenzo and  
Fleming, 2008 
Green alga  
(Selenastrumcapricornutum) 
 
FW Water  
(static) 
Acute  
(72-h)  
4.7 µg l-1 EC50 
(growth) 
Tarazako et al.  
2004 
Green alga 
(Scenedesmus subspicatus) 
 
FW Water 
(static) 
Acute  
(96-h) 
1.4 µg l-1 EC50  
(biomass) 
Orvos et al. 2002 
Alga (Closterium ehrenbergii) 
 
FW Water 
(static) 
Acute  
(48-h) 
620 µg l-1;  
250 µg l-1 
EC50  
Genotoxicity 
 
Ciniglia et al.  
2005 
Blue-green alga 
(Anabaena flos-aquae) 
 
 FW Water 
(static) 
Acute  
(96-h) 
1.6 µg l-1 EC50  
(biomass) 
Orvos et al. 2002 
INVERTEBRATES 
Daphnia magna 
  
FW 
 
Water 
(renewal) 
 
Acute (48-h) 
21 d 
 
390 µg l-1 
40 µg l-1 
 
 
EC50  
NOEC 
reproduction  
 
Orvos et al. 2002 
Ceriodaphnia dubia  FW Water 
(renewal) 
Acute (48-h) 
7 d 
240 µg l-1  
182 µg l-1 
 
EC50  
NOEC 
reproduction  
Orvos et al. 2002 
  FW Water  
(renewal) 
 
 6-7 d 220 µg l-1 IC50 
(growth) 
Tarazako et al.  
2004 
Chironomus tentans 
Hyalella azteca 
 
 FW Water  
(renewal) 
10 d 400 µg l-1  
200  µg l-1 
LC50  Dussault et al.  
2008  
Grass shrimp Embryo SW Water  Acute  651 µg l-1   LC50 DeLorenzo et al.  
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(Palaemonetes  
pugio) 
Larvae 
Adult 
 
(renewal) (96-h) 154 µg l-1   
305 µg l-1  
LC50 
LC50 
2008 
Crustacean 
(Thamnocephalus 
platyurus) 
 
 FW Water  
(static) 
Acute  
(24-h) 
470 µg l-1  LC50 Kim et al. 2009 
Bivalve 
(Mytilus  
galloprovincialis) 
 
hemocytes SW In vitro Acute  
(30 min) 
1 µM ↓ lysosomal 
membrane 
stability 
Canesi et al. 2007 
 Whole 
animal 
 
SW Injection  Acute  
(24-h) 
2.9 ng g-1 Altered 
hemocyte and 
digestive gland 
function 
Canesi et al. 2007 
Zebra mussel 
(Dreisena  
polymorpha) 
hemocytes FW In vitro 
 
In vivo 
 
Acute  
(60 min) 
Acute (96-h) 
0.1 µM 
 
1 nM 
Genotoxicity 
 
Genotoxicity 
Binelli et al. 
 2009a, b 
 
 
 
Rainbow trout 
(Oncorhynchus  
mykiss) 
Adult 
 
 
embryo 
FW 
 
 
FW 
Water  
(flow-
through) 
Acute (96-h) 
 
 
61 d 
 
35 d 
390 µg l-1   
 
 
71.3 µg l-1  
LC50 
 
 
Delayed swim-
up ; ↓ 35-dph 
survival; erratic  
swimming, 
locked jaw 
 
CIBA, 1998 
 
 
Orvos et al. 2002 
Medaka 
(Oryzias latipes) 
Fertilized 
eggs 
FW Water 
(renewal) 
14 d 313 µg l-1  ↓ hatching; 
delayed  
hatching 
Ishibashi et al.  
2004 
 Larvae 
(24-h old) 
  Acute (96-h) 602 µg l-1  LC50  
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 Male fish   21 d 20 µg l-1  ↑ liver Vtg   
 
 fry FW  
 
Acute (48-h) 350 µg l-1  LC50 Foran et al. 2000 
 eggs FW 
SW 
  
in ovo 
injection 
14 d 
1 d post- 
fertilization 
400 µg l-1  
4.2 ng 
egg-1 
IC50 (hatching) 
EC50 (survival) 
 
Tarazako et al. 2004 
Nasseff et al. 2010 
 larvae FW (static)  Acute (96-h) 600 µg l-1  LC50 Kim et al. 2009 
 adult SW  (renewal) 
 
Acute (96-h) 1700µg l-1  LC50 Nassef et al. 2009 
Bluegill sunfish 
(Lepomis  
macrochirus) 
 
 FW Water  
(renewal) 
Acute (96-h) 370 µg l-1 LC50 Orvos et al. 2002 
Fathead minnow 
(Pimephales 
 promelas) 
Adult FW Water  
(renewal) 
Acute (96-h) 260 µg l-1  LC50 (at pH 
7.5) 
Orvos et al. 2002 
 Full life 
cycle 
FW Water   
(TCS in 
mixture) 
 0.1 and 
0.3 µg l-1 
mixture of 
products 
 
No effects Fo;  
↑ larval 
deformities  
in F1  
Parrott and Bennie,  
2005 
Zebrafish 
(Danio rerio) 
eggs FW Water 
(renewal) 
9 d 220 µg l-1  IC50 
(hatching) 
Tarazako et al.  
2004 
 embryo FW 24-well  
Micro 
plates 
 
Acute (96-h) 420 µg l-1  LC50;  
teratogenic 
effects 
Oliveira et al. 
2009  
 Adult 
 
FW Semi-
static  
Acute (96-h) 340 µg l-1  LC50 Oliveira et al.  
2009  
AMPHIBIANS 
Bullfrog 
 
tadpoles 
 
FW 
 
water 
 
Acute (96 h) 
 
0.15 µg l-1  
 
 ↑hindlimb 
 
Veldhoen et al.  
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(Rana catesbeiana) development, ↓ 
body weight, 
disruption of 
thyroid 
hormone-
associated gene 
expression 
 
2006 
Xenopus leavis XTC-2 
cells 
FW In vitro Acute (24 h) 0.03 µg l-1  Altered thyroid 
hormone 
receptor 
mRNA 
expression 
 
Veldhoen et al.  
2006 
Acris crepitans 
blanchardii 
Bufo woodhousii 
woodhousii 
Rana sphenocephala 
Xenopus laevis 
 
Larvae 
 
Stage 30 
 
 
Stage 41 
FW water Acute (96-h) 367  µg l-1   
 
152  µg l-1 
 
562 µg l-1  
343  µg l-1 
 
LC50  Palenske and  
Dzialowski, 2010 
Leopard frog  
(Rana pipiens) 
tadpoles FW Static 
(weekly  
renewal) 
24 d 0.23 µg l-1  
 
230 µg l-1  
↓activity, loss 
of startle 
response, 
 ↓ survivorship 
Fraker and Smith,  
2004 
American toad  
(Bufo americanus) 
tadpoles FW Static  
(weekly 
renewal) 
14 d 230 µg l-1   ↑ activity Smith and Burgett,  
2005 
EC50 – Effective concentration; LC50-Lethal concentration; NOEC – No Observed Effect Concentration
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2.8.1.3 Amphibians 
The effects of TCS were also investigated in amphibians.  There is evidence to indicate 
that TCS affects behaviour and survivorship in tadpoles, however the effects seem to be species-
specific.  TCS increased activity levels in American toad tadpoles, Bufo americanus, although the 
effects on survivorship were not concentration dependent (Smith and Burgett, 2005).  In tadpoles 
of the Northern leopard frog, Rana pipiens, ecologically relevant concentrations of TCS 
decreased activity and survivorship (Fraker and Smith, 2004), indicating that the HQ for this 
specific endpoint is >1.0. In the latter study, no evidence of an interaction between TCS and 
caffeine or acetaminophen, pharmaceuticals often co-occuring in WWTP effluents, was detected. 
Palenske and Dzialowski (2010) assessed the species specific and developmental toxicity of TCS 
in amphibian larvae for Acris crepitans blanchardii, Bufo woodhousii woodhousii, Rana 
sphenocephala, and Xenopus laevis. Bioconcentration factors for X .laevis, B. woodhousii 
woodhousii, and R. sphenocephala were also determined. As is the case with other aquatic 
species, TCS toxicity was dependent upon larval maturity and amphibian species. X. laevis larvae 
were most vulnerable to TCS during the first two developmental stages. Larval LC50 values were 
reported as follows: 259-664 µg l-1 (X. laevis), 367 µg l-1 (A. crepitans blanchardii), 152 µg l-1 (B. 
woodhousii woodhousii), and 562 µg l-1 (R. sphenocephala), with significant differences observed 
for all three amphibian species (Table 2.3). In this study, TCS tissue uptake was related to larval 
species, stage of development and mean mass. Bioconcentration factors ranged from 44 in X. 
laevis up to 740 in B. woodhousii woodhousii. 
2.8.1.4 Mammals 
The toxicity of TCS has been tested in laboratory rodents, and other mammalian models. 
An early study by Lyman and Furia (1969), sanctioned by the Geigy Chemical Corporation, 
provided toxicological data on TCS in rats, concluding that TCS was neither acutely toxic (LD50 
oral > 1 000 mg kg-1) nor carcinogenic.  Later, nephrotoxic effects of orally administered TCS in 
rats were reported by Chow et al. (1977), in a study where the accumulation of p-aminohippurate 
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(PAH) was estimated both in vivo and in vitro, using kidney slices to detect dose-related 
inhibition. A 1989 review on the safety of TCS was published by DeSalva et al. (1989). The 
majority of data in this review cited unpublished results from reports submitted by Ciba-Geigy 
Company to the Antimicrobial I OTC Review Panel. Ciba-Geigy Company tested the acute 
toxicity of TCS on four different species of animals; mouse, rat, rabbit, and dog. Based on these 
studies, TCS was deemed not to be an acute oral toxicant. 
One of the more recent studies detailing the acute toxicity of TCS in mammals was 
conducted by Kanetoshi et al. (1992). The study evaluated the acute toxicity and percutaneous 
absorption of TCS and its chlorinated derivatives in male mice. The results indicated that TCS 
has a low acute toxicity (LD50 > 1g kg-1), a value which is in agreement with the previous 
findings of Lyman and Furia (1969).  The authors previously reported that Irgasan DP300 is 
commonly detected in commercial textile products and that an exposure to sodium hypochlorite 
(domestic bleach), leads to the formation of three different chlorinated derivatives. Worth noting, 
is that the chlorinated derivatives of TCS are significantly more toxic than TCS itself, and as the 
number of chlorine substitutions in the TCS derivatives increases, their LD50 values decrease  
(Kanetoshi et al., 1992). Dermal contact with textiles that have TCS incorporated into their fibres 
may expose consumers to chlorinated TCS derivatives. However, Rodricks et al. (2010) provided 
a recent critical review of the current mammalian literature and developed margins of safety for 
consumer products, concluding that the exposure to TCS in consumer products is not expected to 
cause adverse health effects in humans.  
Current literature suggests that while TCS is not acutely toxic to mammals, aquatic 
species such as algae and certain types of fish are highly sensitive to the antimicrobial. The 
NOEC for fish is in the range of 34.1-200 µg l-1 (Orvos et al., 2002; Ishibashi et al., 2004; 
Capdevielle et al., 2008), a concentration range which exceeds the PECs (0.01 - 0.14 µg l-1 , 
Table 2.2) for TCS. The toxicity of TCS is also dependent on the life stage of the organism, with 
juveniles having a tendency to be more vulnerable to the toxic effects of the antimicrobial.  
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2.8.2 Subacute/subchronic and chronic toxicity 
Toxicity data from prolonged exposure studies of aquatic organisms to TCS are relatively 
scarce (Table 2.3).  Algae were determined to be the most sensitive aquatic organisms in 
experiments lasting up to 21 days, as has been shown in the acute toxicity studies (Orvos et al., 
2002).  Significant adverse effects on survival and reproduction were also detected in the 
invertebrate, Daphnia magna. While juvenile rainbow trout were adversely affected by chronic 
exposures to TCS, fathead minnows were not.  Parrott and Bennie (2009) used fathead minnow 
life-cycle tests to study the sub-lethal effects of environmentally relevant mixtures (ng l-1 range) 
of a personal care product (TCS, up to 115 ng l-1) and six common pharmaceuticals. In 
comparison to controls, no significant differences in survival, growth, development, or 
reproduction were observed in any of the treatment groups. The only significant effect of the 
PPCP mixture was observed in the F1 generation; the 100 and 300 ng l-1 PPCP mixture but not 
1000 ng l-1, produced significant increases in the rates of deformities, including cardiac edema, 
spinal deformities and yolk-sac edema.  The magnitude of the effect was however low since only 
doubling or tripling of the deformity rate compared to controls, was observed. The results of the 
study are noteworthy, as they indicate that the chronic exposure of fathead minnows to an 
environmentally relevant mixture of 7 PPCPs did not affect any of the parameters tested, with the 
exception of F1 larval deformities, where the impact was relatively minor.  
Subacute and chronic toxicity data from mammalian species, including mice, rats, 
hamsters and baboons are extensive, and have been reviewed by Rodricks et al. (2010).  For 
systemic toxicity, excluding endocrine disruption, the effects of TCS were primarily limited to 
changes in the liver and kidneys. TCS induced changes in liver weight, liver enzymes, liver 
hypertrophy, and increased peroxisome size and numbers. In rodent species, renal toxicity was 
evidenced by inflammation and tubular regeneration.  
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2.8.3 Genotoxicity  
Genotoxicity and mutagenicity studies using classical prokaryotic and eukaryotic systems 
were reviewed by Rodricks et al. (2010).  The available evidence led the authors to conclude that 
TCS is neither genotoxic nor mutagenic.  However, there is some evidence to suggest that TCS 
may be genotoxic in certain types of organisms and/or cell types.   
Acute toxicity experiments (96-hour exposure) using hemocytes from zebra mussels 
(Dreissena polymorpha) that were exposed to environmentally relevant concentrations of TCS (1, 
2, 3 nM) provided evidence of genotoxicity after only 24 hours of exposure (Binelli et al., 2009a). 
The genotoxicity of TCS in hemocytes was evaluated with the single cell gel electrophoresis 
(SCGE) assay (also known as the Comet assay), the micronucleus assay, and the Halo test, a 
measure of the apoptotic frequencies, while cytotoxicity was assessed with the neutral red 
retention assay.  The genetic damage accrued in the hemocytes was significant at all three 
concentrations of TCS, following a concentration-dependent and time-dependent pattern. The 
authors of this study concluded that the genotoxicity of TCS in zebra mussels was likely due to a 
combination of oxidative stress and/or a direct effect on DNA. In a follow up study (Binelli et al., 
2009b), hemolymph from zebra mussels was extracted and then used to investigate TCS’s 
potential for both cytotoxicity and genotoxicity. In this experiment, antimicrobial concentrations 
of 0.1, 0.15, 0.2, and 0.3 µM caused extensive DNA damage in hemocytes, as was indicated by 
the SCGE assay and the apoptotic frequency. Although the range of concentrations used in this 
study was very narrow, the results clearly indicated that TCS’s genotoxicity increased in a dose 
dependent fashion. Based on these two studies, there is compelling evidence to suggest that TCS 
has genotoxic effects in zebra mussels, both in vivo and in vitro, although future studies are 
needed to confirm these findings. 
The genotoxicity of TCS has also been evaluated using the Comet Assay in the algal 
species Closterium ehrenbergii (Ciniglia et al., 2005). Algal cells were exposed to TCS for 96-h, 
at concentrations in the range of 0.125-1 mg l-1. At concentrations of 0.25 mg l-1 and greater, the 
73 
 
genetic toxicity of TCS was apparent, with the antimicrobial exerting its toxicity in a dose 
dependent manner. Complete dissolution of the nucleus was observed at concentrations of 0.5 and 
1 mg l-1. Although the results of this study indicate that TCS has genotoxic effects on C. 
ehrenbergii, the concentrations used in the experiment were much higher than those typically 
observed in surface water (HQ < 1.0), and as such, the results should be interpreted with caution. 
The genotoxicity and cytotoxicity of TCS has been tested in animal cell lines.  
Zuckerbraun et al. (1998) demonstrated that TCS is cytotoxic to Smulow-Glickman cells (S-G 
cells), which are derived from a human gingival epithelial cell line.TCS damaged the integrity of 
the plasma membrane and induced apoptotic cell death.  The effects of TCS on gingival cells are 
important, as TCS is a common ingredient in a number of oral hygiene products. Jirasripongpun 
et al. (2008) used the Comet Assay and the Apoptosis Assay to test the genotoxicity of TCS on 
two animal cell lines. KB and Vero cell lines were treated with two concentrations of TCS, the 
50% inhibition concentration (IC50, 0.034 and 0.036 mM respectively) and the maximum 
concentration of TCS in personal care products (0.023 mM). In both cell lines, the number of 
comet cells increased as the concentration and exposure time to TCS increased. Most notably, 
genetic damage accrued from the exposure to TCS was observed at concentrations in the IC20-30 
range, following a 5 day exposure period. At levels of TCS that are normally in personal care 
products, the antimicrobial failed to produce any signs of genotoxicity.  TCS is a lipophilic 
chemical and as such, could potentially accumulate in the body. However, exposure to TCS levels 
that cause genetic damage is unlikely, considering that pharmacokinetic studies have 
demonstrated that the antimicrobial is rapidly metabolized and readily eliminated from the body.  
2.8.4 Mutagenicity and carcinogenicity 
Reviews of data on TCS’s safety by DaSalva et al. (1989), Bhargava and Leonard (1996), 
and more recently by Rodricks et al. (2010), included extensive data from mutagenicity assays, 
many completed by Ciba-Geigy Co. The overwhelming majority of these assays indicated that 
TCS did not exhibit any mutagenic potential, with the exception of the mammalian spot test. The 
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mammalian spot test was first performed by Fahrig et al. (1978) and resulted in a positive 
response, but later yielded negative results when repeated by Russell and Montgomery (1980). 
The study published by Fahrig was criticized, and it has been suggested that the effective dose of 
TCS used by Fahrig would result in maternal toxicity, thus precluding evaluation in the offspring.  
It is not clear why these two studies, using the same method, yielded such very different results. 
Fahrig et al. used a higher dose of TCS dissolved in HBSS, whereby Russell and Montgomery 
deemed TCS to be insoluble in HBSS, opting to dissolve the antimicrobial in methanol instead. 
Montgomery and Russell conjectured that due to the limited solubility of TCS in HBSS, the 
experiment by Fahrig et al. likely failed to inject any of the dams with TCS, which would explain 
the limited toxicity observed at the 50 mg kg-1 dose, a dose which proved to be highly toxic to 
embryos in the study by Russell and Montgomery. The majority of researchers seem to accept the 
findings of the experiment by Russell and Montgomery, as reviews on TCS safety (DaSalva et al., 
1989; Bhargava and Leonard, 1996; Rodricks et al., 2010) consistently conclude that TCS is not a 
mutagen and that personal care products containing the antimicrobial do not pose a risk to human 
health. 
The mutagenic potential of TCS and its photodegradation products were later examined 
by Onodera et al. (1995), in two Salmonella strains tested with and without S9 fractions.  Any 
mutagenic effects of TCS went undetected, due to the high toxicity of the antimicrobial to the test 
species. Following treatment with photo-irradiation and chlorine, TCS in aqueous solution failed 
to elicit a mutagenic effect in either of the Salmonella strains tested. However, it would seem that 
the selection of bacteria to test the mutagenicity of TCS is somewhat questionable, considering 
that TCS is a potent antimicrobial and would be highly toxic to the bacterial test species.  
Currently available evidence from studies using classical assay systems indicates that 
TCS is neither genotoxic, mutagenic, or carcinogenic. However, there is some evidence that TCS 
is able to exert genotoxicity in non mammalian systems, including algae and bivalves. Due to the 
limited number of studies addressing the genotoxicity, mutagenicity, and carcinogenicity of TCS 
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in non- mammalian systems, it is difficult to conclude with certainty that the antimicrobial does 
not display a potential for harm. 
2.8.5 Reproductive and developmental effects 
The reproductive and developmental toxicity of TCS was assessed in several aquatic 
species, under controlled laboratory exposures. Orvos et al. (2002) investigated the early life-
stage toxicity of TCS to rainbow trout. No statistical differences were observed in mean time to 
egg hatch among groups exposed to different concentrations of TCS in water, although swim-up 
behaviour was delayed in the 71.3 µg l-1 treatment (Table 2.3). Decreased rates of fry survival 
were observed in this treatment group. Sublethal effects were also observed during the course of 
the study, and included a loss of equilibrium, locked jaw, erratic swimming, spinal deformities, 
and reduced activity. 
The effects of TCS on early development and reproduction in medaka were studied by 
Ishibashi et al. (2004). In fertilized eggs exposed to 313 µg l-1 of TCS, hatchability and time to 
hatching were significantly decreased and postponed, respectively. A 21 day exposure period to 
the antimicrobial failed to have any observable effect in the number of eggs produced and 
fertility, when comparing the control group to the 20, 100, 200 µg l-1  TCS treatments. TCS 
appears to be quite toxic during the early life stages of medaka, and although the metabolite of 
TCS had weak estrogenic activity, the antimicrobial did not negatively impact the reproductive 
success of paired medaka or the survivability, growth, and sex ratios of the offspring.  
In addition to the acute toxicity of TCS in adult fish, Oliveira et al. (2009) investigated 
the teratogenic effects of TCS on zebrafish larvae. The experiment was designed according to the 
OECD guideline on Fish Embryo Toxicity Test. Zebrafish embryos were exposed to five different 
concentrations of TCS; 0.1, 0.3, 0.5, 0.7 and 0.9 mg l-1 for a 6 day period. The embryos were 
monitored daily for mortality, developmental parameters, and hatching. Additional larvae were 
collected for cholinesterase (ChE), glutathione S-transferase (GST), and lactate dehydrogenase 
(LDH) biomarker analyses. TCS exhibited acute toxicity for embryo/larvae (96 h LC50 of 0.42 mg 
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l-1), resulting in delayed hatching, and mortality at 48 h. The teratogenic effects of TCS were 
observed at concentrations above 0.7 mg l-1. The developmental effects of TCS included delayed 
otolith formation and eye and body pigmentation, spinal malformations, pericardial edema, and 
undersized larvae. In addition to embryo malformations, biomarker levels were also affected: 
ChE activity increased in the 25 mg l-1 treatment, GST activity increased in both the 0.25 and 
0.35 mg l-1 treatments, and LDH activity increased in the 0.25 mg l-1 treatment. The results of this 
study indicate that TCS is toxic to zebrafish embryo/larva and negatively impacts hatching, 
embryonic development, enzyme activities, and survival. Based on the sensitivity of the 
biomarkers analyzed (GST, ChE, and LDH), the authors concluded that concentrations of TCS 
equal to or greater than 0.3 mg l-1 constitutes a significant environmental hazard. 
Reproductive and teratological studies in rats, mice and rabits carried out by Ciba-Geigy 
were reviewed by DaSalva et al. (1989), Bhargava and Leonard (1996), and Rodericks et al. 
(2010).  In the rat study, TCS was administered in the diet. There were no effects on reproductive 
performance at any of the doses, including the highest dose of 3000 mg kg-1. Effects in the 
offspring were detected only in pups from mothers fed the highest dose of TCS. In rabbits, TCS 
was administered by oral intubation to mothers, but no teratogenic effects were observed in the 
offspring.  The reviews concluded that at doses of 150 mg kg-1 and higher, TCS is toxic to 
pregnant rats, but is not an overt teratogen.  Similar conclusions regarding reproductive and 
developmental toxicity of TCS to mammalian species were reached by Rodricks et al. (2010).  
However, a study by Russell and Montgmory (1980), cited mostly for the failure to confirm 
mutagenicity of TCS in the mouse spot test, did provide some reproductive data for TCS.  A 
single intraperitoneal dose of 25 mg kg-1 TCS affected the survival of embryos, significantly 
reducing litter size. In addition to reduced prenatal survival, an average dose of 3.2 mg kg-1 TCS 
resulted in significant decreases in postnatal survival. Despite the pronounced effects of TCS on 
survivability, very few externally identifiable abnormalities were observed in newborn mice in 
the higher dose groups. The study by Russell and Montgomery is one of the few studies to have 
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examined the effects of TCS on mammalian development, as more recent studies have focused 
primarily on aquatic species. 
2.8.6 Endocrine Disruption 
The structural similarity of TCS to known estrogenic and androgenic EDCs, including 
polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and bisphenol A, 
and to thyroid hormones (Norris and Carr, 2006; Veldhoen et al., 2006; Cabana et al., 2007; 
Allmyr et al., 2008) would be predictive, using the structure-activity relationship, of endocrine 
disruption.  Several studies have shown that the antimicrobial has the ability to influence 
endocrine function in a variety of species (Table 2.4). This represents a considerable concern, as 
large amounts of TCS are used on a regular basis, with the antimicrobial having been detected in 
human plasma (Hovander et al., 2002), breast milk  (Adolfsson-Erici et al., 2002), urine (Calafat 
et al., 2008), and the aquatic environment (Chalew and Halden, 2009).  
2.8.6.1 Thyroid Hormones 
Investigations of the propensity of TCS to disrupt thyroid homeostasis are based on the 
structural similarity of the antimicrobial to thyroid hormones. If TCS is indeed capable of 
perturbing the thyroid axis, the implications for developmental processes could be profound.  
The first study to investigate the effects of polyhalogenated aromatic hydrocarbons 
(PHAHs), including TCS, on the metabolism of thyroid hormones was conducted, to the authors’ 
knowledge, by Schuur et al. (1998). The in vitro inhibition of diiodothyronine (T2) 
sulfotransferase activity was measured using rat liver cytosol (Table 2.4). After an incubation of 
the PHAHs with induced liver microsomes, T2 sulfotransferase inhibiting metabolites were 
formed. Specifically, the IC50 for TCS was 3.1±0.7 µM. The results of this study were the first to 
indicate that TCS and its metabolites, like other hydroxylated halogenated compounds, are 
capable of inhibiting in vitro sulfation of thyroid hormones. Thyroid hormones are inactivated by 
sulfation, with sulfation playing a pivotal role in controlling thyroid metabolism during the 
developmental period (Norris and Carr, 2006). Schuur et al. (1998) postulate that fetal exposure 
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to hydroxylated compounds such as TCS, could result in the inhibition of thyroid hormone 
inactivation, with potential consequences to thyroid mediated developmental processes. Future 
studies are needed to address the in vivo potential of TCS to alter T2 sulfotransferase activity, and 
what, if any, effect that would have on the embryo and developing fetus.  
To further assess the endocrine disrupting potential of TCS, Veldhoen et al. (2006) 
conducted a study to assess the potential of TCS to alter thyroid-mediated developmental 
processes in premetamorphic North American bullfrog (Rana catesbeiana) tadpoles (Table 2.4). 
Tadpoles were immersed in low concentrations of TCS for 4 days, and on day 4 were injected 
with 3,5,3’-triidothyronine (T3) or a vehicle control. TCS exposure continued after the injection 
of T3, ending on day 6, day 11, or day 18, with tissue samples collected and morphometric 
measurements made. Pretreatment with TCS concentrations as low as 0.15 µg l-1 accelerated 
metamorphological changes following the administration of T3. Within 48 h of T3 treatment, T3 
mediated TRβ mRNA expression in the tadpole tail decreased and levels of PCNA (proliferating 
nuclear cell antigen) transcript in the brain increased. In the absence of T3, TCS alone affected 
thyroid hormone receptor α transcript levels in the brain and resulted in transitory weight loss. 
The results of this study indicate that environmentally relevant levels of TCS are capable of 
disrupting developmental processes that are contingent on thyroid hormones in the bullfrog.  Fort 
et al. (2010), exposed Xenopus laevis (South African clawed frog) larvae to TCS (0.6-32.3 µg l-1) 
over a 21-day exposure period. Although the authors concluded that TCS did not have an effect 
on larval development, thyroid histology, plasma thyroxine levels, and/or survivorship, the 
reported data suggest that TCS did have an effect on the postembryonic development of the 
tadpoles. Moreover, there was a significant difference between the exposed group and the control 
in the expression of TRβ, which was induced by a magnitude of 1.5 in the 1.5 and 7.2 µg l-1 TCS 
treatments. A reduction in larval growth in the 1.5 µg l-1 treatment was also observed. The 
evidence available from amphibian studies suggests that metamorphosis of amphibians is highly 
sensitive to TCS and that the HQ value (PEC divided by NOAEC) may be greater than 1.0.  
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Following the study by Veldhoen et al. (2006), Crofton et al. (2007) tested the hypothesis 
that in vivo, TCS exposure influences serum levels of thyroxine (T4) in rats. Long-Evans females 
were given TCS (0, 10, 30, 100, 300, or 1000 mg kg-1 day-1) via oral gavage for a short-term 4-
day dosing schedule. Rats were sacrificed 24 h after the final TCS treatment and serum obtained. 
TCS doses of 100 mg kg-1 day-1 and higher decreased serum levels of T4, with the 30 mg kg-1 day-1 
dose as the no observed effect level (NOEL).  This study was the first to demonstrate that TCS 
decreases serum levels of T4 in female rats. The effects of TCS on pubertal development and 
thyroid function in the male Wistar rat were investigated by Zorrilla et al. (2009).  Prepubescent 
male rats were administered daily doses of 0, 3, 30, 100, 200, or 300 mg kg-1 TCS via oral gavage 
for 31 days. At TCS doses of 30 to 300 mg kg-1, serum levels of T4 decreased in a dose dependent 
fashion. However, observed decreases in serum levels of T4 only corresponded to decreases in T3 
levels at the 200 mg kg-1 dose, and colloid depletion was only observed in thyroid sections of the 
300 mg kg-1 treatment group. Compared to the controls, no significant differences in serum levels 
of thyroid-stimulating hormone (TSH) were noted in any of the treatments.  To test the hypothesis 
that TCS decreases circulating T4 levels by upregulating hepatic metabolism of thyroid 
hormones, Paul et al. (2010) used a 4-day exposure protocol in rats to analyze levels of hepatic 
enzyme induction (phase I and II enzymes), serum T4, serum T3, and TSH. Exposure to TCS 
caused a decrease in total T3 and T4, an upregulation of mRNA expression and an increase in the 
activity of a number of phase I and phase II enzymes. The results of the study support earlier 
work, which has demonstrated that TCS-induced hypothyroxinemia is likely due to the induction 
of hepatic enzymes, which augment the catabolism of T4. Although it is possible that TCS may 
have direct effects on the thyroid gland and the production of thyroid hormones, previous studies 
have found no evidence to indicate this is occurring. 
A study by Allmyr et al. (2009) is the first to have examined the effect of TCS on thyroid 
homeostasis in humans. Participants of the study brushed their teeth twice a day, for a period of 
14 days, with a commercially available brand of dentifrice, Colgate total, containing 0.3% (w/w) 
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TCS. Blood samples were collected from the participants prior to TCS exposure and the day 
following the termination of the exposure period. Concentrations of TCS in plasma were 
significantly higher at the end of the exposure period. However, despite a significant difference  
between pre and post-exposure levels of plasma TCS, the increase in TCS had no effect on 
circulating levels of 4β-Hydroxycholesterol, a cholesterol metabolite used as an indicator of 
CYP3A4 activity, TSH, free T4, and free T3.  The study concluded that the regular use of TCS 
containing toothpaste does not induce CYP3A4 activity or disrupt thyroid homeostasis. 
Unfortunately, the small study population coupled with the short-term exposure period, limit the 
validity of these findings. Future studies should aim to address the effects of long-term exposure 
to TCS in human subjects, from multiple exposure pathways, for prolonged periods of time.  
Thus far, there has only been one human study (Allmyr et al., 2009) chronicling the effect 
of TCS on thyroid homeostasis. In this study, TCS did not alter circulating levels of thyroid 
hormones. In contrast, animal studies have shown that TCS decreases blood levels of T4, without 
concomitant changes in TSH concentrations. Environmentally relevant levels of TCS have also 
been shown to disrupt thyroid mediated developmental processes in premetamorphic North 
American bullfrog tadpoles (Veldhoen et al., 2006), though not in prometamorphic South African 
clawed frog tadpoles (Fort et al., 2010).  TCS studies on thyroid disruption suggest that the 
antimicrobial is capable of acting on the thyroid receptor and altering the clearance of thyroid 
hormones, although future studies are needed to confirm this suspected mechanism of action and 
whether or not these effects are limited to animals. Given that TCS has been implicated in the 
disruption of thyroid hormone homeostasis and has been detected in breast milk samples of 
nursing mothers, the priority of future studies should be to ascertain whether or not TCS exposure 
can negatively affect fetal and postnatal development. A better understanding of the mechanisms 
of TCS-mediated thyroid disruption is warranted, in addition to species-specific differences. 
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2.8.6.2 Sex Hormones 
TCS is structurally similar to the anthropogenic estrogens, diethylstilbestrol and 
bisphenol A, in addition to the anti-estrogen, 2,3,7,8 tetrachloro-p-dibenzo-dioxin (TCDD) 
(Jacobs et al., 2005). Despite these structural similarities, an in vivo fish study by Foran et al. 
(2000) suggested that the antimicrobial was weakly androgenic, not estrogenic. In this study, 
Japanese medakas (Oryzias latipes) were exposed to TCS for 14 days, at concentrations of 1, 10, 
100, 500 μg l-1, and 1 mg l-1. The effect of TCS on phenotypic sex ratios was determined by 
inspecting fin size and shape. The antimicrobial had no effect on the sex ratio of exposed fish, 
although a slight male bias in the 100 μg l-1 treatment, and an accompanied difference in fin 
length between males of different exposure groups, indicated a possible anti-estrogen or a weakly 
androgenic effect (Table 2.4). 
Ishibashi et al. (2004) further investigated the estrogenic potential of TCS. The estrogenic 
activity of TCS was measured using the induction of hepatic vitellogenin (Vtg) in male medaka, 
and an in vitro yeast two-hybrid assay. Hepatic Vtg levels were increased significantly in males 
exposed to TCS at 20 and 100 µg l-1, although this was not the case in the 200 µg l-1 treatment 
group. The estrogenic activity of TCS was measured in the yeast two-hybrid assay alone and in 
the presence of rat S9 liver fractions. Alone, TCS had a weak estrogenic activity, but with the 
addition of the rat S9 liver treatment, the estrogenic activity of the antimicrobial was increased 
two-fold. The results of the study suggest that the metabolite of TCS is a weak estrogen, with the 
potential of inducing Vtg in male medaka.  
Houtman et al. (2004) identified TCS at relatively high concentrations in the bile of male 
breams (Abramis brama) collected at river sites in the Netherlands. The estrogenic potencies of 
TCS and other compounds in the bile were assessed using the ER-CALUX (Estrogen Responsive 
Chemical Activated Luciferase Gene Expression) assay (Houtman et al., 2007).  Estradiol and 
estrone were the major contributors to estrogenic activity, where TCS concentrations of up to 
0.1mM gave no indication of any estrogenic activity. The authors concluded that the 
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antimicrobial did not contribute significantly to the estrogenic activity measured in the bile of 
male breams. It is important to keep in mind that key differences between the toxicity of 
compounds in vivo and in vitro exist. 
The potential of TCS to induce Vtg production and decrease sperm counts, both being 
well established biomarkers of endocrine disruption, was assessed in male mosquito fish 
(Gambusia affinis) by Raut and Angus (2010). A 35 day exposure period to TCS induced Vtg 
production and decreased sperm production, moreover, the hepatosomatic index of TCS exposed 
fish was significantly elevated compared to controls. However, it is important to note that in this 
study, endocrine disruption was observed at TCS concentrations approximately 100 times greater 
than those typically detected in surface water, and as such, it is not known if environmentally 
relevant concentrations of TCS would produce similar results. 
Matsumara et al. (2005) investigated the effects of TCS on plasma Vtg levels, 
testosterone synthesis, and hepatic CYP1A and CYP2B activities in male Xenopus laevis. 
Waterborne TCS at environmentally relevant concentrations did not have any estrogenic effects, 
while male frogs treated with intraperitoneal injections of TCS at 4-400 µg g-1 body weight had 
lower plasma Vtg and testosterone levels than the control group. Hepatic CYP1A and CYP2B 
activity, as measured by ethoxyresorufin O-deethylase (EROD) or 7-pentoxyresorufin O-
depentylase (PROD), was not significantly different from the controls. The authors hypothesized 
that the observed decrease in plasma Vtg may be partially explained by the (anti)estrogenic 
effects of TCS in male X. laevis. 
The evidence provided by fish and amphibian models suggests that TCS has endocrine 
disrupting activity, however the number of studies with these species is limited.  The research 
efforts to assess endocrine disruption in mammalian models are more extensive.  A potential 
explanation for TCS’s ability to act as an endocrine disruptor comes from evidence that the 
antimicrobial activates the human pregnane X receptor (hPXR). This receptor is stimulated by a 
wide array of environmental chemicals and is responsible for inducing enzymes that metabolise 
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steroids and detoxify xenobiotics (Jacobs et al., 2005). In the study by Jacobs et al. (2005), the 
human hepatoma cell line (HuH7) was used to quantify PXR activity. Cells were exposed to 
concentrations of TCS from 0.01 µM-10 µM and the capacity of TCS to induce PXR activity was 
expressed as the percentage of the positive control. At 46.2%, TCS proved to be a moderate 
inducer of hPXR activity. In contrast to the other compounds tested, TCS was the only one to 
show concomitant increases in % max induction, with doses above 10 µM.  
Subsequently, Chen et al. (2007) tested the in vitro (anti)androgenic effect of TCS on 
testosterone induced transcriptional activity, in a cell line lacking essential steroid metabolizing 
enzymes. These cells (2933Y) are highly sensitive to endogenous steroids, in addition to 
anthropogenically sourced endocrine disruptors. At TCS concentrations of 1.0 µM and 10 µM, 
testosterone-induced transcriptional activity was reduced by 38.8% and 92%, respectively. In the 
absence of testosterone, TCS did not exhibit any androgenic activity, at concentrations up to 10 
µM.  A second study to test the in vitro endocrine disrupting effects of TCS was done by Gee et 
al. (2008). This study examined both the estrogenic and androgenic activity of TCS in 
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Table 2.4: Endocrine-disrupting effects of Triclosan (TCS)  
Test species/system Life stage Aquatic 
system 
Route of  
exposure 
 
Test 
duration 
TCS exposure Effects Reference 
Fish 
Medaka  
(Oryzias latipes) 
 
embryos 
 
FW 
 
Water 
 
14 d 
 
100 μg l-1 
Weak androgenic (or 
anti-estrogenic) effect 
(↑male fin size, slight 
male bias sex ratio) 
 
Foran et al. 
2000 
 Male fish FW Water 14 d 20 μg l-1 Weak estrogenic 
activity; ↑Vtg in male 
fish; activity in yeast 
assay 
 
Ishibashi et 
al. 2004 
Mosquitofish, 
(Gambusia affinis) 
Male fish FW Water 35 d 101.3 μg l-1 ↑vitellogenin,  
↓ sperm count 
 
Raut and 
Angus, 2010 
Bream  
(Abramis brama) 
Bile of 
male fish 
FW Field sites 
Netherlands 
 No activity up to 
0.1mM 
No estrogenic activity 
detected in ER-
CALUX assay 
 
Houtman et 
al. 2004 
Amphibians 
North American 
bullfrog (Rana 
catesbeiana) 
tadpoles FW In vivo 18 d 0.15 μg l-1 Disruption of T3-
dependent 
developmental 
metamorphosis 
processes  
 
Veldhoen et 
al. 2006 
South African 
clawed frog  
(Xenopus laevis) 
 
tadpoles FW In vivo 21 d 1.5 μg l-1 
0.6-32.4 μg l-1 
 
↓larval growth;  
No effect on 
metamorphosis 
 
Fort et al. 
2010  
 males FW Water; 
ip injection 
14 d 20-200 μg l-1; 
inject 4-400 µg g-1 
No effect on Vtg  in 
males; no effects on 
Matsumara et 
al. 2005 
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body weight CYP1A and EROD;  
↓ Vtg in ip injected 
males 
Mammals 
Sheep 
 
placenta 
  
In vitro 
  
0.6 nM 
 
↓estrogen sulfonation 
(IC50) 
 
 
James et al. 
2009 
Rats (Wistar) Pre- 
pubescent 
males 
 
 
 Oral 
(gavage) 
31 d 200 mg kg-1 
 
 
30 mg kg-1 
No effect on timing of 
puberty; ↓levels of 
plasma testosterone 
and T4 
 
 
Zorrilla et al. 
2009 
 Males; 
Isolated 
Leydig 
cells 
 In vivo 
(daily 
intubation) 
In vitro 
60 d 
 
2 h 
5-20 mg kg-1 
 
0.01-10 µM 
Disruption of LH, 
FSH, pregnenolone  
and testosterone 
synthesis; 
↓mRNA expression of 
StAR and 
steroidogenic enzymes 
 
Kumar et al. 
2008; 2009 
Rats (Long Evans) Adult 
female 
 Oral  
(gavage)  
 
4 d 100 mg kg-1 day-1 ↓plasma T4 
 
Crofton et al. 
2007 
 Females 
Weanlings 
 
 Oral 
(gavage) 
4 d 300 mg kg-1 day-1  ↓plasma T4 and T3 
 
Paul et al. 
2010  
Human adults  brush 2/day 
with TCS 
tootpaste 
14 d 0.3%w/w TCS No effect on thyroid 
status 
Allmyr et al. 
2009 
Cell-based assays 
MCF37 breast 
cancer cells 
   
In vitro 
  
10 µM 
 
Estrogenic and 
androgenic effects 
 
Gee et al. 
2008 
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2933Y cells (human)   In vitro  1.0 µM and 10 µM ↓testosterone-induced 
transcriptional activity  
 
Chen et al. 
2007 
Cell-based nuclear-
receptor-responsive 
and calcium 
signaling bioassays 
(AhR, ER, AR, RyR) 
  In vitro  1-10 µM (for ER- 
and AR-responsive 
gene expression; 
0.1-10 µM (for RyR 
response) 
Weak AhR activity; 
antagonistic activity in 
ER- and AR-dependent 
gene expression; 
interaction with RyR1,  
↑Ca2+ mobilization in 
skeletal myotubes 
 
Ahn et al. 
2008 
HuH7 cells (human 
hepatoma cell line) 
transfected with 
human pregnane X 
receptor (hPXR) 
  In vitro  >10 µM Activation of hPXR Jacobs et al. 
2005 
Induced rat liver 
microsomes 
  In vitro  3.1 µM (IC50) ↓diiodothyronine (T2) 
sulfotransferase 
activity 
Schuur et al. 
1998 
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 breast cancer cells. At environmentally relevant concentrations, TCS was capable of producing 
both estrogenic and androgenic effects. TCS displaced radiolabelled estradiol from estrogen 
receptors of MCF7 human breast cancer cells, whilst also inhibiting testosterone from binding to 
the rat androgen receptor.  
The endocrine disrupting potential of TCS was further investigated by Ahn et al. (2008) 
using in vitro cell-based and nuclear-receptor–responsive bioassays for aryl hydrocarbon (AhR), 
estrogen (ER), androgen (AR) and ryanodine receptors. The results of the cell- based AhR-
mediated bioassay demonstrated that TCS is an AhR inducer, a receptor which has been 
implicated in various toxic and biological responses. In both the cell-based ER- and AR-mediated 
bioassays, TCS acted antagonistically, but was a powerful disruptor of Ca2+ regulation. The 
authors concluded that the results of their study provided sufficient reason to be concerned about 
the antimicrobial’s neurotoxic potential. These results are further supported by previous studies 
that have shown that TCS alters thyroid homeostasis (Veldhoen et al., 2006). Moreover, there is 
evidence that TCS can also influence endocrine function indirectly, through effects on the 
metabolism of key hormones, including the thyroid hormones. The effects of TCS on EROD, 
PROD, UDP-GT and sulfotransferase enzymes, all of which play a role in the metabolism and 
clearance of hormones from the body, have been reported (Hanoika et al., 1997; Jinno et al., 
1997; Kanetoshi et al., 1992; Schuur et al., 1998).  In addition, several in vivo studies have shown 
that TCS has endocrine disrupting effects.    
Further evidence for the (anti)androgenic effect of TCS was provided by Kumar and 
colleagues, who sought to describe the targets of TCS endocrine disruption, in addition to the 
mechanism(s) of action. An earlier study with Leydig cells exposed to TCS in vitro (Kumar et al., 
2008), was followed by a whole animal study (Kumar et al., 2009). Male rats were dosed with 5, 
10, or 20 mg kg-1 of TCS per kg of body weight per day. Rats were treated with TCS once a day 
for a period of 60 days. RT-PCR analysis indicated that TCS decreased mRNA levels for 
testicular steroidogenic acute regulatory (StAR) protein, cytochrome P450scc, cytochrome 
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P450C17, 3β-hydroxysteroid dehydrogenase (3β-HSD), 17β-hydroxysteroid dehydrogenase (17β-
HSD), and androgen receptor (AR). The translation of testicular StAR and AR protein was also 
disrupted by the antimicrobial. Decreases in serum levels of lutenizing hormone (LH), follicle 
stimulating hormone (FSH), cholesterol, pregnenolone, and testosterone were observed. 
Histopathological analysis of the testes and sex accessory glands were indicative of widespread 
malformations. TCS-induced decreases in testosterone and spermatogenesis were likely the result 
of decreases in serum levels of LH and FSH, thereby implicating the pituitary-gonadal axis, at 
various levels, as a target for endocrine disruption. 
The reproductive effects of TCS on testosterone-dependent endpoints in rats were not as 
clearly evident in a study by Zorrilla et al. (2009), which sought to assess the effect of TCS on 
puberty, as well as thyroid hormones (see section above) in male Wistar rats. The antimicrobial 
had no effect on the growth or onset of preputial separation. A significant difference in serum 
testosterone levels was observed in the 200 mg kg-1 treatment, but not in the 300 mg kg-1 
treatment. In addition, the age of pubertal onset and the development of androgen-dependent 
reproductive tissues did not differ significantly between the experimental and control groups.   
James et al. (2009) tested the vulnerability of the placenta to the endocrine disrupting 
effects of TCS. TCS proved to be a powerful inhibitor of estradiol sulfonation in the placental 
tissue of sheep, with IC50 of 0.6 nM TCS. As the majority of estrogen secreted by the placenta is 
sulfoconjugated and estrogen sulfonation have been linked to pregnancy loss (Tong et al., 2005), 
TCS could potentially have a negative impact on the fetal environment and pregnancy 
maintenance. Environmental and/or household exposure to TCS in humans can lead to blood 
levels in the low nM range (Allmyr et al., 2006, 2008) The possibility then exists for placental 
levels of TCS to reach concentrations high enough to interfere with placental estrogen 
metabolism.  
There is good evidence for the endocrine disrupting effects of TCS, although it remains 
unclear as to whether TCS has (anti)estrogenic effects, (anti)androgenic effects, or both. Foran et 
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al. (2000) concluded that based on changes in fin length and slightly skewed sex ratios in medaka 
fish, TCS is a weak androgen.  A later study by Ishibashi et al. (2004), reported that a TCS 
metabolite induced Vtg production in male medaka, suggesting estrogenic activity. Evidence 
from amphibian studies supported the role of TCS as an anti-estrogenic chemical. Several in vitro 
studies have demonstrated the potential for TCS to act as an anti-estrogen and/or anti-androgen 
(Chen et al., 2007; Gee et al., 2008; Ahn et al., 2008). Studies with male rats (Zorrilla et al., 2009; 
Kumar et al., 2009) have shown that TCS decreases serum levels of testosterone and the activity 
of several important steroidogenic enzymes. Lastly, TCS is a powerful inhibitor of estrogen 
sulfonation in sheep placental tissue, and as such, could have deleterious effects on the ability of 
female mammals to maintain a full term pregnancy. Because TCS has been shown to have 
estrogenic and androgenic activity at environmentally relevant levels, there is sufficient reason to 
be concerned about the impact of the antimicrobial on aquatic ecosystems and human health. 
2.9 Efficacy and Antibacterial Resistance 
 
2.9.1 Efficacy 
The efficacy of TCS-containing consumer products has recently been called into 
question, as several studies have reported that the antimicrobial is no more effective than regular 
soap.  
2.9.1.1 Health-care settings 
The efficacy and safety of TCS in health care settings was reviewed by Jones et al. 
(2000). The popularity of TCS in health care settings has long endured the test of time, as the 
antimicrobial has proven its immediate, broad-spectrum antimicrobial effects, in addition to the 
fact that TCS elicits neither dermal irritation nor photosensitization effects. Interestingly, cell 
culture experiments have even shown that the antimicrobial has anti-inflammatory, anti-allergic, 
anti-asthmatic activity and can even protect against cell damage. All of the aforementioned 
characteristics are very important for ensuring antimicrobial acceptance and compliance in health 
care settings.  
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The antimicrobial effects of TCS have been established for concentrations of 0.2 to 2.0%. 
TCS formulations of 1% have been proven effective for managing antibiotic-resistant 
Staphylococcus aureus outbreaks in health care settings, in the form of either hand wash solutions 
or bathing antiseptics (Jones et al., 2000). TCS is often favoured over other antimicrobial 
products due to its mild nature, helping to increase handwashing compliance in health care 
workers. According to the authors, a 1% TCS formulation is preferable for securing high rates of 
hand washing compliance and reducing nosocomial infections in high-risk, high-frequency 
handwashing health care settings (see Jones et al., 2000). It is worth reinforcing that while the use 
of TCS formulations appears to be beneficial in high-risk, high-frequency handwashing health 
care settings, these benefits do not necessarily translate into the domestic domain.  
2.9.1.2 Personal Care Products 
As previously mentioned, a staggering number of personal care products contain TCS, at 
varying concentrations. As TCS is not subject to stringent government regulation, concentrations 
of TCS in consumer products can vary substantially, although they generally remain in the range 
of 0.1-0.45% (w/v) (Aiello et al., 2007). A review on the efficacy of TCS containing hand soaps, 
with efficacy defined as antibacterial activity above and beyond that of plain hand soap, revealed 
that at concentrations typically present in antibacterial soaps, TCS was not superior for reducing 
bacterial counts on the hands or decreasing the prevalence of infectious diseases (Aiello et al., 
2007). In studies that showed TCS reduced bacterial populations on the hands (Bhargava and 
Leonard, 1996), longer hand washes and/or high concentrations of the antimicrobial were used, 
accounting for the higher efficacies recorded. Due to the lack of data supporting the efficacy of 
TCS containing antimicrobial soaps, the use of these products seems unnecessary in light of 
concerns about the potential for the selection of antibiotic cross-resistance and impacts on the 
aquatic environment. 
Despite a lack of data on the efficacy of TCS in antibacterial soaps, there is a growing 
body of evidence to suggest that in oral care formulations, TCS and TCS/copolymers deliver 
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effective antibacterial protection by causing bacterial lysis. TCS is the most commonly used 
antibacterial agent in oral care formulations (van den Broek et al., 2008). According to a review 
on the management of halitosis by van den Broek et al. (2008), a dentifrice formulated with 0.3% 
TCS, 2.0% of a copolymer of polyvinyl methyl ether maleic acid, and 0.243% sodium fluoride 
significantly reduced the incidence of organoleptic sores and hydrogen sulphide releasing 
bacteria. Moreover, the antimicrobial and anti-inflammatory properties of TCS have been proven 
to reduce plaque and gingivitis, in addition to slowing the progression of periodontal disease 
(Rosling et al., 1997; Cullinan et al., 2003; Gunsolley, 2006; Rautemaa et al., 2007). The long-
term use of antimicrobials is however worrisome, as resistance is always a lingering concern, 
although there is no data to suggest that TCS-resistant strains of pathogens have emerged 
alongside the incorporation of the antimicrobial into oral care formulations (Rosling et al., 1997; 
Cullinan et al., 2003; Rautemaa et al., 2007). Based on the evidence from several review studies, 
the weighing of the risks and benefits of TCS in oral care formulations strongly favours the use of 
the antimicrobial in dentifrice and mouthwashes (Sreenivasan and Gaffar, 2002; Gilbert et al., 
2007).  
2.9.1.3 Plastics and other materials 
The number of applications for TCS has expanded immensely over the years, with the 
antimicrobial now being impregnated in a number of different materials, ranging from medical 
devices to athletic clothing to meat packaging, in the hopes of providing the user with long-
lasting antibacterial protection. The extent to which TCS is able to prevent the proliferation of 
bacterial populations in many of these products has not been adequately established. Ensuring 
that TCS is consistently released, at concentrations that are high enough to limit bacterial growth, 
remains a significant challenge for manufacturers. 
The use of TCS in textiles has been banned in Europe, due to concerns of antibiotic 
resistance and the generation of toxic by-products, primarily 2,8-dichlorodibenzo-p-dioxin. 
However, manufacturers in North America continue this practice on a wide scale basis. The 
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premise of this manufacturing process is that TCS will migrate to the surface of the textile, 
providing extended antimicrobial release throughout the lifespan of the fibre (Gao and Cranston, 
2008). Despite these claims of antibacterial protection, experimental evidence to support the 
practice of impregnating clothing fibres with TCS remains limited.  
There is no doubt that manufacturers are feeling increased pressure from consumers to 
create products that provide extended antibacterial protection. The development of Microban© 
products, an innovative technology that enables TCS to be incorporated into virtually any type of 
plastic material (either directly into the plastic or as a coating with a second type of film), while 
allowing the antimicrobial to accumulate on the surface to inhibit bacterial growth, has garnered 
the attention of the food packaging industry (Vermeiren et al., 2002; Quintavalla and Vicini, 
2002).  It has been thought that by incorporating antimicrobial agents such as TCS, into food 
packaging, the shelf-life and safety of the product(s) would be ameliorated. Although this 
technology seems very promising, several in vitro studies demonstrated that TCS incorporated 
products do little to prevent the growth of bacteria in commercial applications, likely due 
interactions between TCS and food particles (Cutter, 1999; Vermeiren et al., 2002).  
The effectiveness of TCS incorporated plastic has been investigated by Cutter (1999). In 
plate overlay assays, TCS demonstrated antibacterial activity, but when the plastic was vacuum-
packaged and refrigerated, bacterial growth was not sufficiently reduced. The authors attributed 
the failure of the TCS polymer to inhibit bacterial growth to the interactions between TCS and 
adipose deposits in meat. The antimicrobial efficacy of a polymer coated in TCS, for the purpose 
of packaging perishable foods, has also been evaluated in a study by Chung et al. (2003). The 
applicability of the study is limited, in that only one type of bacteria was used, Enterococcus 
faecalis, in addition to the fact that incubations were carried out at one temperature only, 30⁰C. 
The results of the study specify that only minute amounts of the antimicrobial are released from 
the polymer, although one must consider that the minimum inhibitory concentration for TCS is 
fairly low. Despite only small amounts of TCS being released, bacterial inhibition by the TCS 
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coating was clearly seen in both the agar diffusion test and a liquid culture test, although neither 
test was performed at refrigeration temperature. Plate overlay assays at refrigeration temperature, 
with different bacterial strains, are needed to confirm the antimicrobial efficacy of TCS in food 
packaging. 
More recently, Camilloto et al. (2009) evaluated the antimicrobial efficacy of three 
different concentrations (0, 2000, and 4000 mg kg-1) of a TCS active film in the preservation of 
sliced ham. The activity of the film was tested both in vitro and in sliced ham inoculated with 
E.coli and S. aureus. In the in vitro experiment, film efficiency was measured by the diameter of 
the inhibition halos around the TCS containing film, in agar plates that had been inoculated with 
E. coli, S. aureus, L. innocua, S. choleraesius, or P. aureginosa. The film only showed inhibition 
effects against E.coli and S. Aureus. Correspondingly, in the sliced ham packaged with the TCS 
containing film, a reduction of 1.5 logarithmic cycles for E.coli and S. aureus was observed after 
12 days of storage at 7±2 ⁰C. The efficac           
suggestive of a potential for the use of the antimicrobial in food packaging, as the film controlled 
the proliferation of certain types of bacteria that cause food borne illnesses. 
Studies on the efficacy of TCS incorporated film have been far from conclusive, perhaps 
in part due to methodological variations. The efficacy of these films is likely dependent on the 
type of polymer material, the method of TCS incorporation and production, the concentration of 
antimicrobial used, and also the bacterial strains and conditions used (Camilloto et al., 2009). 
Testing antimicrobial films at refrigeration temperatures, with a variety of meat products, is 
paramount, since this type of packaging is generally used with refrigerated foods and fatty acids 
from meat are thought to decrease the efficacy of TCS containing films (Cutter, 1999).  
2.9.1.4 Medical Devices 
Medical devices are often a site of bacterial proliferation, which can cause debilitating 
infections and even death. Bacterial adhesion to medical devices is a serious medical problem that 
places a significant strain on the health care system. A proposed solution to this problem has been 
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the incorporation of antibacterial agents into medical polymers. The antibacterial potency of TCS 
incorporated into plasma-modified medical polyethylene (PE) and bulk PVC has been 
investigated (Zhang et al., 2006; Ji and Zhang, 2008). The results of these two studies 
demonstrated that TCS-incorporated bulk PVC significantly reduced bio-film on polymer 
surfaces and that plasma-modified PE with TCS provided adequate antibacterial protection. 
However, these studies were laboratory based, and it has been previously shown in antibiotic 
cross-resistance studies that the effects observed in the laboratory setting often do not translate to 
the ‘real world’. Further studies are needed to confirm that TCS impregnated medical polymers 
are genuinely able to reduce bacterial adhesion and proliferation. 
The results of the studies by Zhang et al. (2006) and Ji and Zhang (2008) do not agree 
with previous studies on the antibacterial efficacy of TCS incorporated polymers. Junker and Hay 
(2004) compared biofilm populations on ABS plastic impregnated with or without TCS, after 1-3 
weeks of exposure to drinking water. A lack of measurable differences in bacterial populations 
between TCS-impregnated and control plastic was observed, a phenomenon which can be 
explained by the fact that only a minute amount of TCS actually migrated from the plastic.  
Previously, Kalyon and Olgub (2001) investigated the antibacterial efficacy of TCS-
incorporated polymers, reporting that TCS was only capable of inhibiting bacterial growth for a 
limited period of time, after which bacterial growth flourished. The authors suggested that the 
majority of TCS was not available to bacteria, as was evidenced by the fact that the amount of 
TCS incorporated into the polymer was much higher than the minimum inhibitory concentration 
(MIC) for the bacterial species. The findings of this study are in concordance with those of 
Imazato et al. (1995), who studied the efficacy of dental polymers containing TCS. The TCS 
incorporated polymer composites reduced bacterial proliferation for 12 hours, but once the 24 
hour mark had been reached, the number of bacteria on the surface of the control and the TCS-
incorporated composite were virtually the same.  
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Despite the fact that TCS impregnated polymers are commercially available in a wide 
range of products, few studies have been able to document their efficacy. With the noteworthy 
exception of oral care products, the antimicrobial efficacy of numerous TCS-containing products 
has yet to be validated. There is an urgent need to critically evaluate the false sense of security 
that the mass marketing of antimicrobial products creates, considering that the injudicious use of 
antimicrobials may lead to antibiotic cross-resistance and should be avoided.  
2.9.2 Antibiotic cross-resistance 
Traditionally, TCS was thought not to be implicated in antimicrobial resistance because 
of its broad-spectrum antibacterial properties and multiple bacterial targets. However, this 
understanding has been called into question, as several studies have demonstrated the potential 
for TCS to target a specific bacterial enzyme, enoyl-acyl carrier protein reductase (McMurray et 
al., 1998). Indeed, laboratory studies have shown that TCS-resistant bacteria can be cultured with 
relative ease, and it has been suggested that TCS-resistant bacteria may be the result of mutations 
in and/or the over-production of enoyl reductase, changes in the membrane permeability, or 
efflux (Russel, 2004). However, it is important to remember that at higher concentrations, 
biocides, like TCS, have widespread targets. It is usually only at lower concentrations, not 
typically in-use concentrations, that biocides become more selective in their targets (Russell, 
2003, 2004). 
The fact that TCS can target a specific enzyme could potentially be a public health issue 
in the future, as antimicrobials are not intended to target any particular cellular constituents in 
bacteria (Jones et al., 2000). Instead, it is antibiotics that exert their destructive powers by 
targeting specific cellular components of bacteria. Unfortunately, it is the case that these cellular 
targets regularly undergo mutations, subsequently rendering the antibiotic ineffective. Once it 
was discovered that TCS had the ability to target a specific enzyme in bacteria, researchers began 
speculating that the antimicrobial may have the potential to prime bacteria for antibiotic cross-
resistance.  
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A review by Russell (2004) examined the link between TCS and antibiotic resistance. 
Typical in-use concentrations of TCS generally far exceed minimal inhibitory concentrations 
(MICs) for most bacterial species, with the exception of P. aeruginosa. A TCS-susceptible 
mutant of P. aeruginosa, when exposed to TCS, activates an efflux pump that decreases the 
susceptibility of the bacterial strain to ciprofloxacin (Russell, 2003). However, later studies have 
failed to implicate TCS in ciprofloxacin resistance in the clinical setting. Nor is there any 
evidence to suggest that TCS is linked to antibiotic resistance in S. aureus. Moreover, 
comprehensive surveys on the use of TCS in the home have failed to correlate the antimicrobial 
with antibiotic resistance (Cole et al., 2003).  
A later review by Yazdankhah et al. (2006) concluded that although cross-resistance 
between TCS and other clinically relevant antimicrobials has been documented for E. coli and 
Salmonella spp. in the laboratory setting, these findings have yet to be confirmed in clinical 
environments. However, the authors of the study draw attention to the fact that very few studies 
have been done on clinical isolates, suggesting that future studies on this topic may yet expose 
such a link. There is also a large knowledge gap in the literature concerning the impact of TCS 
use on commensal bacteria, which have the potential to transfer resistance to bacterial strains that 
are known to be human pathogens.  Future studies should address the effect of TCS on bacteria 
under typical conditions in community and health care settings, and the relationship between TCS 
use and microflora.  
Interestingly, some researchers have suggested that although TCS resistance has been 
associated with antibiotic cross-resistance in the laboratory setting, these findings do not carry 
over to clinical environments (Russell 2003, 2004; Gilbert et al., 2007; Aiello et al., 2007). This 
discrepancy is not necessarily surprising, as laboratory tests on TCS resistance have used 
predominantly pure cultures, in nutrient rich environments, both of which are not representative 
of real world conditions (Gilbert et al., 2007). As it currently stands, there is a lack of clinical 
evidence to suggest that the use of TCS has lead to the propagation of antibiotic resistant 
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staphylococci, antibiotic-resistant Gram-negative bacteria, or isoniazid-resistant M. tuberculosis, 
although some researchers continue to speculate that this type of cross-resistance is just over the 
horizon (Russell, 2003; Aiello et al., 2007).  
Conclusions about TCS and a lack of antibiotic cross-resistance in a variety of 
environments must be drawn with a considerable degree of trepidation, as studies examining the 
issue have not provided enough evidence to assuage fears that the use of the antimicrobial is 
devoid of risk. Based on the fact that antibiotic cross-resistance has been demonstrated in the 
laboratory setting, further studies are needed to confirm that in clinical, household, and 
community settings, the judicious use of TCS does not, and will not, lead to antibiotic resistance. 
It would then seem logical to suggest that gratuitous use of TCS should be all but eliminated, 
whilst allowing for the continuation of its important clinical functions.  The use of TCS should be 
limited to applications where it has been demonstrated to be effective, which  includes health care 
settings and in oral hygiene formulations (Gilbert and McBain, 2002; Cozad and Jones, 2003; 
Russell, 2004). Currently, the Canadian Medical Association is calling for a ban on antibacterial 
products because of concerns that these products may actually promote bacterial growth. 
Previously, many European countries, such as Sweden, have actively discouraged consumers 
from using antimicrobial products. 
2.10 Conclusions and Further Research  
 
Based on the existing literature, the judicious use of TCS should be considered safe, and 
although antibacterial cross-resistance has been found in the laboratory setting, there is no 
evidence to suggest that it is occurring in clinical and/or household environments. However, there 
are a number of different issues surrounding the use of TCS that warrant further research; 
environmental by-products, bioaccumulation potential, toxicity to aquatic organisms, endocrine 
disrupting effects, and the potential for TCS to prime bacteria for antibiotic resistance. These 
issues are of importance for the safeguarding of human health, aquatic ecosystems, and the 
environment. 
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CHAPTER 3. PRIMARY RAINBOW TROUT ADRENOCORTICAL CELL CULTURE – 
MODIFICATION OF THE METHOD ORIGINALLY DEVELOPED BY 
LEBLOND AND HONTELA (1999) 
 3.1  Introduction 
 
A number of different chemicals are commonly detected in surface water (Buchanan et 
al., 2010; Wu et al., 2010), yet the effects of these complex chemical mixtures on aquatic species 
remain relatively unknown. Chemicals can interact with other compounds in the water to increase 
or decrease their toxicity, potentially jeopardizing the health and survival of aquatic organisms. 
The use of fish species in biological research has been increasing steadily since the 1960’s, as 
researchers are beginning to recognize the advantages of choosing to work with fish models, 
instead of more traditional mammalian systems (Bolis et al., 2001). In vitro systems, including 
fish cell cultures, make excellent models for environmental toxicology research (Bolis et al., 
2001).  
A primary cell culture of the rainbow trout head kidney where cortisol producing 
adrenocortical cells are located, has been developed by Leblond and Hontela (1999) and will be 
henceforth referred to as the adrenocortical bioassay. The adrenocortical bioassay is well-suited 
for toxicological studies, as a biochemical tool for monitoring the effects of water-borne 
chemicals on corticosteroid synthesis. A significant advantage of the Leblond and Hontela 
primary cell culture, over the  human adrenocortical tumour cell line (H295R), is that the H295R 
cell line does not adequately respond to ACTH stimulation, due to low levels of ACTH receptor 
expression (Masters and Palsson, 1999). It then follows, that studies using the ACTH challenge 
test would need to select a primary cell culture method of adrenal cells instead. 
In fish, corticosteroids play an important role in modulating metabolism, osmotic 
regulation, immune function, and reproduction (Mommsen et al., 1999). The head kidney of 
teleost fish is similar to the adrenal gland of mammals; the head kidney produces cortisol in 
response to ACTH, although the cortisol producing cells do not form a compact gland (Mommsen 
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et al., 1999). The ACTH challenge test (Hontela and Vijayan, 2009) can be used to screen for 
endocrine disrupting effects of water-borne toxicants using rainbow trout head kidney cells in a 
primary culture and a cortisol radioimmunoassay. Typically, results from in vitro toxicological 
studies are confirmed with in vivo experiments and a mechanism of action elucidated.  
A limitation of the Leblond and Hontela method is the considerable amount of cell 
aggregation that typically occurs following tissue digestion.  In order to address this challenge 
and other less significant problems, such as low cortisol secretion and subsequent high cell 
densities required for plating, the method was modified. The objective of the current study was to 
compare the performance of the modified primary culture method to the original method 
(Leblond and Hontela, 1999), using qualitative and quantitative comparisons, including the 
degree of cell dispersion, cell yield, and the amount cortisol secreted in response to the ACTH 
challenge test.  
3.2  Materials and Methods 
 
3.2.1. General 
Male and female juvenile rainbow trout (Oncorhynchus mykiss), body weight 58.8 ±3.3g, 
were obtained from the Allison Creek Brood Trout Station (Crowsnest Pass, Alberta, Canada). 
Fish were maintained in a 1500-L flow-through tank at 13-150C, on a photoperiod of 12L: 12D. 
Fish were fed to satiation with commercial trout chow food. Prior to the commencement of tissue 
harvesting, fish were acclimated in the laboratory for a period of two weeks. Tissue culture 
media, digestion enzymes, ACTH, bovine serum albumin, and sodium bicarbonate, were 
purchased from Sigma-Aldrich Canada Ltd. (Oakville, Ontario). Cortisol radioimmunoassay kits 
were purchased from MP Biomedicals (#07-221102, Medicorp, Montréal, Canada). 
3.2.2. Preparation of adrenocortical cell suspensions (Leblond and Hontela, 1999; original 
method) 
Fish were anesthetized with MS-222 (0.5g l-1 of water) buffered with sodium bicarbonate 
to a pH of 7. A 1-cc heparinized syringe was used to remove a maximum blood sample from the 
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caudal vein. Following blood sampling, fish were perfused through the heart with 30 ml of a 
0.7% saline solution. The head kidney was excised and the tissue placed in room temperature 
MEM. Tissue fragments were minced into 1-mm3 and transferred into a 15 ml conical centrifuge 
tube for enzymatic dispersion using collagenase/dispase and DNase, as previously described 
(Leblond and Hontela, 1999). Tissue was digested in a shaker incubator for one hour at 230C and 
gently pipetted every 15 min to further facilitate cell dispersion. 
Digested tissue was filtered through nylon mesh (30µM pore size). Undigested tissue was 
mechanically dispersed with a plastic transfer pipet and the cell suspension filtered. The cell 
suspension was centrifuged for 5 min at 200g. The pellet was re-suspended in 0.75 mL of MEM 
and the cell yield and viability determined by counting the cells in a hemocytometer in the 
presence of trypan blue.  The cell suspension was adjusted to a cell density of 75 X 106 and plated 
at a volume of 100 µL per well in a 96-well microplate. Following plating, cells were incubated 
in MEM at 15⁰C for two hours prior to ACTH stimulation. 
3.2.3 Stimulation of cortisol secretion 
After centrifugation, cells were re-suspended in 100 µL of MEM containing 1 U ml-1 
ACTH (Porcine adrenocorticotropin, ACTH 1-39, Sigma). Cells were incubated in an 
environmental chamber for 1 hour at 150C. Following the one-hour stimulation, cells were 
centrifuged for 5 min at 200g and the supernatant collected and frozen at -800C. Cortisol secretion 
(ng ml-1) in the supernatant was assessed using a radioimmunoassay for cortisol (MP 
Biomedicals).  
3.2.4 Method modifications 
Fish were placed on ice and a 1-cc heparinized syringe was used to remove a maximum 
blood sample from the caudal vein. The head kidney was excised and the tissue placed in ice cold 
medium, 0.02% Ethylenediaminetetraacetic acid disodium salt (EDTA) prepared in Dulbecco’s 
Phosphate-Buffered Saline (DPBS) without Ca2+ and Mg2+. Prior to enzymatic digestion, tissue 
fragments were rinsed with ice cold 0.02% EDTA and minced into 1-mm3 pieces with two 
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scalpels. Tissue was digested in a shaker incubator for two hours at 210C. Digested tissue was 
washed with 0.02% EDTA and filtered through nylon mesh (30µM pore size). The pellet was re-
suspended in 1 mL of 0.02% EDTA and the cell yield and viability determined by counting the 
cells in a hemocytometer in the presence of trypan blue. Following plating, cells were centrifuged 
for 5 min at 200g and re-suspended in MEM for a two hour incubation period prior to ACTH 
stimulation. 
3.2.5 Data analysis 
The difference in cortisol secretion (ng ml-1) and cell yield (the number of wells plated) 
between the two methods was compared using a one-way analysis of variance (ANOVA) and 
followed by Student’s t-test (α=0.05).  
3.3 Results 
 
Cortisol secretion in response to ACTH stimulation in the new method was considerably 
higher than the original method, as shown in Table 3.1. The cell yield in the new method was 
slightly higher than the original, although this trend was not statistically significant. A 
considerable benefit of the new method is that cell aggregations do not form in the cell 
suspension, thus enabling the researcher to use less mechanical force during cell dispersion 
ensuring that receptor integrity is maintained. Additionally, the new method can be used with fish 
≥200 g, whereas the original method was unable to produce a cell culture capable of measurable 
cortisol secretion in response to ACTH stimulation when fish of this size were used. 
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Table 3.1 Comparison between originala and modified head kidney primary cell culture methods   
 
  
Original 
Method 
Modified  
Method 
Technique 
Tissue & solutions on ice No Yes 
Digestion temperature 23⁰C 21⁰C 
Digestion time 1 hr 2 hrs 
Centrifugation temperature 15⁰C 4⁰C 
Medium MEM HBSS, Ca & Mg free 
EDTA No Yes 
 Suitable for fish ≥200g No Yes 
Performance 
Clumping Yes No 
 
Cell yield (number of  
wells) 
13.4 ± 3.78b 14.3 ± 2.60 
Avg. secretion  (ng ml-1) 18.6 ± 5.10* 31.1 ± 11.4* 
Max. secretion (ng ml-1) 23.6 43.3 
    
a (Leblond and Hontela, 1999),  b cell yield and secretion data are presented as mean ± standard 
deviation (n=5 for original method and n=8 for modified method),t(11)=2.28, p=0.04. Asterisks 
denote that two means are statistically different (α=0.05).  
3.4 Discussion 
 
Two primary cell culture methods for the head kidney of rainbow trout were compared. 
The modified in vitro cell culture preparation was superior to the method developed by Leblond 
and Hontela (1999), because cell aggregations were reduced, the cells secreted more cortisol in 
response to the ACTH challenge test, and measurable secretion was achieved in fish ≥ than 200g. 
Increased cortisol secretion in the new method was likely due to the use of a Ca2+ and Mg2+ free 
0.02% EDTA solution and a longer digestion period.  
A two hour digestion compared to a one hour digestion proved to be more effective for 
dissociating cells from the extracellular matrix, without affecting the integrity of ACTH surface 
receptors. Endocrine cells are very sensitive and special care must be taken not to damage the 
tissue when dissociating the cells. Enzymatic digestions are typically superior to mechanical 
methods, as they have proven to be less damaging to the cells (Waymouth, 1974). In conjunction 
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with enzymatic tissue dispersion, the use of a chelating agent such as EDTA and/or Ca2+ and 
Mg2+ free media can further eliminate cell-to-cell adhesion. 
The use of Ca2+ and Mg2+-free media reduces the likelihood that cell aggregations will 
occur in the cell suspension, as both of these ions play a role in cell-to-cell adhesion (Waymouth, 
1974; Takeichi, 1990). EDTA is widely used as a chelating agent in cell culture preparations. It is 
involved in the sequestering of metal ions, helping to prevent the joining of cadherins (cell 
adhesion molecules), thereby maintaining cells in suspension (Waymouth 1974; Flora and 
Pachauri, 2010). A considerable amount of mechanical force can be necessary to disperse clumps 
of cells in suspension, which can damage surface receptors, leading to decreased cortisol 
secretion in response to ACTH stimulation. Additional changes in the new method included 
keeping tissue on ice, the use of ice cold solutions, a lower digestion temperature, and 
centrifugations at 4⁰C, likely helped to prevent cell damage and cell death, possibly contributing 
to the increase in cortisol secretion.  
An increase in cortisol secretion is significant, because this means the cell density 
(number of cells ml-1) at which cells are typically plated, can be lowered. When conducting in 
vitro toxicity experiments on the effects of two or more chemicals, a large number of wells are 
required. If the cell density of the suspension is decreased, the number of wells yielded would 
potentially increase by 30-40%, making it more feasible to conduct mixture experiments. A 
limitation of the original method is the lower cortisol secretion and the difficulty to obtain an 
adequate number of wells to conduct mixture experiments at the cell density typically plated (75 
X 106 cells ml-1). 
3.5 Conclusion 
 
The protocol for the head kidney cell preparation developed by Leblond and Hontela 
(1999) was modified and its performance found to be superior, as determined by qualitative and 
quantitative analysis. 
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CHAPTER 4. THE EFFECTS OF TRICLOSAN, 2,4-D, AND THEIR BY-PRODUCTS ON 
THE ADRENOCORTICAL CELLS OF RAINBOW TROUT, 
ONCORHYNCHUS MYKISS 
4.1 Introduction 
 
A pressing issue in water quality research is the presence of endocrine disrupting 
compounds in surface water and their effect(s) on aquatic and human life. A number of different 
water-borne chemicals have endocrine disrupting effects including pharmaceuticals, pesticides, 
industrial chemicals, and heavy metals (Witorsch and Thomas, 2010; Corcoran et al., 2010; 
Shenoy and Crowley 2011). Endocrine disrupting compounds (EDCs) are defined by Crisp et al. 
(1998) as: “exogenous agents that interfere with the synthesis, secretion, transport, binding, 
action, or elimination of natural hormones in the body that are responsible for the maintenance of 
homeostasis, reproduction, development, and/or behavior” (p.17). 
During the wastewater treatment process, personal care products, and pesticides are only 
partially removed and will be discharged with effluent into receiving waters (Kuster et al., 2008). 
In addition to water discharged from WWTPs, other sources of water-borne toxicants may 
include wastewaters from livestock operations, agriculture, and industry. These complex mixtures 
of chemicals are continually released into surface waters, where the fate and effects of many of 
these chemicals in the aquatic environment remain relatively unknown.  
This study focused on four chemicals typically detected in surface water: the 
antimicrobial Triclosan (TCS), detected  up to 2.3 µg l-1 (Kolpin et al., 2002; Morrall et al., 2004), 
the herbicide 2,4 dichlorophenoxyacetic acid (2,4-D), detected up to 439 µg l-1  (Anderson, 2005; 
Gibson et al., 2007; Kuster et al., 2008), and their by-products, methyl-Triclosan (M-TCS) and 
dichlorophenol (DCP), detected up to 10 ng ml-1 and 19.96 µg l-1, respectively (Lindstrom et al., 
2002;  Andresen et al., 2007; Gao et al., 2008).  The study focused specifically on their potential 
for endocrine disruption in vitro, using primary cultures of rainbow trout interrenal cells. The 
interrenal tissue (analogous to the mammalian adrenal gland) of teleost fish includes, among other 
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cell types,  adrenocortical cells and plays an integral role in the regulation of growth, immune 
function, reproduction, and osmoregulation (Norris and Carr, 2006). Primary cultures of rainbow 
trout adrenocortical cells have been used to test for potential endocrine disrupting activity of 
various water-borne toxicants, because the hypothalamo-pituitary-interrenal axis is a vulnerable 
target (Hontela and Vijayan, 2009). 
TCS is a broad-spectrum antibacterial and antifungal, with a number of commercial 
applications, although it is used primarily in personal care products such as hand soap, dish 
detergent, deodorant, toothpaste, plastics, and textiles (for review see Chapter 2). As consumers 
continue to demand products that offer ongoing antibacterial protection, manufacturers are 
increasing their use of TCS in common household products, despite the fact that several studies 
have called into question the efficacy of TCS in inhibiting the proliferation of bacteria (Kalyon 
and Olgbub, 2001; Junker and Hay, 2004; Aiello et al., 2007). The majority of products 
containing TCS are washed down household drains, eventually making their way to municipal 
WWTPs, where approximately 5% of antimicrobial is discharged into receiving waters (Singer et 
al., 2002). TCS has been measured in fish tissues, human plasma, breast milk, and urine, 
indicating a ubiquitous presence in surface water (Wolff et al., 2007; Calafat et al., 2008). 
2,4-D, a broad-leaf phenoxy herbicide synthesized from chloroacetic acid and DCP, is 
one of the most widely used herbicides in the world.  A synthetic auxin, 2,4-D disrupts protein 
synthesis and mitosis, causing abnormal growth patterns, and eventually tumours (Brook, 2008). 
In Alberta, 2,4-D accounted for almost 21.1% of pesticide sales in 2003, which translates into 763 
357.6 kg of the herbicide (Byrtus, 2007). Agricultural applications are the primary source of 2,4-
D release into the aquatic environment. Pesticide drift and runoff into groundwater and surface 
water is not uncommon. However, 2,4-D is a versatile pesticide and is used for a number of non-
agricultural applications, e.g. forestry, turf, aquatic weeds (Bus and Hammond, 2007).  
Once in the aquatic environment, both TCS and 2,4-D undergo degradation processes, 
producing several by-products. TCS undergoes photolysis and biological methylation to produce 
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DCP and M-TCS, respectively; 2,4-D produces DCP as one of its primary by-products. The 
detection rate of DCP in surface water is similar to those of its parent-compounds (House et al., 
1997). Due to its Kow value of 3.06, DCP is expected to absorb to particulate matter and 
sediment. A study on the bioconcentration potential of DCP by Kondo et al. (2005) concluded 
that the chemical displays a low to moderate potential for bioconcentration. M-TCS is more 
environmentally persistent than TCS, probably the result of its greater lipophilicity (Chu and 
Metcalfe, 2007; Coogan et al., 2007). In general, water-borne toxicants with a high molecular 
weight and a log Kow >5, such as M-TCS, have a tendency to partition into sediment, and are not 
commonly detected in surface water. 
The effects of TCS and 2,4-D on aquatic organisms have yet to be clearly delineated. In 
fish, amphibians, and mammals, TCS can act both androgenically (Foran et al., 2000; Kumar et 
al., 2008; 2009; Zorilla et al., 2009) and estrogenically (Ishibashi et al., 2004; Matsumara et al., 
2005; Raut and Angus, 2010). Additionally, several studies have demonstrated a potential for 
TCS to disrupt thyroid hormones (Veldhoen et al., 2006; Crofton et al., 2007; Paul et al., 2010). 
Similar to other pesticides, 2,4-D is suspected of disrupting thyroid homeostasis (Charles et al., 
1996; 
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                               (TCS)                                 (M-TCS)              (2,4-D) 
                  
               2,4-Dichlorophenol   Testosterone                           Estradiol 
(DCP)  
                          
   
                                     Thyroxine (T4)                                          Triidothyronine (T3) 
  
                    Cortisol                           Diethylstilbestrol    Bisphenol A  
                                        (DES)                                              (BPA)          
 
Figure 4.1. A structural comparison of TCS, M-TCS, 2,4-D, and DCP to endogenous hormones 
and known endocrine disruptors. 
 
Rawlings et al., 1998; Kobal et al., 2000; Raldua and Babin, 2009). The herbicide impedes 
normal sperm development (Amer and Aly, 2001), induces testicular changes in rats (Oakes et al., 
2002), increases androgen-dependent tissue weights (Kim et al., 2002), and exhibits androgenic 
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activity in vitro (Kim et al., 2005). Human evidence suggests that pesticide applicators exposed to 
2,4-D have poor quality sperm, increased levels of lutenizing hormone (LH) and are more likely 
to have children with birth defects (Garry et al., 2001). As for the estrogenic potential of 2,4-D, it 
would appear that the reagent grade 2,4-D does not display any estrogen-like activity, while the 
commercial grade herbicides, 2,4-D LV4 and 2,4-D amine, do (Lin and Garry, 2000). These 
results indicate that the inert ingredient(s) in the pesticide formulations were responsible for the 
estrogenic endocrine disruption, highlighting the importance of testing commercial pesticide 
formulations.  
In contrast to their parent-compounds, much less is known about the toxicity of the by-
products DCP and M-TCS. Results from studies by Jobling et al. (1995) and Kramer and Giesy 
(1999), failed to uncover any estrogenic effects. Weak estrogenic activity was detected by Jones 
et al. (1998), Nishihara et al. (2000), and Han et al. (2002). There is a burgeoning body of 
evidence to suggest that the endocrine disrupting potential of DCP stems from the chemical’s 
ability to act as an AR antagonist (Kim et al., 2002; 2005; Li et al., 2010). This makes DCP a 
potential threat to aquatic life, because the exposure of fish to anti-androgens is associated with 
the induction of intersex, decreased spermatogenesis, and lower sperm counts (Kiparissis et al., 
2003). As for the by-product M-TCS, to date, there have been no studies investigating its toxicity. 
Aquatic organisms are consistently exposed to complex mixtures of water-borne chemicals, 
released from a number of anthropogenic source(s). The chemicals and their by-products 
investigated in this study are commonly detected in surface waters and the concentrations tested 
are those actually measured in the environment.  They  all  contain phenolic moieties, and based 
on the findings that similar types of chemicals have endocrine disrupting effects, this study tested 
their potential to disrupt the synthesis of cortisol in a primary cell culture of rainbow trout  
adrenocortical cells.  
4.2 Materials and Methods 
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4.2.1 Chemicals 
Triclosan and M-TCS were obtained from Ciba Speciality Chemicals (Mississauga, 
Ontario). DCP was purchased from Sigma-Aldrich (Oakville, Ontario). 2,4-D ester was a 
generous gift from Dr. C. Sheedy at the Lethbridge Research Station. Multi-well (96-well) tissue 
culture plates were purchased from Fisher Scientific (Ottawa, Ontario). Tissue culture media, 
digestion enzymes, adrenocorticotropic hormone (Porcine adrenocorticotropin, ACTH 1-39, 
Sigma), bovine serum albumin, sodium bicarbonate, and lactate dehydrogenase (LDH) assay kits 
were purchased from Sigma-Aldrich Canada Ltd. (Oakville, Ontario). Cortisol radioimmunoassay 
kits were purchased from MP Biomedicals (#07-221102, Medicorp, Montréal, Canada). 
4.2.2 Fish 
Male and female juvenile rainbow trout (Oncorhynchus mykiss), body weight 
(162.1±14.0 g), were obtained from the Allison Creek Brood Trout Station (Crowsnest Pass, 
Alberta, Canada). Fish were maintained in a 1500-L flow-through tank at 13-150C, on a 
photoperiod of 12L: 12D. Fish were fed to satiation with commercial trout chow food. Prior to the 
commencement of tissue harvesting, fish were acclimated in the laboratory for a period of two 
weeks.  
4.2.3 Preparation of adrenocortical cell suspensions 
Animal use protocols were approved by the University of Lethbridge Animal Care 
Committee in accordance with national guidelines.  Fish were anesthetized with MS-222 (0.5 g l-1 
of water) buffered with sodium bicarbonate to a pH of 7. To remove a maximum of blood from 
the head kidneys, fish were bled with a 1-cc heparinized syringe from the caudal vein, then 
perfused through the heart with 30 ml of a 0.7% saline solution, as described previously (Leblond 
and Hontela, 1999). The head kidney was excised and the tissue placed in ice cold medium, 
0.02% Ethylenediaminetetraacetic acid disodium salt (EDTA) prepared in Dulbecco’s Phosphate-
Buffered Saline (DPBS) without Ca2+ and Mg2+. Prior to enzymatic digestion, tissue fragments 
were rinsed with ice cold 0.02% EDTA and minced into 1-mm3 pieces. Tissue was digested in a 
121 
 
shaker incubator for two hours at 210C. During digestion, medium was stirred with a transfer 
pipette every 10 min to facilitate tissue dispersion. 
Digested tissue was washed with 0.02% EDTA and filtered through nylon mesh (30 µm 
pore size). Undigested tissue was mechanically dispersed with a plastic transfer pipette and the 
cell suspension filtered. The pellet was re-suspended in 1 mL of 0.02% EDTA and the cell yield 
and viability determined with trypan blue. Following plating, cells were centrifuged for 5 min at 
200 g and re-suspended in MEM for a two hour incubation period prior to ACTH stimulation. 
The cell suspension was adjusted to a cell density of 75 X 106, and plated at a volume of 100 µL 
per well in a 96-well microplate. Cells were pre-incubated for 1 hour. 
4.2.4 Toxicant Exposure 
After the pre-incubation period, cells were centrifuged and MEM removed. Cells were 
exposed to the 100 µL of a single toxicant (TCS, 2,4-D, M-TCS or DCP) or a binary mixture of 
toxicants (TCS/2,4-D, DCP/2,4-D, or M-TCS/TCS) for one hour. Cells were centrifuged, and 
supernatant collected and stored at -81⁰C for an in vitro LDH based cell viability assay.  
4.2.5 Stimulation of Cortisol Secretion 
After centrifugation, cells were washed in a balanced salt solution to remove any toxicant 
residue, and were re-suspended in 100 µL of MEM containing 1 U ml-1 ACTH. Cells were 
incubated in an environmental chamber for 1 hour at 150C. Following the one-hour stimulation, 
cells were centrifuged for 5 min at 200 g and the supernatant collected and frozen at -800C. 
Cortisol concentration (ng ml-1) was measured in 75 µL of the supernatant with the 
radioimmunoassay, as described previously (Leblond and Hontela, 1999).   
The LDH assay was used to measure cell viability. LDH release into the medium is an 
indicator of a loss of membrane integrity and cell death. Following toxicant exposure, supernatant 
was collected and stored at -80⁰C until analysis. Samples were pipetted at two volumes, 5 and 10 
µL, into a 96-well microplate and the Lactate Dehydrogenase Mixture added to each well. Plates 
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were incubated in the dark, at room temperature, for 20 min. The reaction was terminated by the 
addition of 1N HCl. The absorbance was measured in a microplate reader at two wave-lengths, 
490 and 690 nm. Cell viability was expressed as a percentage of the lysis treatment, with 
maximum LDH released in the medium used as 100% cell death. 
4.2.6 Data Analysis 
Statistical analyses were performed using JMP Version 8 and data expressed as mean ± 
standard error. All raw cortisol data (ng ml-1) from the cortisol radioimmunoassay was converted 
to a percentage of control (cells not exposed to the toxicant), with cells from one fish representing 
one replicate (n=1). For the single toxicants, a one-way Analysis of variance (ANOVA) was 
performed, while a two-way ANOVA was used for the binary mixture experiments. Dunnett’s 
test was used to compare the effect of single toxicant treatments to the control. Tukey’s HSD was 
used to analyze the binary mixture data to determine how the addition of the second toxicant 
affected the toxicity of the first chemical. A probability level of p<0.05 was considered 
statistically significant. 
4.3 RESULTS 
 
4.3.1 Single toxicant exposure  
4.3.1.1 Cortisol secretion 
The endocrine disrupting potential of the toxicants TCS, M-TCS, 2,4-D, and DCP was 
determined in vitro using a rainbow trout adrenocortical cell bioassay. The cells were exposed to 
each toxicant at concentration of 0.01-110 µM for 60 min.  The functional integrity of the cells 
was assessed by the capacity to respond to ACTH and secrete cortisol, and cell viability was 
estimated by LDH release.  The dose response curves for each single toxicant are shown in Figure 
4.2. The half maximal effective concentrations (EC50) for the single toxicants are indicated in 
Figure 4.2. All four single toxicants significantly inhibited cortisol secretion in rainbow trout 
adrenocortical cells (p < 0.05) (Figure 4.2.). The maximum inhibiting potencies of the individual 
chemicals are as follows; 67% (2,4-D), 65% (DCP),  42% (TCS), 32% (M-TCS),), with EC50 
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ranked as follows:  2,4-D, DCP, TCS, M-TCS. Furthermore, at low, environmentally relevant 
concentrations of TCS (0.01µM) and 2,4-D (0.01-1µM), corticosteroid producing cells were 
unable to produce normal amounts of cortisol, following exposure to ACTH.  
Comparisons of calculated EC50 values for the parent-compounds, TCS and 2,4-D, and 
their by-products, indicate that the parent compounds are more potent inhibitors of cortisol 
secretion than their by-products, M-TCS and DCP, respectively. Despite differing toxicities, the 
parent compounds and their by-products exhibited similarly shaped dose-response curves, as 
illustrated in Figure 4.2., suggesting the parent compounds and their by-products display related 
chemical behaviour. Howewer, it is important to acknowledge the possibility that the marked 
decrease in corticosteroid production at the maximum concentration of 2,4-D and DCP tested 
(100µM), could in part be due to the interference of these chemicals with the cortisol 
radioimmunoassay. Further testing is required to address this limitation. 
4.3.1.2 Cell Viability Assay 
The cell lysing activity of the toxicants was generally quite low, rising slightly with 
increasing toxicant concentration (Figure 4.2.). For the single toxicant experiments, there was no 
difference in cell viability between the toxicant treatments and the control for MTCS and DCP (p 
< 0.05).  In the TCS experiment, the 10 µM treatment was significantly different from the control, 
resulting in 8% cell death. The exposure of cells to 44 µM of 2,4-D resulted in 6% cell death, a 
rate which was significantly different from the control, although far too low to explain the 
inhibition of cortisol secretion. 
4.3.2 Exposure to binary mixtures 
4.3.2.1 Cortisol secretion 
The endocrine disrupting potential of binary mixtures of the parent compounds and their 
respective by-products is shown in Figure 4.3. Maximum inhibiting potencies of a binary mixture 
of the two parent-compounds, and each parent compound with their respective by-product ranged 
from 75% (TCS/MTCS), 56% (2,4-D/DCP), to 48% (2,4-D/TCS) (Figure 4.3.). In all three of the 
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binary mixture experiments, the addition of the second toxicant failed to alter the inhibiting 
potency of the EC50 of 2,4-D or TCS (p < 0.05). Based on these results, the binary mixtures tested 
did not additively or synergistically decrease cortisol secretion. A limitation of the binary mixture 
experiment is that the concentration of 2,4-D and TCS tested may have been too high to detect a 
change in toxicity, with the addition of the second chemical. Future studies should test a wider 
range of toxicant concentrations to ensure, that if present, additive effects would be detected. 
4.3.2.1 Cell Viability Assay 
Cell viability in the binary mixture experiments did not decrease with the addition of a 
second toxicant (p < 0.05), as shown in Figure 4.3. In both the 2,4-D/TCS and 2,4-D/DCP 
experiments, there was no difference in cell mortality between the control and toxicant exposed 
groups. In the TCS/MTCS experiment, only TCS alone (110 µM) and TCS with 10 µM M-TCS 
were significantly different from the control. Cell death in the binary mixture experiments did not 
exceed 16%, and cannot solely account for the observed decreases in cortisol secretion. 
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Figure 4.2. Cortisol secretion and cell mortality (% of control) of rainbow trout adrenocortical 
cells exposed to  a) TCS; F(5, 110)=6.49, p=0.0001, b) 2,4-D; F(6, 74)=8.28, p=0.0001, c) M-
TCS, F(4, 39)=4.52, p=0.0048 and d) DCP; F(4,38)=6.33, p= 0006, in vitro for 60 min. Data is 
expressed as a % (mean± standard error) of control (cells receiving no toxicant;  
* indicates a significant difference, p< 0.05. 
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Figure 4.3. Cortisol secretion and cell mortality (% of control) of rainbow trout adrenocortical cells exposed to binary mixtures of 
toxicants  a) TCS and 2,4-D (44µM); F(5, 47)=10.25, p=0.0001, b) DCP and 2,4-D (44µM); F(5, 35)=6.79, p=0.0002, c) MTCS and TCS 
(110µM); F(5, 65)=40.11, p=0.0001 in vitro for 60 min. Data is expressed as a % (mean± standard error) of control (cells receiving no 
toxicant; * indicates a significant difference, p< 0.05. 
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4. 4   DISCUSSION 
 
Endocrine disrupting compounds alter the production, release, distribution, and/or 
elimination of endogenous hormones. Pathways of endocrine disruptioninclude interactions with 
membrane receptors, the aryl hydrocarbon receptor, enzymes involved in hormone synthesis, and 
the influence of these compounds on nuclear hormone receptors (le Maire et al., 2010). The 
objective of this study was to simultaneously assess the capacity of individual and binary 
mixtures of two commonly detected water-borne toxicants, TCS and 2,4-D, and their by-products, 
M-TCS and DCP, to disrupt corticosteroid production in a primary cell culture of rainbow trout 
adrenocortical cells. It was hypothesized, based on evidence from studies investigating 
chemically-induced disruption of hormonal systems (Colburn, 2004; Devillers et al., 2006; 
Kumar et al., 2008) that the exposure to these chemicals would inhibit cortisol secretion. In 
comparison to chemicals that alter estrogen and androgen synthesis and action, much less is 
known about non-sex steroid endocrine disruption. There is a substantial need to determine the 
extent to which water-borne toxicants are capable of disrupting the production of cortisol, 
because this hormone plays a pivotal role in the regulation of an animal’s physiology (Mommsen 
et al., 1999). The cell model used in this study is an excellent screening tool for the assessment of 
the endocrine disrupting activity of chemicals typically detected in surface water, allowing for 
comparative assessments of single toxicants, binary mixtures, and complex mixtures. Once a 
potential for disruption of the corticosteroid pathways has been established, mechanistic studies 
can be conducted to elucidate the mechanism(s) of altered steroid hormone production. 
A cell culture of fish adrenocortical cells was selected for this study even though the 
H295 cell line, a human adrenocortical carcinoma cell line, is a well-accepted in vitro model for 
assessing endocrine disruption to the HPA axis (Hecker and Geisy, 2008). This in vitro model has 
been used successfully in studies that profiled the cortisol disrupting effects of a number of 
different water-borne toxicants (Hontela and Vijayan, 2009; Miller and Hontela, 2011), including 
pesticides such as atrazine, mancozeb, diazinon, and endosulfan (Bisson and Hontela, 2002). In 
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the present study, all four chemicals alone and in binary mixtures, inhibited rainbow trout 
adrenocortical cells from synthesizing normal amounts of cortisol in response to the ACTH 
challenge test.  
To determine whether the inhibition of cortisol secretion was primarily the result of 
endocrine disruption, it was necessary to rule out the possibility of cell death or cytotoxicity. In 
all four single toxicant exposures, cell death was never greater than 10%.  In cells receiving the 
highest concentration of toxicant, cortisol secretion decreased by 30-60%, and could not be 
accounted for by cell death alone (see Figure 4.2.). The cytoxicity of binary mixtures of TCS, 2,4-
D, and their by-products exhibited similar results to the single toxicant experiments, with cell 
mortality remaining low, while cortisol secretion was inhibited by up to 85% (see Figure 4.3.). 
Based on the results from the cell viability assay, it was concluded that the decrease in the ability 
of these cells to respond to ACTH was due primarily to endocrine disruption, not cell death.  
 A limitation of many in vitro based endocrine disruption screening assays is that the 
concentration of toxicants typically tested is far greater than what is measured in environmental 
matrices. As a result, the environmental relevance of these studies often comes into question. In 
this study, environmentally relevant concentrations of TCS (0.01 µM or 2.89 µg l-1 ) and 2,4-D 
(0.1 µM  or 22.1 µg l-1) were used and produced considerable disruption of cortisol secretion.  
These concentrations are within the range of those reported in surface waters,  specifically 2.3 µg 
l-1 for TCS (Kolpin et al., 2002; Morrall et al., 2004), and 439 µg l-1  for 2,4-D  (Anderson, 2005; 
Gibson et al., 2007; Kuster et al., 2008).  
The chemicals screened for endocrine disruption in this study all contain a phenolic 
moiety, a characteristic which has become a hallmark for endocrine disruption (Devillers et al., 
2006). It was hypothesized that based on the structural similarities of these chemicals to known 
endocrine disrupters, the chemicals tested would display some degree of hormone perturbation. 
Corticosteroid production is stimulated by ACTH, responsible for increases in cholesterol uptake 
into the steroidogenic cells, facilitating the movement of cholesterol into the mitochondria, and 
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activating the steroidogenic enzymes, including steroid acute regulatory protein (StAR) and the 
cytochrome P-450-mediated cholesterol side-chain cleavage enzyme (P450scc). Endocrine 
disrupting chemicals can influence any one, or more, of these key steps, thereby inhibiting the 
production of corticosteroids. 
Based on what is currently known of endocrine disrupting compounds, alterations in 
corticosteroid production caused by TCS, M-TCS, 2,4-D, and DCP may occur as the result of a 
decrease in cholesterol production, decrease in the expression of StAR protein, or reduced 
expression of a number of key steroidogenic enzymes (Odermatt et al., 2006). Previous studies 
have shown that these toxicants, with the exception of M-TCS, affect thyroid hormones, the 
estrogen receptor, and/or the androgen receptor (Han et al., 2002; Raldua and Babin, 2009; Li et 
al., 2010; see review by Dann and Hontela, 2011). Although many of the studies on endocrine 
disruption have focused on StAR protein (Murugesan et al., 2007; Kitamura et al., 2005) and 
P450scc, other enzymes such as 17α-hydroxylase, 3β-hydroxysteroid dehydrogenase (3β-HSD), 
and 21-and 11β-hydroxylases (CYP11β) (Miller, 1988; Lyssimachou and Arukwe, 2007) must 
not be overlooked. The synthesis of StAR protein and P450scc is governed by the acute release of 
tropic hormones such as ACTH or luteinizing hormone (LH), and occurs rapidly in all 
steroidogenic tissue (Arukwe, 2008).  
In steroid producing cells, StAR protein funnels cholesterol from the outer mitochondrial 
membrane to the inner membrane for conversion to pregnenolone. The movement of cholesterol 
across mitochondrial membranes by StAR protein is widely considered to be the rate limiting step 
of steroidogenesis (Stocco, 2001). Two extensively used pesticides, lindane and dimethoate, 
block the expression of StAR protein, resulting in decreased levels of serum testosterone (Walsh 
et al., 2000; Walsh and Stocco, 2000). Other chemicals that specifically target StAR protein 
include: econazole (Walsh et al., 2000), glyphosate (Walsh et al., 2000), carbachol (Janossy et al., 
2001), ethanol (Khisti et al., 2003), arsenite (Zhao et al., 2005), anisomycin (Zhao et al., 2005), 
bromocriptine (Kan et al., 2003), and spironolactone (Hischerova et al., 2004). More recently, a 
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study by Kumar et al. (2009) reported that TCS decreased transcription and translation of StAR  
and P450scc proteins in rat testes. 
This finding is significant, as these proteins play a critical role in the steroidogenic 
cascade, and appear to be more sensitive to the toxic insults of endocrine disrupting compounds 
than enzymes further downstream from P450scc (Walsh et al., 2000). Geslin and Auperin (2004) 
have provided a clear link between cortisol genesis and the upregulation of StAR protein and 
P450scc in the head kidney of rainbow trout. Futhermore, in juvenile salmon exposed to pp-DDE 
and EE2, changes in the expression of StAR protein and P450scc in interrenal tissue were 
observed.  
It is clear that the inhibition of several key enzymes involved in steroid hormone 
production can account for a substantial degree of hormone disruption observed both in vitro and 
in vivo. In addition to the inhibition of StAR protein and cytochrome P450scc enzyme, inhibition 
of 3β-hydroxysteroid dehydrogenase (3β-HSD) (Blaha et al., 2006), and 17β-hydroxysteroid 
dehydrogenase (17β-HSD) (Akingbemi et al., 2001; Xu et al., 2006) by endocrine disruptors have 
been well documented. Although the mechanisms of corticosteroid disruption by TCS, 2,4D and 
their by-products were not within the scope of the current study, future work should focus on the 
impacts of these chemicals on the expression and activity of key steroidogenic  enzymes. 
In conclusion, the commonly detected water-borne toxicants, TCS, 2,4-D, and their by-
products, M-TCS and DCP, act, at environmentally relevant concentrations,  as endocrine 
disruptors in primary cell cultures of rainbow trout interrenal cells. The endocrine disrupting 
potency, expressed as EC50 for inhibition of cortisol secretion, of the tested chemicals was ranked 
as 2,4-D > DCP > TCS > M-TCS, indicating that the parent compounds are more potent than the 
by-products.  There was no evidence for interactions between TCS and 2,4D, a mixture often 
detected in the aquatic environments.  Endocrine toxicology relating to the adrenal gland is of 
paramount importance, because this gland is the most common target for endocrine disrupting 
compounds in vivo, yet has not received its fair share of attention in the literature. Future studies 
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are needed to determine at which level(s) of the hypothalamo-pituitary-interrenal axis these 
endocrine disrupting compounds are acting on, and the molecular and cellular mechanisms of 
their toxicity.  
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CHAPTER 5. GENERAL CONCLUSIONS 
Corticosteroids play a pivotal role in many physiological processes, including immunity, 
cognitive function, growth, metabolism, reproduction, mineral balance, and blood pressure. The 
ubiquitous presence of anthropogenic chemicals in surface water is a widespread problem, as 
many of these chemicals are capable of altering the normal biological functioning of endogenous 
hormones. Endocrine disrupting compounds can arise from numerous sources and may fall under 
the following classes of chemicals: pesticides, industrial chemicals, pharmaceuticals, personal 
care products, and/or heavy metals. The endocrine disrupting activity of two commonly detected 
water-borne toxicants, a personal care product, triclosan (TCS), a pesticide, 
dichlorophenoxyacetic acid (2,4-D), and their by-products, methyl-triclosan (M-TCS) and 
dichlorophenol (DCP), on the adrenocortical cells of rainbow trout was investigated. Although it 
has been shown in earlier studies that TCS, 2,4-D, and DCP exhibit a potential for endocrine 
disruption, it was unknown if these chemicals are capable of affecting corticosteroid balance. In 
this study, all four chemicals showed significant inhibitory effects on corticosteroid genesis, 
although there were considerable differences in their activity. The chemical that exhibited the 
highest endocrine-disrupting potency was 2,4-D, followed by triclosan (TCS), dichlorophenol 
(DCP), and methyl-triclosan (M-TCS). Both parent-compounds proved to be more toxic than 
their degradation products. More research with suitable test systems is needed to determine the 
mechanism(s) of action of these corticosteroid disruptors and the health risk that they may 
present. 
 
 
 
 
 
 
